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Medulloblastomas are tumours of cerebellar origin and are thought to arise from the 
malignant transformation of progenitor cells in the developing cerebellum. A number 
of developmental signalling pathways are required for the precise cell specification, 
proliferation, migration and differentiation involved in forming the mature 
cerebellum and it is the dysregulation of these processes that can lead to the eventual 
formation of a tumour. Genes encoding components of the canonical Wnt/!-catenin 
signaling pathway are mutated in around 15% of medulloblastomas and germline 
mutations that activate this pathway are known to predispose to medulloblastoma. 
Despite this, the contribution of Wnt/!-catenin signaling to normal cerebellum 
development is not yet well understood and the developmental origins of 
medulloblastoma arising from activation of this pathway are only beginning to be 
revealed. Therefore, the aims of this thesis were to characterise the spatio-temporal 
nature of Wnt/!-catenin signalling during cerebellum development and to investigate 
its function, with the broad goal of informing our understanding of how 
medulloblastoma arises from oncogenic activation of Wnt/!-catenin signalling.  
 
To address the first aim I utilised a LacZ expressing Wnt/!-catenin signalling 
reporter mouse to characterize the spatio-temporal pattern of Wnt/!-catenin pathway 
activation during cerebellum development. Analysis of LacZ reporter expression 
revealed a pattern of transient Wnt/!-catenin activity in discrete cell populations 
throughout cerebellum development. I found that Wnt/!-catenin activity is present 
during the early specification of granule cells at the cerebellar rhombic lip but not 
during the expansion of this cell population at later stages. During perinatal 
development Wnt/!-catenin activity shifts to the cerebellar ventricular zone, a known 
germinal centre for GABAergic interneurons and glia, and was observed in cells 
radiating out from this region. By early postnatal development the expression of the 
Wnt/!-catenin reporter became progressively restricted to the developing Bergmann 





To investigate the function of Wnt/!-catenin in these cell lineages and how its 
dysregulation could contribute to medulloblastoma, I used a combination of ex vivo 
organotypic culture, in utero electroporation and tissue-specific gene targeting to 
manipulate components of the pathway. Culturing slices of E18.5 cerebellum in the 
presence of small molecule activators of the Wnt/!-catenin pathway revealed a 
reduction in the expression of glial markers Sox9 and GFAP. In addition, interneuron 
lineage marker Pax2 was also reduced, supporting the conclusion that dysregulation 
of Wnt/!-catenin signalling affects the generation of cell lineages from the 
ventricular zone. To investigate this hypothesis further, I constitutively activated the 
Wnt/!-catenin signalling pathway in the developing cerebellum using Cre-Lox gene 
targeting to knock out Apc, a negative regulator of the pathway, in ventricular zone 
derived lineages. Cre-induced recombination of Apc resulted in nuclear accumulation 
of !-catenin, a sign that the pathway had become ectopically activated. Furthermore, 
a reduction in the expression of Sox9 and Pax2 was also observed in these mutant 
cells. From these data, I conclude a potential role for Wnt/!-catenin signaling in the 
regulation of glial/interneuron progenitors. 
 
Combined, these data support a model where Wnt/!-catenin signalling could perform 
multiple functions in specification of the granule lineage, regulation of 
glial/interneuron progenitors and in glial differentiation/maturation. Importantly, 
dysregulation of progenitor self-renewal and differentiation is widely acknowledged 
to promote tumourigenesis. Thus, the data in this thesis support a potential 
mechanism for the development of medulloblastoma from the dysregulation of 
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Developmental signalling pathways regulate the myriad interacting processes 
required for the generation and maintenance of complex body structures from a small 
number of progenitor cells. The processes of cell specification, proliferation, 
migration, differentiation and apoptosis are all required throughout development and 
are controlled by a number of different developmental signalling pathways. 
Dysregulation of these processes can endow a cell lineage with a survival advantage 
such that it can, over time, accumulate the additional mutations required for a tumour 
to develop. The Wnt/!-catenin signalling pathway is a well-established regulator of 
various developmental processes and its oncogenic activation has been identified in a 
number of different cancers. Medulloblastoma, an aggressive tumour that forms in 
the cerebellum, is one such cancer that has been associated with activated Wnt/!-
catenin signalling. This suggests that these tumours could arise as a result of Wnt/!-
catenin signalling becoming dysregulated during development. However, the 
function of this pathway in cerebellum development is not yet fully understood. 
 
1.1 Anatomy of the cerebellum 
The cerebellum is a brain region primarily responsible for fine coordination of motor 
control. To achieve this, the cerebellum acts as a site for integration and modulation 
of electrical impulses from a variety of different central and peripheral nervous 
system regions.  This task is carried out through the internal circuitry of a 
surprisingly small number of interconnected inhibitory and excitatory neuronal cell 
types. The identity of these cells and their anatomical location has been well 
described over the course of the last century (Altman and Bayer, 1997).  
1.1.1 Gross anatomy of the cerebellum 
Formed from tissue of the metencephalon (the most anterior region of the hindbrain 
– HB), the cerebellum sits above the fourth ventricle and HB immediately posterior 




along the medial-lateral axis into two symmetrical lateral hemispheres and a distinct 
medial portion called the vermis. These regions can be readily distinguished by the 
anterior-posterior foliation pattern. This was described by the comparative anatomist 
Olof Larsell, who identified that the vermis of all mammals studied can be divided 
into 10 key lobes (designated as roman numerals I-X, Fig 1.1C) with the more 
complex foliation observed in species like humans and other apes resulting from 
subdivisions of these 10 lobes (Larsell, 1970). This conservation of basic structure 
suggests the mechanisms responsible for development of the cerebellum are 
conserved between species.  
1.1.2 Cellular composition of the cerebellum 
Within each lobe the cerebellum displays a surprisingly homogenous laminated 
histology comprised of three neuronal layers, each of which can be characterised by 
their component neurons (Fig 1.1D). At the centre of the cerebellar cortex sits the 
white matter (WM), which consists of myelinated axonal tracts surrounding three 
symmetrical clusters of deep cerebellar nuclei (DCN). The DCN are composed of 
two key neuronal lineages: the inhibitory "-Aminobutyric acid (GABA)ergic 
inhibitory neurons, and glutamatergic excitatory neurons. The internal granule layer 
(IGL) is the first neuronal layer and borders the white matter core of the cerebellum. 
This layer is densely populated by granule cells (GCs) – the most abundant type of 
neuron in the brain. In addition, a considerably smaller population of interneurons 
resides within the IGL – consisting of GABAergic Golgi and Lugaro interneuons, as 
well as the excitatory glutamatergic unipolar brush cells (UBCs) and velate 
protoplasmic astrocytes. Superior to the IGL sits the Purkinje cell (PC) layer (PCL), 
which contains the somata of PCs arranged in a monolayer across the surface of the 
IGL. Wedged between the sizable PCs sit a unique class of radial glial cell called the 
Bergmann glia. Both PCs and Bergmann glia extend their processes from the PCL 
into the outermost layer of the cerebellum – the molecular layer (ML). The main 
components of this cell sparse layer are the characteristic arboreous PC dendrites and 
parallel GC axon fibres. In addition, the Bergmann glial radial processes span the 
entire width of the ML and terminate in end feet at the pial surface. Sparsely 




interneurons, basket and stellate cells (Fig 1.1D). This arrangement of excitatory and 
inhibitory neurons and the microcircuitry between them allows for the modulation of 
signals entering the cerebellum.  
1.1.3 Functional circuitry within the cerebellum 
The cerebellum receives input signals from most regions of the brain as well as the 
spinal cord via two major afferents, mossy fibres and climbing fibres, which 
terminate within the IGL and ML respectively (Fig. 1.2). Within the IGL, mossy 
fibres provide input to the GCs through a structure called the glomerulus, which 
consists of mossy fibre axon terminals, Golgi interneuron axon terminals and GC 
dendritic boutons sheathed in velate astrocyte fibres (Chan-Palay and Palay, 1972; 
Itoh, 1984). The climbing fibres in contrast transcend the IGL and terminate at 
multiple points within a single PC dendritic tree. After GC activation by mossy fibres 
(modulated by the inhibitory Golgi cells), the signal is transferred through their 
axons, which extend from the GC into the ML and bifurcate into parallel fibres that 
run along the medial-lateral axis and synapse with PC dendrites across its path. Thus, 
a single mossy fibre input can influence hundreds of different PCs (Altman and 
Bayer, 1997). An additional level of signal complexity is offered by the extent of PC 
dendrite arborisation within the ML such that a single PC can contact as many as 
200,000 GC axons (Tyrrell and Willshaw, 1992). This excitatory input to the PCs 
from the mossy fibres via GCs is modulated by the additional excitatory input from 
climbing fibres that synapse directly with the PC dendrite shaft and inhibitory inputs 
from the two ML interneuron populations. Stellate cell axons synapse onto PC 
dendrites, while basket cell axons synapse with the PC somata. Thus, all cerebellar 
inputs and microciruits converge on the PCs (Fig. 1.2), which integrate them into a 
single output that is carried via the PC axons to the DCN and onwards to the spine, 
brain stem and thalamus.  
Figure 1.1 - Anatomy of the adult mouse cerebellum.
The adult mouse cerebellum is located betwen the MB and HB regions (A-B). The 
vermis of the cerebellum can be divided into 10 lobes (I-X), each with a similar 
laminated structure (C). The cellular composition of the cerebellum consists of a 
WM core, surrounded by the IGL, PCL and then ML (D). (Brain regions: OB = 
olfactory bulb, Cx = cortex, Th = thalamus, MB = midbrain, Cb = cerebellum, HB = 
hindbrain. Cell types: DCN = deep cerebellar nuclei, A = astrocyte, B = basket cell, 
BG = Bergmann glia, G = Golgi cell, PC = Purkinje cells, S = Stellate cells. Cell 
layers: ML = molecular layer, PCL = Purkinje cell layer, IGL = internal granule 


















































Figure 1.2 - Cerebellar circuitry.
Cerebellar input signals are brought via the mossy fibre or climbing fibre afferents. 
Mossy fibres terminate in the glomerulus, which contains the GC dendrite terminals 
and inhibitory Golgi cell axon terminals. This signal is transfered through the parallel 
axon fibres to many PC dendrites. PCs also receive input from the climbing fibre 
afferents. These two inputs converge on the PC and exit the cerebellum via the DCN. 
Inhibitory modulation is provided to the GCs by Golgi cells and to PCs by basket 

















1.2 Development of the cerebellum 
The structural complexity and cellular heterogeneity of the adult cerebellum forms as 
the result of a tightly regulated programme of cell specification, proliferation, 
differentiation, migration and maturation beginning in embryogenesis and continuing 
until adulthood. These processes occur under the control of several interacting 
developmental signalling pathways, with myriad downstream transcription factors 
and cellular effectors. Below, the general cellular processes involved in cerebellum 
development is described and several of the key signalling molecules known to be 
involved are highlighted.  
1.2.1 Tissue specification and early organisation 
Unlike other brain regions, the cerebellar primordium is specified during the later 
stages of embryogenesis (approximately embryonic day (E) 9.5 in mouse). At this 
time point the main compartments of the central nervous system (CNS) can be 
morphologically distinguished from anterior to posterior: the telencephalon and 
diencephalon (forebrain), mesencephalon (midbrain), and the metencephalon and 
myelencephalon (hindbrain). Between the mesencephalon and metencephalon a 
morphological boundary develops, called the midbrain-hindbrain junction (MHJ), 
with the metencephalic tissue immediately posterior to this giving rise to the 
cerebellum (Zervas et al., 2004). The initial specification and patterning of the 
cerebellar anlage occurs under the control of signals from an organising centre at the 
MHJ called the isthmic organiser (IsO) (Brand et al., 1996; Martínez et al., 1995; 
Martinez et al., 1991).  
 
This signalling centre forms by E7.5 at the expression boundary of two opposing 
homeobox transcription factors: Otx2 (expressed in the mesencephalon) and Gbx2 
(expressed in the metencephalon and myelencephalon) (Simeone, 2000). A cascade 
of genetic interactions then follows, culminating in the combined expression of 
secreted signalling molecules FGF8 and Wnt1, and the transcription factor En1 that, 
by E9.5, demarcates the IsO gene expression signature: Wnt1 and Otx2 expressed to 




boundary (Fig 1.3A) (Crossley and Martin, 1995; Davis and Joyner, 1988; Simeone, 
2000). The importance of Wnt1 expression as an organising molecule is 
demonstrated by knockout mouse models, which display severe MB-HB (MHB) 
developmental abnormalities (McMahon and Bradley, 1990; Thomas and Capecchi, 
1990). The transcriptional link between Wnt1 and En1 was demonstrated by a study 
that showed firstly Wnt1 expression is required for En1 expression and secondly that 
the phenotype of the Wnt1 knockout mouse can be rescued by addition of En1 
(Danielian and McMahon, 1996). Furthermore, it has also been shown that En1 
expression is required for the maintenance (but not initiation) of Fgf8 expression 
(Liu and Joyner, 2001) and that the expression of Wnt1 is in turn maintained by Fgf8 
expression (Adams et al., 2000).  
 
Thus, a picture begins to emerge of a complex and interconnected gene network 
within the IsO whereby the active genes feedback on each other (Fig 1.3B). 
However, while all these genes (and their downstream partners) are required for IsO 
function, the key effector molecule for patterning of the surrounding regions is FGF8 
(Crossley and Martin, 1995; Crossley et al., 1996; Martinez et al., 1999; Meyers et 
al., 1998; Reifers et al., 1998). These studies highlighted the IsO as a key Fgf8 
expression domain and demonstrated that loss of FGF8 results in a failure of the 
surrounding MB and cerebellar tissue to develop while ectopic expression of FGF8 
in other brain regions causes the ectopic development of MB/cerebellar structures. 
From these early inductive cues provided by the IsO, the cerebellar primordium is 
established and the cell lineages are specified.  
Figure 1.3 - Specification of the isthmic organiser.
The isthmic organiser is defined by a gene expression boundary at the midbrain 
hindbrain junction (MHJ) between Otx2 in the mesencephalon (Mes) and Gbx2 in the 
metencephalon (Met). This then initiates the expression of Fgf8 to the posterior, 
Wnt1 to the anterior and En1 across the boundary (A). All five genes act in a 
















1.2.2 Cell specification within the ventricular zone and white matter 
Cell birth in the cerebellar primordium begins at the ventricular zone (VZ), a layer of 
specialised radial glia lining the dorsal aspect of the fourth ventricle (Fig 1.4). 
Marked by the expression of known radial glial markers GLAST, Nestin, GFAP and 
BLBP (Casper and McCarthy, 2006; Dahlstrand et al., 1995; Hegedus et al., 2007), 
The VZ is one of the primary germinal zones for the cerebellum and produces the 
entire complement of cerebellar GABAergic and glial cell lineages. This begins at 
E10.5 with the birth of GABAergic DCN neurons (Hoshino et al., 2005; Sudarov et 
al., 2011), which migrate into a cell-sparse cluster called the nuclear transitory zone 
(NTZ) towards the anterior of the early cerebellum. PCs are then born in sequential 
waves from E10.5 until E13.5 (Altman and Bayer, 1997; Hashimoto and Mikoshiba, 
2003; Miale and Sidman, 1961; Sudarov et al., 2011). Importantly, these two 
populations have been recently shown to develop from discrete and non-overlapping 
domains of the VZ neuroepithelium (Mizuhara et al., 2010), supporting the 
conclusion that the cells making up the VZ are developmentally heterogenous. After 
becoming post-mitotic, PCs initiate expression of the calcium binding protein 
Calbindin (Andressen et al., 1993) and migrate radially towards the pial surface of 
the cerebellum along the glial scaffold provided by the VZ radial glia (Edwards et 
al., 1990). Following the birth of the PC population, the VZ generates a population of 
Bergmann glia progenitors which have been birth dated to within 24 hours after PCs 
and have been shown to closely follow their radial migration path through the early 
cerebellum (Yamada et al., 2000; Yamada and Watanabe, 2002; Yuasa, 1996). 
Slightly overlapping with the tail end of PC and Bergmann glia cell birth, VZ radial 
glia then begin to produce the remainder of the inhibitory GABAergic lineage 
(stellate, basket, Golgi and Lugaro interneurons) (Hoshino et al., 2005) and the 
remaining glia. However, the precise temporal development of these different cell 
types has only recently been resolved. 
Figure 1.4 - Development of cell lineages within the cerebellum.
The germinal centres in the developing cerebellum can be defined by the cell 
lineages they produce: glutamatergic neurons at the URL and GABAergic 
neurons/glia at the VZ. By E12.5 (A) the cerebellum has begun to generate 
glutamatergic DCN neurons at the URL which migrate in the SPS to the NTZ. 
GABAergic DCN neurons and PCs are born at the VZ. By E14.5 (B) the URL has 
switched to the production of GPCs, which migrate over the pial surface to form the 
EGL. The VZ has produced the Bergmann glia progenitors and begins generating the 
progenitors that give rise to interneurons. By E18.5 (C) cerebellum lamination and 
foliation becomes apparent as the GPCs within the EGL begin to terminally 
differentiate and migrate into the IGL. PCs and Bergmann glia form a monolayer of 
cells during this process. The interneurons and remaining glia are then born from 
VZ-derived progenitors within the WM (NTZ = nuclear transitory zone, SPS = sub 
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BrdU birth-dating experiments have revealed that the Golgi, basket and stellate 
interneurons are born in an inside-out manner (Leto et al., 2009), with Golgi cells 
becoming post-mitotic first, followed by basket and then stellate cells – a process 
that is not complete until approximately postnatal day (P)15. The development of 
this cell lineage can be followed through the expression of Pax2, which is expressed 
during the final mitosis and persists until the cells become terminally differentiated 
(Maricich and Herrup, 1999; Weisheit et al., 2006). These studies identified 
expression of Pax2 in cells adjacent to, but not physically present in, the VZ from 
E12.5 (likely the developing DCN interneurons) and were able to trace the 
expression of Pax2 through to P15 from which point expression begins to diminish to 
undetectable levels by P30. This expression pattern followed that predicted by 
sequential interneuron development identified by birth dating studies (Leto et al., 
2009) with expression spreading and then regressing from inside out.  
 
Interestingly, additional evidence suggests that the generation of interneurons does 
not occur directly from the VZ but from progenitors that delaminate and continue to 
proliferate in the WM (Leto et al., 2006; Milosevic and Goldman, 2002; Milosevic 
and Goldman, 2004; Zhang and Goldman, 1996). More recent findings have shed 
new light onto the precise temporal nature of GABAergic interneuron development. 
Sudarov et al. (2011) used a tamoxifen inducible Cre-recombinase allele driven by 
the Ascl1 promoter to carry out an elegant series of genetic fate mapping experiments 
tracing the generation of cell lineages from the VZ during development. Ascl1 has 
previously been demonstrated as essential for the generation of the full complement 
of cerebellar interneurons (Grimaldi et al., 2009). In this study, Sudarov et al. found 
that all VZ derived neurons and glia arise from Ascl1 expressing progenitors and that 
the differentiation of all GABAergic interneurons occurs sequentially, first from 
Ascl1 expressing VZ radial glia and then in an inside out pattern from Ascl1 
expressing WM progenitors. It was further revealed that the generation of astrocytes, 
after the early birth of the Bergmann glia population, also occurs from the Ascl1 
expressing progenitor population. This has recently been shown to occur in response 





However, the neuronal/glial potency of these WM progenitors remains unclear. The 
findings by Zhang and Goldman (1996) demonstrated that WM progenitors labelled 
in early postnatal rats gave rise to Golgi, basket and stellate interneurons as well as 
Bergmann glia and velate astrocytes but it was not clear whether these arose from a 
single or multiple progenitor populations. Consistent with the latter, Milosevic and 
Goldman (2002) revealed that the WM progenitor population can be separated into 
distinct and non-overlapping glial or neuronal lineages. However, a subsequent 
publication (Milosevic and Goldman, 2004) revealed that a limited number of 
isolated progenitors from the early postnatal WM were able to generate heterogenous 
neuronal and glial cell populations in vitro. Furthermore, they demonstrated that 
progenitors isolated from the VZ generated heterogenous populations at a greater 
frequency, supporting a model where progenitors delaminating from the VZ lose 
their potential early during migration through the WM and become progressively 
restricted to the glial or neuronal lineages. This conclusion is supported by recent 
evidence that GFAP expressing WM progenitors can give rise to both glia and 
interneurons over specific time windows during early postnatal development 
(Silbereis et al., 2009). Additionally, Sudarov et al. (2011) found that reduced Ascl1 
expression leads to an increase in the production of astrocytes within the cerebellum, 
suggesting the gene could play a role in fate decisions from a multipotent progenitor 
pool. While further investigation is clearly required to conclusively determine the 
nature of WM progenitors during cerebellum development, the recent observation 
that the adult cerebellum contains a population of multipotent cells, based on the 
expression of neural stem cell marker CD133 (Lee et al., 2005), would support the 
hypothesis that multipotent progenitors persist from postnatal development through 
to adulthood.  
1.2.3 Cell specification at the upper rhombic lip 
In contrast to the glia and GABAergic neurons of the cerebellum, all glutamatergic 
neurons are derived from a separate germinal zone called the rhombic lip (RL). This 
relatively late-forming transient structure arises towards the caudal limit of the 
cerebellum at the interface between the developing neural tube and the roof plate of 




reveal the RL as a caudal extension of the VZ neuroepithelium, although importantly 
it is the physical interaction of the most caudal of these cells with the roof plate that 
endows cells with the inductive RL signals (Wingate, 2001; Wingate and Hatten, 
1999). The RL is split into two domains, the upper RL (URL), which forms the edge 
of rhombomere (r)1 and the fourth ventricle, and the more extensive lower RL 
(LRL), which forms the boundary between r2-8 and the fourth ventricle. Between 
these two domains the choroid plexus (CP) invaginates into the fourth ventricle. Both 
of these RL domains can be molecularly defined by the expression of the 
transcription factor Math1 (Ben-Arie et al., 1997; Machold and Fishell, 2005; Wang 
et al., 2005), which has been shown to be essential for the development of GCs and 
neurons of the HB pre-cerebellar nuclei (Ben-Arie et al., 1997; Ben-Arie et al., 
1996). Wnt1 and Wnt3A are also expressed in both the URL and LRL (Dymecki and 
Tomasiewicz, 1998; Landsberg et al., 2005; Louvi et al., 2007; Nichols and Bruce, 
2006; Rodriguez and Dymecki, 2000).  
 
It is from the URL that the glutamatergic neurons of the cerebellum arise (Fig. 1.4). 
The first of these are the projection neurons of the DCN, which are born from E10.5 
to E12.5 (Fink et al., 2006). Initially expressing the transcription factor Pax6 
followed by Tbr1 and Tbr2, these neurons are specified within the germinal region at 
the URL and migrate across the pial surface of the developing cerebellar anlage in a 
caudal to rostral direction forming a cell layer called the sub-pial stream (SPS). Upon 
reaching the rostral end of the SPS the cells bundle into the NTZ, which later gives 
rise to the DCN. From E12.5 onwards, development of the GC lineage commences 
with the birth of granule progenitor cells (GPCs) at the URL (Machold and Fishell, 
2005; Wang et al., 2005). GPCs maintain the expression of Math1 and Pax6 as they 
proliferate within the URL before adopting a unipolar morphology and exiting the 
URL zone from E13.5. GPCs then migrate in a caudal to rostral direction over the 
pial surface of the cerebellum forming the external granule layer (EGL) (Alder et al., 
1996; Wingate and Hatten, 1999). As the URL progenitors continue to proliferate 
and produce migratory GPCs, the EGL expands to surround the entire cerebellar 
anlage by E16.5. In addition to transcription factors Tbr2, Pax6 and Math1, the GPCs 




which are required for full development of the GC population (Aruga et al., 2002; 
Aruga et al., 1998; Gebbia et al., 1997; Nagai et al., 1997). The third cell population 
generated from URL progenitors are the UBCs. These glutamatergic neurons are 
born towards the end of URL GPC genesis, at around E18.5 (Englund et al., 2006). 
Similar to the preceding two populations of glutamatergic neurons generated at the 
URL, UBCs also express the transcription factors Math1, Pax6 and Tbr2, and exit the 
URL along two migratory paths. Initially, UBCs migrate in a rostral direction below 
the EGL to the developing WM, where they become widely dispersed before 
migrating into the postnatal IGL. In addition, a population of UBCs was found to 
migrate rostrally in a ventral stream along the VZ before exiting the cerebellum and 
ending in the hindbrain (Englund et al., 2006).  
1.2.4 Cell specification at the lower rhombic lip 
Like the URL, the LRL also exists as a transient progenitor domain. Given its close 
anatomical and developmental proximity to the URL, it generates a strikingly 
different complement of neurons – both in terms of anatomy and function. Quail-
chick embryo grafting experiments revealed that the LRL gives rise to a ventrally 
migrating population of cells that populated the pre-cerebellar nuclei within the brain 
stem from E12.5 through to late embryogenesis (Tan and Le Douarin, 1991; Wingate 
and Hatten, 1999). Genetic fate mapping experiments following the progeny of Wnt1 
expressing LRL progenitors confirmed these findings and demonstrated that the LRL 
can be further separated into dorsal and ventral domains, with the dorsal progenitors 
giving rise to mossy fibre neurons that populate the multiple pre-cerebellar nuclei 
within the brain stem and ventral progenitors giving rise to climbing fibre neurons 
that exclusively populate the inferior olive nuclei (Landsberg et al., 2005; Rodriguez 
and Dymecki, 2000). Math1 fate mapping experiments support this identification of 
individual progenitor domains within the LRL (Wang et al., 2005). 
1.2.5 Lineage differentiation and lamination of the cerebellum 
As the cells of the cerebellum are specified and begin their migration from the two 
germinal centres, a series of coordinated events leads to the cerebellum acquiring its 




considerable expansion of GPCs within the EGL followed by their subsequent 
migration and population of the IGL (Fig 1.4). The EGL is characterised by 
extensive proliferation from E18.5 during the first two weeks of postnatal 
development, as the abundant GC population is generated from the GPCs. Several 
lines of evidence suggest that this proliferation is dependent on paracrine interactions 
with neighbouring GCs and also on the Sonic hedgehog (Shh) morphogen secreted 
by the PCs which sit below the EGL (Dahmane and Ruiz i Altaba, 1999; Gao et al., 
1991; Wechsler-Reya and Scott, 1999). Consistent with this, ectopic activation of the 
Shh signalling pathway in the cerebellum results in EGL hyperplasia (Goodrich et 
al., 1997; Kim et al., 2003; Oliver et al., 2005) and the Zic proteins, expressed in the 
GPCs, have been shown to transcriptionally regulate the Gli family of Shh signal 
transduction proteins (Koyabu et al., 2001). The Notch signalling pathway has also 
been implicated in GPC expansion (Lütolf et al., 2002). The Notch pathway 
functions through the binding of a Jagged ligand to a Notch receptor, which then 
induces the activity of a family of Hes transcription factors. Within the GPC 
population, the ligand Jagged-1 has been shown to promote proliferation of GPCs 
through the receptor Notch-2 and the downstream effector Hes-1 (Solecki et al., 
2001). Interestingly this activity is thought to function downstream of the Shh 
pathway (Dakubo et al., 2006). In addition, FGF signalling has been shown to 
modulate the Shh response in GPCs (Yu et al., 2011), illustrating how different 
pathways converge to regulate a developmental process.  
 
While proliferation of the EGL occurs until approximately P15, populations of GCs 
become post mitotic and exit the cell cycle from the early postnatal period, raising 
the question of what forces particular GCs to exit the cell cycle while their 
neighbours remain in a proliferative state. Interestingly, two domains of the EGL 
have been identified – the inner and outer EGL – with the inner EGL expressing cell 
cycle inhibitors, such as P27/kip1 (Miyazawa et al., 2000) and REN (Argenti et al., 
2005). REN has been shown to function as a Shh signal antagonist, providing an 
explanation for how cells previously cycling under the control of Shh can exit the 
cell cycle while Shh persists in the extracellular environment (Argenti et al., 2005). 




complex, but one theory is that this is mediated by an FGF signal within the EGL. 
Consistent with this, an array of FGF ligands and receptors have been identified 
throughout the developing cerebellum (Yaguchi et al., 2009). FGF2, in particular, 
was identified within the EGL during early postnatal stages (Yaguchi et al., 2009) 
and has been shown experimentally to reduce GPC proliferation and promote GC 
differentiation (Fogarty et al., 2007). Signalling by BMP secreted factors is also 
known to promote the differentiation of GPCs. The BMP2 ligand, expressed within 
the EGL, has been shown to antagonise the Shh signal through its downstream 
effector Smad5 (Rios et al., 2004). 
 
During the proliferation of GPCs from late embryonic to early postnatal stages, the 
PCs, originally specified at the VZ, begin dispersing to form a monolayer of cells 
below the EGL. The dispersal of PCs from a multilayered cell cluster to a consistent 
monolayer occurs as the cerebellum expands with the proliferation of GPCs. This 
process is thought to be controlled by the expression of Reelin from the NTZ initially 
and then from the GPCs (Rice and Curran, 2001). Reelin is an extracellular matrix 
(ECM) protein and was identified as the gene product mutated in the reeler mouse 
model (D'Arcangelo et al., 1995) - a well-studied model of ataxia characterised by 
extensive cellular disorganisation within the cerebellum (Rice and Curran, 2001).  
 
The Bergmann glia provide structural support for the continued development of the 
cerebellum and have been shown to closely follow PCs from their birth at the VZ. 
Analysis of glial proteins GLAST and Tenascin reveal extensive expression 
immediately below the developing PC population during late embryogenesis-early 
postnatal development (Yamada et al., 2000; Yamada and Watanabe, 2002; Yuasa, 
1996). This layer then becomes progressively compacted around the PCL as the PCs 
establish their monolayer during the first postnatal week. However, 3H-thymidine 
label retention analysis has revealed that glial cells continue to be generated from the 
VZ and to expand within the developing cerebellar WM at this late embryonic-early 
postnatal stage (Altman and Bayer, 1997). By P7 the Bergmann glia become 
distinguishable from other astrocytes, characterised primarily by their unipolar shape 




proliferating EGL (Yamada and Watanabe, 2002). Expression of members of the 
Sprouty family of FGF feeback antagonsists in the developing Bergmann glia 
population suggests tight regulation of this pathway is important for their 
development (Yu et al., 2011). Notch signalling is also known to be required for the 
correct positioning of Bergmann glia within the PCL  (Komine et al., 2007; Lütolf et 
al., 2002).  
 
During this early postnatal time frame, the GCs begin to exit the inner EGL and 
migrate radially into the cerebellum via specific interactions with the developing 
Bergmann glial fibres (called interstitial junctions) that extend into the ML - a region 
that forms from the space left behind by migrating GCs. During this exit from the 
EGL, GCs begin to express a number of mature neuronal markers such as class 3 !-
tubulin and NeuN (Tomoda et al., 1999; Weyer and Schilling, 2003). The GCs then 
migrate through the PCL to their final location within the IGL, a process that is 
complete by P21 (Altman and Bayer, 1997; Sillitoe and Joyner, 2007; Wang and 
Zoghbi, 2001). During their migration, GCs leave behind the characteristic 
bifurcated axon fibre in the ML, which will eventually synapse with the developing 
PC and Golgi cell dendrites. As the terminally differentiated GCs begin to enter the 
IGL, the cerebellar anlage starts to expand resulting in the formation of the folia. 
Initially, the pial surface of the cerebellum appears smooth. However, by E17.5 
several shallow fissures become evident that produce the five primary lobes 
(anterobasal, anterodorsal, central, posterior and inferior). During postnatal growth 
these primary lobes undergo extensive growth and begin to subdivide into the 
subsequent 10 mature lobes that make up the gross appearance of the adult 
cerebellum (I-X) (Altman and Bayer, 1997; Larsell, 1970). The generation of the 
fissures that lead to the primary and then the final folia are the result of anchoring 
centres forming at the base of each fissure (Sudarov and Joyner, 2007). This begins 
with an inward thickening of the EGL at each presumptive fissure, which then causes 
a slight invagination of the PCs and a fanning out of the glial fibres from the pial 
edge of the fissure. After this, expansion of the folia becomes largely mechanical as 






During this time, the populations of Golgi, basket and stellate interneurons become 
terminally differentiated from the WM progenitor population and migrate to their 
final locations within the IGL and ML, a process that is complete around the time 
GC population of the IGL ends (P21). The genetic fate mapping study undertaken by 
Sudarov et al. (2011), the most high resolution summary of temporal interneuron 
generation to date, revealed that the IGL-resident Golgi interneurons are born first 
(between E14.5-E18.5). Basket and then stellate interneurons are then born from 
WM progenitors up until P7 before migrating to their final location in the inner and 
outer ML respectively.  
 
As a result of these processes (Fig. 1.5), the full lamination of the cerebellum is 
evident by P21, with the DCN forming the cerebellar core surrounded by the WM, 
which carries the key afferents in and out of the cerebellum, in turn surrounded by 
the densely packed IGL, the PCL monolayer and finally the extended ML. The last 
stage of cerebellum development, which continues well into early adulthood, is the 
growth of axons and dendrites as the microcircuitry within the cerebellum becomes 
established and refined.  
Figure 1.5 - Timing of cell birth during cerebellum development.
Initial differentiation of the various cerebellar cell lineages has been established from 
numerous studies using birth dating and genetic fate mapping approaches. Adapted 

























1.2.6 Development of cerebellar circuitry 
The generation of the connections required for cerebellum function begins with the 
arrival of the two key cerebellar inputs – mossy and climbing fibres. Retrograde 
tracing experiments carried out a number of years ago revealed that mossy fibre 
afferents from the various pre-cerebellar nuclei into the developing IGL occurs 
sequentially from mid-embryonic to early postnatal periods (Ashwell and Zhang, 
1992). These early axons then branch off and send small projections towards the 
developing PCL, which make contact with PCs and early migrating GCs. The 
establishment of GC-mossy fibre synapses then follows and it is the early activity 
between these GC-mossy fibre connections that is thought to initiate the full 
maturation of GCs (Hatten and Heintz, 1995).  
 
The arrival of climbing fibre inputs and the establishment of connections with PCs 
coincides with the dispersal of PCs into the monolayer at around E17.5 (Ashwell and 
Zhang, 1992; Hatten and Mason, 1990). As the key output generators for the 
cerebellum, PCs undergo a number of changes during their maturation once they 
have established the monolayer between the IGL and ML. The most notable of these 
is the growth and elaboration of their extensive dendritic arbours through the entire 
width of the ML. Beginning within the second postnatal week, this process is known 
to be dependent on the interaction between PCs with neighbouring PCs and, most 
importantly, GC axons (Baptista et al., 1994). These initial contacts between PC 
dendrites and the GC axons eventually lead to mature synapse formation. 
Concordantly, the axons from the PCs exit the cerebellum through the WM to form 
contacts with the DCN neurons. After the establishment of cerebellar input and 
output connections and the key connections between PCs and GC, the inhibitory 
interneuron connections with each of these cell populations are formed. Little is 
currently understood about this, but the connections formed are important for 





1.3 The Wnt/!-catenin signalling pathway 
The process of generating a fully functional adult cerebellum relies on the 
coordinated action of a number of different developmental signalling molecules and 
their downstream transduction pathways. As discussed above, the signalling 
molecules Shh, Notch, BMP and FGF are all known to function at various points 
during cerebellum development. Signalling by the Wnt family of secreted 
glycolipoproteins represents another key mechanism for regulation of cell 
proliferation, polarity, migration, apoptosis and fate determination during tissue 
development and homeostasis (Logan and Nusse, 2004). Wnt signalling is known to 
be actively involved in neural development and, not surprisingly, its dysregulation is 
linked to developmental defects and cancer. Below follows a description of Wnt 
signalling, with particular attention paid to signalling through the Wnt/!-catenin 
pathway.  
1.3.1 A brief history of Wnt signalling 
The name Wnt comes from a combination of wingless and Int1 – two gene 
homologues identified in Drosophila and mouse respectively in the 1980s (Rijsewijk 
et al., 1987). The Int1 gene was initially identified as an oncogene that, upon 
activation by the mouse mammary tumour virus (MMTV), contributed to the 
development of mammary carcinoma (Nusse and Varmus, 1982). This gene was then 
shown to be homologous to the Drosophila development gene wingless (Rijsewijk et 
al., 1987), which is required for embryo segmentation and leads to severe cuticle 
abnormalities when mutated. The observation in Drosophila that mutations in 
porcupine, dishevelled and armadillo genes led to a similar phenotype, followed by 
genetic epistasis experiments analysing the relationship between them, allowed the 
initial construction of a Wnt signal transduction pathway with porcupine lying 
upstream of wingless and then dishevelled, shaggy/zeste-white 3 and armadillo lying 
downstream (Noordermeer et al., 1994). Concurrently, it was noted that injection of 
mouse Wnt1 mRNA into early stage Xenopus embryos resulted in body axis 
duplication (McMahon and Moon, 1989), allowing development of a robust assay to 




homologue of dishevelled), !-catenin (vertebrate homologue of armadillo) and a 
dominant-negative GSK3 (vertebrate homologue of shaggy/zeste-white 3) into 
Xenopus embryos revealed an identical phenotype to Wnt1 mRNA injection (Guger 
and Gumbiner, 1995; He et al., 1995), consistent with the components and activity of 
the newly identified Wnt pathway being conserved between invertebrates and 
vertebrates.  
 
Combined, these early Drosophila and Xenopus studies revealed the nature of a 
highly conserved signalling pathway activated by a secreted Wnt ligand. Since then, 
comparative genomics has identified 19 different secreted mammalian Wnt ligands, 
which can be further divided into 12 subfamilies that are conserved across the animal 
kingdom, from Nematostella and Drosophila to Xenopus, mouse and human (van 
Amerongen and Nusse, 2009).  In addition, three families of Wnt receptor molecules 
(termed Fz in mammals) have been identified across the same animal groups, with a 
total of 10 Fz molecules (Fz1-10) in mice and humans (van Amerongen and Nusse, 
2009). This illustrates the potential for a remarkable degree of Wnt signalling 
complexity (particularly in mammals) based on the different permutations of 
receptor/ligand combinations.  
 
Initially, Wnt pathway functions were divided into either ‘canonical’ or ‘non-
canonical’ groups based on the correlation of the former with an increase in the 
cellular levels of !-catenin and an increase in !-catenin mediated transcription 
(Shimizu et al., 1997). The non-canonical pathways have traditionally been defined 
as the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. The first of 
these was based on findings in Drosophila that wingless is required for cell polarity 
independently of armadillo (the Drosophila !-catenin homologue) (Vinson and 
Adler, 1987), while the second stemmed from observations in Xenopus that certain 
Wnt ligands can stimulate intracellular Ca2+ release, again through a !-catenin 
independent mechanism (Slusarski et al., 1997). However, as will be discussed 
below, recent findings suggest this classification is an oversimplification (van 




catenin mediated activation of downstream target genes is referred to as the ‘Wnt/!-
catenin signalling pathway’ as opposed to the ‘canonical’ pathway.  
1.3.2 Wnt/!-catenin signal transduction and components of the pathway 
The 19 mammalian Wnt ligands are cysteine rich proteins of between 350-400 amino 
acids with an N-terminal secretion peptide (MacDonald et al., 2009). After 
translation, Wnt proteins undergo several modifications that are essential for their 
function, including glycosylation and palmitoylation of a conserved cysteine residue  
by the acyltransferase Porcupine (Porcn) (Takada et al., 2006; Willert et al., 2003). 
An additional gene termed Wntless (WIs - also known as evenness interrupted, evi) 
was identified in Drosophila as responsible for trafficking the Wnt ligand from the 
Golgi to the plasma membrane for secretion (Bänziger et al., 2006). After secretion 
by the Wnt-producing cells, the ligand binds the seven-pass transmembrane Fz 
receptor at the surface of the target cell (Bhanot et al., 1996). For Wnt/!-catenin 
signalling the binding of a Wnt ligand to the Fz receptor also involves the 
cooperation of a single-pass transmembrane protein called LRP5/6 in mammals 
(Pinson et al., 2000).  Interestingly, multiple Wnts have been observed to bind single 
Fz receptors and vice versa (Bhanot et al., 1996), indicating a degree of promiscuity 
between the ligand/receptor interaction.  
 
At the level of receptor binding, Wnt signalling (through !-catenin dependent or 
independent pathways) is subject to modulation by a series of agonists and 
antagonists. The secreted Fz related proteins (sFRPs) and Wnt inhibitory protein 
(WIF) act antagonistically by binding to Wnt and, in the case of SFRPs, also to Fz 
(Bovolenta et al., 2008). Adding to the complexity of this modulation, SFRPs have 
also been shown to act as agonists of the pathway in certain contexts (Esteve et al., 
2011). An additional antagonist of Wnt signalling is the protein Dickkopf (Dkk), 
which is technically an antagonist of the LRP5/6 co-receptor (Semënov et al., 2001) 
and thus only affects Wnt/!-catenin signalling. Agonists of Wnt/!-catenin signalling 
include two proteins called Norrin and R-spondin, both of which have been shown to 




Xu et al., 2004). Although R-spondin was recently shown to complement Wnt/!-
catenin activity by signalling through an independent pathway mediated by the Lgr5 
receptor (de Lau et al., 2011).  
 
Binding of a Wnt ligand to the Fz/LRP5/6 receptor complex initiates signalling 
through the key effector molecule !-catenin. Under conditions when the Fz/LRP5/6 
receptor complex is not engaged by a ligand, the cytoplasmic levels of !-catenin are 
regulated by a protein complex called the !-catenin destruction complex (Fig 1.6). 
This complex consists of a number of proteins, including tumour suppressors Axin 
and APC, and the kinases CK1 and GSK3 (which is present in both # and ! 
isoforms). Due to the ability of Axin to bind each of these constituent proteins it is 
thought to act as a general scaffold for the complex (Kimelman and Xu, 2006; Lee et 
al., 2003). Once recruited to the complex, CK1 and GSK3 sequentially 
phosphorylate !-catenin at a series of residues near its N-terminus, signalling the 
phospho-!-catenin for destruction by a ubiquitin ligase complex (Aberle et al., 
1997). The role of APC in the destruction complex is surprisingly less well 
understood – despite the well-documented genetic evidence of its importance in !-
catenin regulation (Kinzler and Vogelstein, 1996; Morin et al., 1997; Sansom et al., 
2004). However, several conserved Axin and !-catenin binding motifs have been 
identified in the APC protein (Näthke, 2004). In addition, it has been shown to 
interact directly with GSK3! (Rubinfeld et al., 1996), strongly suggesting a role in 




Figure 1.6 - Core components of the Wnt/!-catenin signalling pathway.
(A) In the absence of a bound Wnt ligand, a protein complex consisting of Axin, 
APC, CK1 and GSK3 mediates the phosphorylation of !-catenin, marking it for 
ubiquitination and subsequent degradation. (B) When a Wnt ligand binds the 
Fz/LRP5/6 co-receptor complex, a cascade of events is inititated involving 
phosphorylation of Dsh and LRP5/6 and removal of the protein complex from !
-catenin. This allows non-phosphorylated !-catenin to accumulate and translocate 
into the nucleus where it disrupts the Groucho/TCF repressor complex and initiates 



































The destruction complex also appears to demonstrate a number of self-regulatory 
mechanisms. In addition to phosphorylating !-catenin, CK1 and GSK3! have been 
shown to also phosphorylate Axin and APC, which leads to increased affinity for !-
catenin and subsequently enhanced !-catenin degradation (Kimelman and Xu, 2006). 
The opposite effect has been shown to result from the action of two external 
phosphatases, PP1 and PP2A, which dephosphorylate Axin and APC (Luo et al., 
2007) causing a reduction in the activity of the destruction complex. Furthermore, 
the overall kinetics of !-catenin destruction appears to be largely regulated by 
cellular Axin levels, which are considerably lower than the other destruction 
complex components (Lee et al., 2003). This provides a potential explanation for 
how Wnt/!-catenin signal transduction can be insulated by fluctuating levels in the 
other components, which are known to be involved in additional cellular processes. 
Current understanding of these events is limited, but together this suggests the 
destruction complex is a considerably more fluid entity than described by classical 
Wnt signalling dogma.  
 
Upon engagement by their respective ligands, the Fz/LRP5/6 complex initiates a 
sequence of events that results in the inhibition of !-catenin destruction complex 
kinase activity (Fig 1.6). The key action of this intracellular signalling cascade is the 
Wnt ligand-induced phosphorylation of LRP5/6, which generates a docking site for 
Axin (Mao et al., 2001; Tamai et al., 2004). Interestingly this phosphorylation is 
understood to be carried out by Axin-bound GSK3 and CK1 (Zeng et al., 2008; Zeng 
et al., 2005). Recruitment of the Axin/GSK3/CK1 protein complex to the membrane 
is thought to be carried out by Dsh, which interacts with Fz and becomes 
phosphorylated upon binding of a Wnt ligand (Wallingford and Habas, 2005). 
Combined, this leads to the generally accepted theory that Wnt induced activation of 
Fz/LRP5/6 causes the Dsh-mediated recruitment of Axin-GSK3/CK1 to the 
membrane allowing for the phosphorylation of LRP5/6. However, the specific 
sequence of events that then results in the inhibition of !-catenin phosphorylation is 
currently uncertain. For example, it is not clear whether the whole destruction 
complex is recruited to the membrane or whether it is disrupted in the cytoplasm and 




dephosphorylated !-catenin initially at the plasma membrane shortly after 
Fz/LRP5/6 activation would support the latter (Hendriksen et al., 2008). Regardless, 
the end result is the inhibition of destruction complex activity and the accumulation 
of dephosphorylated !-catenin in the cytoplasm.  
 
After cytoplasmic stabilisation of !-catenin, it translocates to the nucleus through 
association with the transcription factor FoxM1 (Zhang et al., 2011a) to initiate the 
downstream transcriptional response. This occurs through an interaction with the 
TCF/LEF transcription factor complex. In the absence of Wnt/!-catenin signalling, 
TCF/LEF represses gene expression through interaction with the transcriptional 
repressor Groucho. !-catenin has been shown to displace Groucho, resulting in the 
formation of a transcriptionally active complex (Daniels and Weis, 2005). This 
transcriptional complex recognises a conserved DNA seqeuence containing a 
CCTTTGATC motif (Korinek et al., 1997) that is present in the regulatory region of 
Wnt/!-catenin target genes. The specificity of the !-catenin/TCF/LEF complex for the 
DNA motif has been demonstrated by transgenic reporter mice that express a reporter 
protein, usually !-galactosidase (!-gal) or green fluorescent protein (GFP), under the 
control of several of these binding sites (DasGupta and Fuchs, 1999; Korinek et al., 
1997; Maretto et al., 2003). A large number of taget genes have been identified that are 
activated by the !-catenin/TCF/LEF transcriptional complex (see 
http://www.wnt.stanford.edu for a comprehensive summary), resulting in the potential 
for Wnt/!-catenin signaling to activate a variety of transcriptional programmes. 
Consistent with this, a wide range of cellular processes are known to be regulated by 
Wnt/!-catenin activity, the majority of which appear to be specific to cell type and 
developmental stage (Logan and Nusse, 2004).  
1.3.3 Complexities and recent insights into Wnt signal transduction 
It is important to note that a number of the components of the Wnt/!-catenin 
pathway also hold alternative cellular functions that need to be taken into 
consideration when discussing experimental manipulation of Wnt signalling. !-
catenin, for example, is a well characterised component of adherens junctions (Peifer 
et al., 1992) in addition to its role as a signalling molecule. Unlike the highly 




to adherens junctions appears highly stable. APC has also been shown to have a 
number of structural functions in addition to its role as a signalling molecule, 
including microtubule assembly (Kroboth et al., 2007; Zumbrunn et al., 2001) and 
mitotic spindle orientation (Yamashita et al., 2003). The relationship between these 
alternative functions and Wnt/!-catenin signalling is not well understood.  
 
The dynamics of Wnt signal transduction are also not as clear-cut as traditionally 
presented. It is widely known that, in addition to signalling via !-catenin, Wnt 
ligands can also induce the PCP or Ca2+ pathways through Fz binding (Slusarski et 
al., 1997; Vinson and Adler, 1987). However, it is becoming evident that there is a 
certain degree of interaction between these three pathways. For example, activation 
of the LRP5/6 co-receptor, known to induce signalling through !-catenin, has been 
shown to inhbit signalling through the PCP pathway by disrupting the ability of non-
canonical Wnt ligands (e.g. Wnt5A) to bind Fz (Bryja et al., 2009; Tahinci et al., 
2007). Similarly, the Wnt/!-catenin pathway antagonist Dkk has also been shown to 
affect PCP signalling through the LRP5/6 co-receptor (Caneparo et al., 2007). There 
is also evidence to suggest that signalling through !-catenin can feedback on itself, 
both positively and negatively. Activation of Wnt/!-catenin signalling can induce 
expression of Axin and Dkk, both negative regulators of the pathway (Chamorro et 
al., 2005; Jho et al., 2002). Conversely, Wnt/!-catenin signalling can also positively 
feed forward through the activation of R-spondin and TCF/LEF expression (Hovanes 
et al., 2001; Kazanskaya et al., 2004). These observations all suggest that Wnt signal 
transduction is better thought of as a network of interactions with multiple outcomes, 
cross-talk and regulatory inputs, rather than several distinct linearly progressing 
pathways (van Amerongen and Nusse, 2009).  
 
1.4 Multiple roles for Wnt/!-catenin signalling in neural 
development 
The large network of proteins involved in Wnt/!-catenin signalling and the 




context dependent. Such complexity is consistent with the wide range of 
developmental processes that Wnt/!-catenin signalling has been implicated in; 
including proliferation, fate determination, differentiation, migration and apoptosis 
(Clevers, 2006). All of these processes are required for the induction, patterning, 
growth and maturation of the central nervous system and, not surprisingly, Wnt/!-
catenin signalling has been identified as a key developmental pathway coordinating a 
range of developmental processes at each of these stages.  
1.4.1 Neural patterning 
After induction of neural tissue in the early embryo, development of the central 
nervous system begins with the regionalisation and patterning of the area. This is 
achieved through the diffusion of multiple signalling molecules across the anterior-
posterior, medial-lateral and dorsal-ventral axes endowing all cells with positional 
information. Wnt/!-catenin signalling has been proposed to act early on in neural 
development as an anterior-posterior patterning factor. Wnt ligands are expressed in 
a gradient from posterior-high to anterior-low in the developing neural tube and that 
this signal is necessary and sufficient for the anterior-posterior patterning of the early 
neural tube (Kiecker and Niehrs, 2001). Additionally, the development of anterior 
brain structures then relies on the inhibition of Wnt/!-catenin signalling in the 
anterior, partly through the expression of the Wnt antagonist Dkk by anterior cells 
(Glinka et al., 1998; Mukhopadhyay et al., 2001). Wnt/!-catenin signalling is also 
important for establishing the dorsal-ventral axis, with experiments in chick embryos 
showing that Wnt expression suppresses ventral cell fates and induces dorsal 
characteristics in the developing telencephalon (Gunhaga et al., 2003). Any given 
cell’s positional identity is then defined based on the receipt of a combination of 
different secreted molecules and subsequently an appropriate transcriptional response 
is generated. The developing neural tissue is therefore compartmentalised into 
defined regions (e.g. telencephalon, diencephalon, mesencephalon) that allows the 





1.4.2 Regulation of neural stem cell function  
Within specific brain regions, Wnt/!-catenin signalling is then involved as a key 
regulator of the progenitor populations responsible for generating the various 
lineages of differentiated cell types present within the adult brain. Establishment of 
full cerebral cortical lamination, for example, results from the regulation of 
progenitor and transit amplifying cell proliferation and differentiation. Cortical 
neurons are produced during embryogenesis from a population of radial glia that line 
the lateral ventricles. These multipotent neural stem cells (NSCs) divide 
asymmetrically to produce either terminally differentiated neurons, intermediate 
progenitor cells (IPCs) or an additional daughter radial glia. IPCs are essentially 
transit amplifying cells and act to amplify the neurogenic pool by dividing to 
produce two terminally differentiated neurons (Molyneaux et al., 2007). 
Considerable experimental evidence suggests this process is regulated, at least in 
part, by the Wnt/!-catenin signalling pathway (Fig 1.7).  
 
A number of Wnt ligands have been identified expressed in a gradient from a 
signalling centre (the cortical hem), which resides near the dorsal midline of the 
cortex (Fotaki et al., 2010; Grove et al., 1998; Machon et al., 2007). From here, the 
Wnt signal is thought to play a role in regulation of the radial glia lining the lateral 
ventricle. Consistent with this, activation of Wnt/!-catenin signalling in chick 
cortical explants generated a concordant increase in the expression of dorsal cortical 
transcription factors such as Pax6 (Gunhaga et al., 2003). The role of Wnt/!-catenin 
signalling in regulation of the radial glia population was originally thought to be 
mitogenic (Megason and McMahon, 2002), a conclusion that has been supported by 
a combination of loss/gain-of-function studies. Loss of the LRP6 co-receptor or !-
catenin causes a drastic reduction in cortical growth, likely due to the premature 
differentiation of radial glia (Woodhead et al., 2006; Zhou et al., 2006). Conversely, 
an increase in cortical Wnt/!-catenin activity promotes the self-renewal of radial glia 
and causes an expansion of the cortex (Chenn and Walsh, 2002; Ivaniutsin et al., 
2009; Machon et al., 2007). These findings support a role for Wnt/!-catenin 
signalling in regulating self-renewal of the radial glial population. 
Figure 1.7 - Wnt/!-catenin signalling and NSC regulation.
Wnt/!-catenin signalling is known to regulate two processes in the generation of 
neurons from NSCs in the cortex. (A) Under normal conditions the NSC divides to 
produce an additional NSC and a transit amplifying IP cell. This then undergoes 
further asymmetric division to produce a daughter neuron and an additional IP cell - 
thus amplifying the total neuronal pool over time. Activated Wnt/!-catenin signalling 
has been shown experimentally to increase the self-renewal of NSCs (B), or force the 
differentiation of neurons from IP cells (C). The former results in a larger cortex due 
to a larger stem cell pool, while the latter results in a small cortex due to the depleted 












A more spatio-temporal specific role in neurogenesis was determined by further 
work that controversially suggested that Wnt/!-catenin signalling can also act to 
promote neurogenesis (rather than self-renewal) (Hirabayashi et al., 2004). However, 
recent evidence has reconciled this inconsistency as the result of an additional role 
for Wnt/!-catenin signalling in driving neurogenesis from IPCs (Munji et al., 2011). 
This further reflects the context specificity for the responses generated by Wnt/!-
catenin signal transduction – self renewal and proliferation in one cell type (NSCs) 
and differentiation in another (IPCs).  
1.4.3 Development of cellular connections 
While thought to function through cytoskeletal modifications rather than !-catenin 
mediated transcription, it is worth briefly mentioning the fact that a number of Wnt 
ligands are known to be required for the development of neuronal connections during 
brain development, particularly within the cerebellum. Wnt7a has been identified as 
a ligand expressed by GCs during development at the time when they first begin to 
form connections with mossy fibre axons (Lucas and Salinas, 1997) and induces 
axonal remodelling in the incoming mossy fibres through cytoskeletal changes 
mediated by GSK3! inhibition and Dsh activation (Ciani et al., 2004; Hall et al., 
2000; Lucas and Salinas, 1997). On the other side of a synapse, Wnt ligands have 
been identified as regulators of dendritogenesis. In hippocampal neurons, Wnt7b is 
required for dendritic arborisation. The Wnt antagonist Sfrp1 (one of the secreted 
frizzled related proteins) inhibits dendritic branching of hippocampal neurons in 
vitro, while overexpression of Wnt7b causes over-elaboration (Rosso et al., 2005). 
Wnt3 expression has been identified in PCs during postnatal growth when their 
dendritic trees are developing (Salinas et al., 1994), although it has not yet been 
demonstrated to be an essential regulator of this process. Lastly, Wnt signalling has 
also been implicated in the process of synaptogenesis. During the development of 
GC/mossy fibre connections the expression of Wnt7a is maintained throughout 
synaptogenesis and increases expression of synapsin 1, a pre-synaptic protein 
involved in synapse formation and maturation (Hall et al., 2000; Lucas and Salinas, 
1997). Combined, the processes of axon guidance, dendritic elaboration and 




cellular mechanisms initiated upon binding of a Wnt ligand are clearly an important 
component of these activities.  
 
1.5 Medulloblastoma: Cerebellum development gone wrong 
When developmental signalling pathways like the Wnt/!-catenin pathway become 
dysregulated, cancer is often the end result. At a fundamental level, cancer arises 
from a multistep process involving the accumulation of genetic aberrations that 
drives the progressive transformation of a normal cell lineage into a malignant 
derivative (Hanahan and Weinberg, 2000). The malignancy of cancer cells arises 
from a number of characteristics that are endowed upon them from these genetic or 
epigenetic changes, including resistance to cell death, sustained proliferation, 
replicative immortality and the ability to invade surrounding tissue (Hanahan and 
Weinberg, 2011; Hanahan and Weinberg, 2000). Given the link between the classic 
developmental signalling pathways (such as Shh, Wnt and BMP signalling) and these 
traits, it is not surprising that their dysregulation is implicated in a wide variety of 
tumour types, including the cerebellar neoplasm medulloblastoma.  
1.5.1 Wnt/!-catenin signalling and cancer 
The association between dysregulated Wnt/!-catenin signalling and cancer is long 
established. Indeed, discovery of the first mammalian Wnt ligand was born from a 
study into the transcriptional mechanisms of viral-mediated mammary 
tumourigenesis (Nusse and Varmus, 1982). Since then, the most well documented 
malignancy established primarily from dysregulated Wnt/!-catenin signalling is 
colorectal cancer, characterised by aberrant growth of the epithelial lining of the 
lower gastrointestinal tract. Individuals with a predisposition syndrome to this cancer 
(called familial adenomatous polyposis – FAP) were found to harbour a mutation in 
APC (Kinzler et al., 1991a; Kinzler et al., 1991b). Patients thus inherit one defective 
APC allele and as a result develop large numbers of epithelial outgrowths, termed 
polyps, in which the second APC allele is subsequently lost. Inevitably some of these 




observed in about 90% of sporadic colorectal cancer cases (Kinzler and Vogelstein, 
1996).  
 
Loss of APC function in intestinal epithelia leads to the stabilisation of !-catenin and 
the activation of Wnt/!-catenin signalling, resulting in a number of defects to 
intestinal self renewal (Sansom et al., 2004). Under normal conditions, intestinal 
epithelial cells are continuously produced by a stem cell compartment at the base of 
each villus called the intestinal crypt. Each crypt stem cell divides asymmetrically to 
produce a daughter transit amplifying cell, which then goes on to produce the mature 
epithelial cells that migrate along the surface of the villi before being shed – a 
process that takes approximately 3-5 days in humans. Wnt/!-catenin signalling has 
been shown to maintain the self-renewal of crypt stem cells (van de Wetering et al., 
2002) and to control the EphB receptor / ephrin-B ligand gradient, which plays a role 
in maintaining the crypt niche environment. When Wnt/!-catenin is constitutively 
activated in crypt stem cells this process becomes disrupted and results in the 
accumulation of crypt stem cells that are unable to migrate or differentiate (Sansom 
et al., 2004). This is what constitutes a benign polyp, which eventually accumulates 
the additional mutations required for progression to an adenoma. This phenotype has 
also been observed in mice that harbour a somatic Apc mutation, similar to that 
observed in patients with FAP (Moser et al., 1990). Strikingly, these mice develop 
severe intestinal polyposis, mirroring the human condition. The mutation was 
subsequently identified in the Apc gene (Su et al., 1992) and given the name Apcmin 
(multiple intestinal neoplasia).  
 
This observation that a disruption in Wnt/!-catenin mediated stem/progenitor cell 
self-renewal and differentiation leads to cancer has also been inferred from other 
systems. Within the hair follicle, for example, Wnt/!-catenin signalling has been 
established as a key factor regulating the transit amplifying cell population 
(DasGupta and Fuchs, 1999) and constitutive activation has been shown to lead to 
hair follicle tumours (Gat et al., 1998). Consistent with these observations, activating 
mutations in the Wnt/!-catenin signalling pathway have been identified in human 




observations from the intestine, these observations suggest that dysregulation of 
Wnt/!-catenin signalling is an important contributing factor to cancer originating 
from tissues where normal development relies on this pathway.  
1.5.2 Clinical details and neuropathology of medulloblastoma 
Medulloblastoma is the most common paediatric malignancy of the central nervous 
system and covers a family of related cerebellar tumours. Although mainly occurring 
in children, medulloblastoma has also been reported in adolescents and adults. 
Medulloblastomas are classified as primitive neuroectodermal tumours, which covers 
a wider range of brain tumours (not limited to the cerebellum) that exhibit a number 
of characteristics, including the fact they are usually high-grade, undifferentiated, 
neuroepithelial in origin and can consist of both neuronal and glial components 
(Rorke, 1983). Within the medulloblastoma family, tumours have been classified 
into three main categories, based primarily on histopathological features (Fig. 1.8 A-
D), age of onset and prognosis: classical, nodular/desmoplastic and large 
cell/anaplastic (Louis et al., 2007). Classical medulloblastomas develop primarily 
within the vermis of the cerebellum, account for around 75% of medulloblastomas 
and are characterised by densely packed small, homogenous round cells. These 
tumours arise late in childhood and have the least severe prognosis of 
medulloblastoma. Desmoplastic medulloblastoma accounts for about 10% of cases 
and is characterised by a biphasic tissue pattern with regions of high cellular 
differentiation and low cell density (nodules) surrounded by areas of more 
undifferentiated cells. This variant predominates in a slightly older age group than 
classical medulloblastoma but has a worse prognosis. Lastly, the large cell/anaplastic 
variant accounts for the remainder of cases and is characterised by large cells with 
pleiomorphic nuclei, abundant cytoplasm and a high mitotic index. In addition, these 
tumours arise in the youngest age group (normally around 3 years of age), are much 
more invasive and have the worst prognosis (Behesti and Marino, 2008; Gilbertson 
and Ellison, 2008; Hatten and Roussel, 2011).  
Figure 1.8 - Histopathological variants and molecular subtypes of 
medulloblastoma.
Medulloblastoma can be divided into four histopathological variants: Classic (A), 
nodular/desmoplastic (B), anaplastic (C) and large-cell (D). Classification of 
medulloblastoma by transcriptomic profile revealed five subtypes (E). Those with 
activated Wnt/!-catenin or Shh signalling were present in two defined groups with 
consistent histopathological and clinical profiles. The remaining three molecular 
subtypes are less well defined. A-D adapted from Gilbertson and Ellison (2008). E 









1.5.3 Molecular characterisation of medulloblastoma 
While the neuropathology of medulloblastoma variants has been established for 
some time, recent advances in the molecular characterisation of medulloblastoma are 
now beginning to offer important insights into the mechanisms that drive growth of 
the different variants of the disease. Much of our current understanding of the 
molecular basis of medulloblastoma has arisen from studies into two hereditary 
syndromes that predispose to the disease (Taylor et al., 2000). Gorlin syndrome is 
one such disease that predisposes to medulloblastoma, amongst other tumours 
including meningioma and basal carcinoma of the skin. This disorder was originally 
linked to chromosome nine in humans (Farndon et al., 1992) and then further 
mapped to a mutation in the PTCH1 gene (Hahn et al., 1996), which encodes the Shh 
membrane receptor Patched. Further analysis revealed PTCH1 mutations in a subset 
of sporadic medulloblastomas (Raffel et al., 1997), strongly implicating a role for 
Shh in the aetiology of a subset of medulloblastoma. A knockout mouse model for 
Ptch provided corroborating evidence for a role of Shh in medulloblastoma. Similar 
to Gorlin syndrome, 15% of mice heterozygous for a Ptch1 mutation developed 
medulloblastoma at between three to six months of age (Goodrich et al., 1997). 
Furthermore, activating mutations in Shh pathway regulators Sufu and Smo have 
been identified in sporadic medulloblastoma (Reifenberger et al., 1998; Taylor et al., 
2002). Combined with the identification of Ptch1 mutations, medulloblastomas with 
activated Shh signalling are thought to account for around 25% of human cases 
(Zurawel et al., 1998).   
 
Turcot syndrome is the second familial cancer predisposition syndrome with a high 
occurrence of medulloblastoma. This disease is characterised by the association of 
primary brain tumours with multiple colorectal adenomas (Hamilton et al., 1995). 
Consistent with the intestinal phenotype but providing a completely novel insight 
into medulloblastoma aetiology at the time, the genetic cause of this syndrome was 
mapped to a mutation in APC (Hamilton et al., 1995), implicating the Wnt/!-catenin 
signalling pathway in the manifestation of medulloblastoma for the first time. 




identified with mutations in APC (Huang et al., 2000) and other components of the 
pathway including !-catenin (CTNNB1) (Eberhart et al., 2000; Zurawel et al., 1998) 
and Axin (AXIN) (Baeza et al., 2003), accounting for around 10-15% of 
medulloblastomas (Hatten and Roussel, 2011). These early mutational analyses 
importantly revealed that two developmental signalling pathways were activated in a 
subset of medulloblastoma.  
 
Building upon this finding, advances in DNA sequencing and gene expression 
analyses have led to the discovery that the activation of Shh or Wnt signalling occurs 
in mutually exclusive subsets of medulloblastoma and that different histological 
variants of medulloblastoma contain distinct transcriptional profiles (Kool et al., 
2008; Northcott et al., 2010; Parsons et al., 2011; Pomeroy et al., 2002; Schwalbe et 
al., 2011; Thompson et al., 2006). One of the earliest transcriptional characterisations 
of medulloblastoma was carried out by Pomeroy et al. (2002), who identified a 
striking difference in the transcriptional profile between the classical and 
desmoplastic variants. Intriguingly, they also identified a clustering of Shh induced 
genes in the desmoplastic variant compared to the classical. This classification was 
notably extended by Thompson et al. (2006) who used more extensive gene 
expression analysis to identify five distinct molecular subtypes of medulloblastoma 
(Designated A-E). This was also the first study to demonstrate that Wnt and Shh 
signalling are activated in two mutually exclusive groups (A for Wnt, B for Shh). 
This clustering of medulloblastoma into five molecular subtypes was also achieved 
independently by Kool et al. (2008). Importantly, they also correlated their data with 
clinical details to identify that the Shh subtype presented as the desmoplastic or 
anaplastic variants in young children, compared to the Wnt subtype that presented 
almost exclusively as the classical variant in older children (Fig. 1.8 E). The clinical 
relevance of the previously established Wnt and Shh medulloblastoma subtypes was 
demonstrated recently by Schwalbe et al. (2011), who reported the development and 






While the difference between Wnt and Shh induced tumours is clear, the molecular 
classification of the latter three subtypes (C-E) has been less convincing. A recent 
study by Northcott et al. (2010) only grouped the non-Shh/Wnt subtypes into two 
additional subtypes, as opposed to three that had been identified previously. This 
inconsistency reflects the multiple genetic and transcriptomic aberrations identified 
in this group of medulloblastomas and the different clustering methods employed. 
Importantly, these latter molecular subtypes represent the majority of 
medulloblastomas (Gilbertson and Ellison, 2008). Furthermore, there is incomplete 
overlap between the histopathologic and molecular profiles. Aside from the 
observations that Wnt and Shh subtypes cluster within the classical and 
desmoplastic/anaplastic variants respectively, there is little consistency between the 
remaining molecular subtypes. Thus, further profiling is necessary in order to build a 
completely complementary picture of the histopathology and genetic profiles of 
medulloblastoma. 
1.5.4 Developmental origins of Shh subtype medulloblastoma 
The identification of clear molecular and histopathological variants of 
medulloblastoma suggests that different genetic aberrations in different cell types 
lead to the different classes of the disease. Combined with present knowledge of the 
molecular mechanisms controlling cerebellum development, this provides important 
insight into the developmental origins of medulloblastoma. The most convincing 
example of this is the identification that activating mutations in the Shh pathway lead 
to tumours arising from the GPC population within the EGL.  
 
Observations that GPC proliferation is largely promoted by a Shh signal (Dahmane 
and Ruiz i Altaba, 1999; Gao et al., 1991) coupled with the consistent identification 
of a molecular subtype of medulloblastoma with activated Shh signalling led to the 
original hypothesis that this subtype of medulloblastoma arises from the 
transformation of GPCs. Initial support for this hypothesis has been generated from 
mice lacking the negative Shh regulator Patched, which show evidence for EGL 
hyperplasia and an increased risk of medulloblastoma (Goodrich et al., 1997; Kim et 




cerebellar cell types does not conclusively prove that the GPC is the cell of origin for 
the tumours observed. The advent of conditional genetic manipulation has since 
provided convincing evidence in support of this hypothesis from studies that have 
activated the Shh pathway solely in GPC cells and demonstrated the formation of 
medulloblastomas strikingly similar to the Shh molecular subtype previously 
identified.  
 
Yang et al. (2008) utilised a Cre recombinase driven by Math1, a transcription factor 
expressed exclusively in rhombic lip derivatives (Ben-Arie et al., 1997; Machold and 
Fishell, 2005; Wang et al., 2005) to target a Ptch1lox allele. This mutation promoted 
extensive proliferation within the EGL, causing obvious hyperplasia and eventually 
medulloblastoma by eight weeks of age. Importantly, the authors then targeted the 
mutation to non-lineage restricted progenitors using a GFAP driven Cre, which is 
expressed in multipotent progenitors at the VZ and RL prior to lineage commitment 
(Casper and McCarthy, 2006). While these mice showed evidence for an expanded 
NSC pool (including an expansion of the VZ) and advanced medulloblastoma by 
only four weeks of age, the tumours only arose from GPCs – as evident by the 
abundant EGL hyperplasia and the GPC markers present in the medulloblastomas. 
These findings were complemented by a study published concurrently using an 
additional RL-specific Cre transgene (Olig2) to constitutively activate Shh to the 
same result (Schüller et al., 2008). Thus, these studies were the first to demonstrate 
that activating mutations in the Shh pathway only generate medulloblastoma from 
the granule lineage – entirely consistent with the GPC cell-of-origin for the Shh 
subtype of medulloblastoma.  
1.5.5 Developmental origins of Wnt/!-catenin subtype medulloblastoma 
While the developmental origin of Shh subtype medulloblastoma is now well 
established, a potential link between development and the Wnt medulloblastoma 
subtype has only recently become apparent. As described above, dysregulated Wnt 
signalling occurs in approximately 10-15% of medulloblastoma cases based on the 
identification of pathway activating mutations in APC, CTNNB1 and AXIN. This Wnt 




histopathological variant, affects older children and has a more favourable prognosis  
(Ellison et al., 2005). These observations support the suggestion that, like the Shh 
subtype, medulloblastomas arising from dysregulated Wnt/!-catenin signalling arises 
in a distinct cell population. However, unlike Shh signalling, our understanding of 
Wnt/!-catenin signalling in cerebellum development is surprisingly limited, making 
predictions on a Wnt subtype medulloblastoma cell-of-origin difficult.  
 
While a role for Wnt/!-catenin signalling during the initial stages of MHB cell 
specification at the IsO is well established (Danielian and McMahon, 1996; 
McMahon and Bradley, 1990; Thomas and Capecchi, 1990), this is unlikely to be 
involved in the aetiology of medulloblastoma as dysregulation of a signalling centre 
such as this would generate a more severe developmental abnormality. Wnt/!-
catenin signalling is also known to be active during development of cell lineages 
from the URL (Davis and Joyner, 1988; Dymecki and Tomasiewicz, 1998; Fischer et 
al., 2007; Nichols and Bruce, 2006; Wilkinson et al., 1987) and LRL (Landsberg et 
al., 2005; Rodriguez and Dymecki, 2000). However, attempts to constitutively 
activate Wnt/!-catenin signalling in the URL-derived granule lineage have not 
revealed any changes that would be consistent with tumourigenesis (Kratz et al., 
2002; Lorenz et al., 2011). Lastly, the fact Wnt/!-catenin signalling is known to be 
an important regulator of neural stem cell self-renewal and differentiation (Munji et 
al., 2011) has led to the hypothesis that it could play a role in development of cell 
lineages arising at the VZ and that its dysregulation in this process is what leads to 
the Wnt subtype of medulloblastoma (Gilbertson and Ellison, 2008). While a 
demonstration of Wnt/!-catenin signalling within this cell population is yet to be 
undertaken, the effects of Wnt/!-catenin pathway activation in the VZ (alongside the 
URL and LRL) during cerebellum development was recently demonstrated (Gibson 
et al., 2010).  
 
The study by Gibson et al. (2010) used a BLBP promoter, which is active in NSCs 
throughout the CNS during development (Hegedus et al., 2007). Importantly, the 
authors identified that the BLBP-Cre transgene was expressed in all key germinal 




Cre transgene to activate a mutant !-catenin allele (Harada et al., 1999), the authors 
report that the only abnormality in the cerebellum of this mouse model was an 
accumulation of LRL-derived cells on the DHB surface by E16.5. The authors also 
demonstrate that this is not a result of increased proliferation, but instead is due to a 
migrational defect where the LRL-derived cells are unable to migrate to their 
respective HB nuclei. Following the loss of tumour suppressor gene TP53, 
medulloblastomas were then observed that displayed a classical histopathology and a 
transcriptomic signature identical to the Wnt subtype.  
 
The conclusion that dysregulation of Wnt/!-catenin signalling at the LRL leads to a 
migrational defect and eventually medulloblastoma is supported by the evidence 
presented by Gibson et al. However, the data presented is not sufficient to conclude 
that all Wnt/!-catenin subtype medulloblastomas arise in this manner. Firstly, while 
the authors identify expression of a reporter allele and observe the accumulation of 
nuclear !-catenin in the VZ and URL, suggesting the transgene is active in these 
respective germinal centres, further analysis of the effects of the mutation in the cell 
lineages arising is lacking. The only analysis performed on cells at the VZ and EGL 
was the expression of proliferation and apoptosis markers at E16.5, which did not 
reveal an effect. The effects on progenitor cell self-renewal, differentiation and 
migration were not analysed. Furthermore, while the authors used an additional Cre-
recombinase transgene to activate Wnt/!-catenin signalling solely in the Math1 
positive(+) URL-derived cell lineage, in order to further test the effects of Wnt/!-
catenin pathway activation in the granule lineage, their results are in stark contrast to 
those observed by Lorenz et al. (2011) who undertook a similar experiment using the 
same Cre-recombinase transgene (Matei et al., 2005) and same floxed !-catenin 
allele (Harada et al., 1999). Lorenz et al. observed extensive developmental 
abnormalities in GC development after Wnt/!-catenin activation, while Gibson et al. 
did not report any abnormalities. Finally, the removal of TP53 (required for full 
tumour development) was only carried out in the BLBP-Cre line and thus it is hard to 
be certain the medulloblastomas observed arose solely from the LRL. This 
experiment now needs to be performed using Cre-reombinase transgenes exclusively 




activation in these germinal centres alone does not contribute to medulloblastoma. 
Thus, while a compelling case for the identification of the developmental origins of 
Wnt/!-catenin induced medulloblastoma has been presented (Gibson et al., 2010), 
the shortcomings within necessitate further experimentation. In addition, further 
investigation into the developmental role of Wnt/!-catenin signalling in the 
cerebellum is required in order to try and reconcile the observations made by Gibson 
et al. with a developmental process.  
 
1.6 Aims of thesis 
The identification of dysregulated Wnt/!-catenin signalling in a subtype of 
medulloblastoma and the correlation between this molecular profile and a consistent 
histopathology and clinical outcome suggests a degree of conservation in the 
development of medulloblastoma arising as a result of dysregulated Wnt/!-catenin 
signalling. Combined with the fact that Wnt/!-catenin signalling is a well established 
regulator of stem/progenitor cell populations in a number of tissues (including the 
CNS), this leads to the hypothesis that Wnt/!-catenin signalling plays a role in 
cerebellum development and that its dysregulation contributes to the aetiology of a 
subtype of medulloblastoma. To test this hypothesis a more thorough developmental 
profile of Wnt/!-catenin signalling in the cerebellum needs to be established and an 
investigation into the normal function of Wnt/!-catenin signalling is required. Thus, 
for this thesis I proposed to address the following three aims: 
 
1. To characterise the extent of Wnt/!-catenin signalling throughout cerebellum 
development. 
2. To investigate the function of Wnt/!-catenin signalling during cerebellum 
development.  
3. To clarify how the dysregulation of this function contributes to the 





In order to address these aims I first carried out a spatio-temporal analysis of Wnt/!-
catenin signalling activity throughout cerebellum development using a !-
galactosidase expressing Wnt/!-catenin transgenic reporter mouse model. Informed 
by the results from this analysis, I carried out a functional investigation into the role 
of Wnt/!-catenin signalling using a combination of small molecule-mediated 
modulation of the pathway ex vivo and genetic activation of the pathway in vivo 




2 Materials and methods 
2.1 Animal procedures 
2.1.1 Husbandry 
Animal care was carried out in accordance with institutional guidelines and UK 
Home Office regulations. Mice were maintained in a 12 hour dark/light cycle with 
food and water provided ad libitum. For timed mating, the morning the vaginal plug 
was detected was designated as E0.5 and the day of birth as P0.  
2.1.2 Mouse lines 
Mice harbouring the BAT-gal reporter allele were maintained on a C57Bl/6J genetic 
background. Wild type mice on the same background were obtained by crossing 
mice hemizygous for the BAT-gal allele and used as negative controls. Mice 
carrying the Nestin-CreERT2 (Nestin-Cre) transgene were obtained on a mixed 
C57Bl/6J background, mice carrying the Apclox, Rosa26eYFP (R26YFP) or Emx1-
CreERT2 (Emx1-Cre) transgenes were all obtained on a CBA/C57Bl/6J mixed 
background. Founder animals carrying individual Nestin-Cre, Emx1Cre, Apclox or 
R26YFP alleles were crossed in order to generate experimental mice with the 
following genotypes (as detailed in the relevant results sections):  
Nestin-Cre+/- ; R26YFP+ -   (Chapter 5) 
Nestin-Cre+/- ; Apclox/lox   (Chapter 5) 
Nestin-Cre+/- ; Apclox/lox; R26YFP+/-  (Chapter 5) 
Emx1Cre+/- ; R26YFP+/+  (Chapter 5) 
Apclox/lox    (Chapter 6) 
Apclox/lox; R26YFP+/-    (Chapter 6) 
All transgenic mice were viable prior to intervention. For Cre-mediated Apc 





2.1.3 Injection of S-phase tracer 
For pulse labelling of S-phase cells at in vivo experimental end points, 200 µl of a 
100 µg/ml Bromodeoxyuridine (BrdU, Sigma) solution in 0.9% NaCl was injected 
intra-peritoneally (IP) to pregnant females two hours prior to dissection.   
2.1.4 Tamoxifen-induced gene recombination 
To activate CreERT2 transgene activity, tamoxifen (Sigma) was dissolved in corn oil 
(Sigma) by sonication for one hour at 37°C at dose-dependent concentrations. 
Induction in embryos was performed using a single dose between 10-12 mg (as 
specified in the relevant results section) administered in 200 µl corn oil by gavage 
into the stomach of pregnant mothers bearing embryos aged between E13.5 and 
E16.5. Induction in early postnatal pups was performed using a single dose of 1.5 mg 
administered in 50 µl corn oil by subcutaneous (SC) injection to the neck fold. 4-
hydroxy (4-OH) tamoxifen was prepared by sonication in 10% Cremaphor (Sigma) 
/H2O and a final amount of 50 µg was also delivered by the same SC method.  
2.1.5 In utero electroporation mediated gene recombination 
E13.5 timed pregnant females were anaesthetised by inhalation with isoflurane and 
maintained in anaesthesia with O2 delivered through a facemask. Uterine horns were 
surgically exposed and approximately 3 µl of purified pCAG-Cre-IRES2-EGFP 
plasmid DNA (Woodhead et al., 2006) (>1.5 µg/µl) in H2O with 2 mg/ml Fast Green 
(Sigma) was injected into the fourth ventricle to each embryo using pulled glass 
capillaries inserted through the roof plate into the ventricle. A PV820 Picrospritzer 
(WPI) was used to deliver short bursts of plasmid solution until the Fast Green dye 
was visible filling the ventricle. Forceps-type electrodes (7 mm, Harvard Apparatus) 
were then positioned around the MHJ of embryos outside the uterine wall (anode 
oriented to the right) and a CUY21 electroporator (Nepa-gene) was used to deliver 
five pulses with the following parameters: intensity = 45V, pulse length = 50ms, 
pulse interval = 950ms. At the end of the procedure uterine horns were repositioned 
in the abdomen and the smooth muscle lining was closed with grade 5 sutures and 




stages during embryonic development and those with successful electroporations 
were identified by epifluorescence microscopy for GFP expression within the 
cerebellum.  
 
2.2 Molecular biology based methods 
2.2.1 Genomic DNA extraction 
Genotypes of all mouse lines were determined using polymerase chain reaction 
(PCR) on genomic DNA extracted from collected embryo limb or adult mouse ear 
clip using the HotShot DNA extraction method (Truett et al., 2000). Tissue was lysed 
by heating to 96°C for 30 minutes in 50 µl lysis buffer (25 mM NaOH, 0.2 mM 
disodium EDTA, pH 12). Samples were then cooled to 4°C and neutralised by 
adding an equal volume of neutralisation buffer (40 mM Tris-HCL, pH5) prior to 
storage at -20°C.  
2.2.2 Genotyping 
Oligonucleotide primers used to genotype by polymerase chain reaction (PCR), their 
appropriate cycling conditions and expected product sizes differed between alleles 
being tested for (Table 2.1). Reactions were all prepared using 12.5 µl GoTaq Green 
master mix (Promega), 0.4 µM of each primer, 2 µl genomic DNA and H2O to a total 
reaction volume of 25 µl. PCR products were separated using gel electrophoresis. 
2% agarose gels were prepared by dissolving agarose (Seakem) with heat in 1x TBE 
before adding SyberSafe (Invitrogen) at a dilution of 1/10,000. Gels were set at room 
temperature for 30 minutes before PCR products were loaded and electrophoresed 
between 60-80 volts for varying amounts of time. Products were visualised using an 
InGenius transilluminator (Syngene) and GeneSnap imaging software (Syngene) and 




2.2.3 Reverse transcriptase PCR (RT-PCR) 
RNA extraction for reverse transcriptase PCR (RT-PCR) was performed on <5 mg 
freshly dissected and snap frozen cerebellum tissue. Tissue was dissected after 
inhaled anaesthetisation with isoflurane followed by decapitation. RNA was 
extracted using an RNeasy Minikit (Qiagen) or, for snap frozen ex vivo cerebellum 
slices, using an RNeasy Microkit (Qiagen) following the manufacturers instructions. 
On-column DNA digestion was performed in all cases during extraction to eliminate 
genomic DNA contamination. cDNA was synthesised from 50ng RNA (measured by 
Nanodrop, Thermo Scientific) using a Sensiscript reverse transcription kit (Qiagen). 
The reactions were prepared with 50ng sample RNA added to 1X RT-Buffer, 10 µM 
random hexamer primers (Promega), 0.5 mM dNTPs (Invitrogen), 10 u RNAse 
inhibitor (Promega), 1 µl Sensiscript reverse transcriptase and made up to 20 µl with 
nuclease free water. Identical reactions were set up in tandem excluding reverse 
transcriptase (-RT) to serve as negative controls for possible genomic DNA 
carryover. Reactions were carried out at 37°C for 60 minutes and stored at -20°C. 
PCR reactions on the synthesised cDNA were carried out as described above using 
conditions specific to each primer pair (Table 2.2).  
2.2.4 Quantitative gene expression analysis 
Quantitative RT-PCR (qRT-PCR) was performed using a Precision qPCR 
SYBRgreen detection kit (PrimerDesign) and commercially synthesised primer pairs 
(PrimerDesign) with an Opticon DNA Engine (MJ Research) following the 
manufacturer’s instructions. All primers used had annealing temperatures of ~58°C 
and an amplicon size of 90-120bp. Reactions were prepared in 20 µl with 1X 
Precision qPCR mastermix, 300nM custom primer pairs, 0.5 µl cDNA (synthesised 
as above) and made up to 20 µl with nuclease free H2O. Reactions were set up in a 
96 well white PCR plate (Bio-Rad) using a QIAgility automated pipetter (Qiagen). 
H2O and –RT negative controls were included for each gene tested. Each reaction 
was begun with a 10 minute 95°C denaturation step followed by 40 cycles of: 
denaturation 15 seconds 95°C, data collection 60 seconds 60°C. Fluorescence was 





For each gene analysed a set of six two-fold serial dilutions of control cDNA (a 
pooled collection of all sample cDNAs analysed) was tested in order to generate a 
standard curve of arbitrarily assigned transcript units. Relative amounts of gene-
specific template present in the sample cDNA were then interpolated from this 
graph. Quantitation was carried out by comparing the relative amounts of gene-
specific template cDNA to a housekeeping reference gene. The appropriate reference 
gene for analysis was identified using a GeNorm reference gene selection kit 
(PrimerDesign). This involved a test of six common reference genes by qPCR with a 
sample of the test cDNA followed by statistical analysis using qBasePLUS 
(BioGazelle). This analysis determined EIF4A2 and 18S as the genes that varied least 
between samples. Direct comparison of these two genes across all samples revealed 
the least amount of variation in expression of EIF4A2 therefore this was used for 
analysis (Appendix 1). Relative amounts of transcript for each gene analysed were 
normalised to EIF4A2 in each case and expressed as a ratio. For every gene analysed, 
samples were run in triplicate using cDNA collected from three individual slices 
from each sample group. 
2.2.5 Plasmid transformation, cloning and purification 
TOP10 chemically competent E. coli cells (Invitrogen) were transformed with 
purified plasmid DNA by incubating on ice for 30 seconds followed by heat shock at 
42°C for 90 seconds before returning to ice. Cells were recovered in 450 µl SOC 
medium (Invitrogen) at 37°C for one hour with shaking before being plated onto pre-
warmed LB agar (1% tryptone, 0.5% yeast extract, 1% NaCl, 1.5% agar, pH 7, 
Sigma) ampicillin (50 µg/ml, Roche) plates and incubated overnight at 37°C. 
Colonies were picked, streaked onto a fresh plate and incubated at 37°C for 4-6 
hours. Cloning was carried out by inoculating 150 ml LB medium (Sigma) with cells 
scraped from a single plate and growing overnight at 37°C with shaking. Midiprep or 
Miniprep (Qiagen) plasmid purification was then carried out according to the 




Table 2.1 - Primer sequences and conditions used for PCR genotyping 
 





Apc Fw 5’ CACTCAAAACGCTTTTGAGGGTTGAAT 3’ 
Rv 5’ GTTCTGTATCATGGAAAGATAGGTGGT 3’ 








Cre Fw 5’ CATTTGGGCCAGCTAAACAT 3’ 
Rv 5’ ATTCTCCCACCGTCAGTACG 3’ 




R26YFP Fw 5’ AAAGTCGCTCTGAGTTGTTAT 3’ 
Rv 5’ GGAGCGGGAGAAATGGATATG 3’ 







LacZ Fw 5’ CGAAATCCCGAATCTCTATCGTGC 3’ 
Rv 5’ GATCATCGGTCAGACGATTCATTGG 3’ 




Mg  Fw 5’ CCCCCAAGTTGGTGTCAAAAGCC 3’ 
Rv 5’ ATGCTCTCTGCTTTAAGGAGTCAG 3’ 















Wnt1 Fw: 5’ TGCACCTGCGACTACCGGCG 3’ 
Rv: 5’ GTGCGCGGGGTGTTCGGGCT 3’ 




Wnt2 Fw: 5’ CGGCCTTGTTTACGCCATC 3’ 
Rv: 5’ TGAATACAGTAGTCTGGAGAA 3’ 




Wnt2b Fw: 5’ GCCAAAGAGAAGAGGCTTAA 3’ 
Rv: 5’ TCAGTCCGGGTGGCGTGGCG 3’ 




Wnt3 Fw: 5’ GCCGACTTCGGGGTGCTGGT 3’ 
Rv: 5’ CTTGAAGAGCGCGTACTTAG 3’ 




Wnt3a Fw: 5’ ATTGAATTTGGAGGAATGGT 3’ 
Rv: 5’ CTTGAAGTACGTGTAACGTG 3’ 




Wnt4 Fw: 5’ GGCGTAGCCTTCTCACAGTC 3’ 
Rv: 5’ TGCATTCCGAGGCACCAGCG 3 




Wnt5a Fw: 5’ TCCTATGAGAGCGCACGCAT 3’ 
Rv: 5’ CAGCTTGCCCCGGCTGTTGA 3’ 




Wnt6 Fw: 5’ ATGGATGCGCAGCACAAGCG 3’ 
Rv: 5’ TTTGCCGTCGTTGGTGCCCA 3’ 




Wnt7a Fw: 5’ CAAGGCCAGTACCACTGGGA 3’ 
Rv: 5’ GGCTCCACGTGGACGGCCTC 3’ 




Wnt7b Fw: 5’ CAAGGCTACTACAACCAGGC 3’ 
Rv: 5’ CACCTCCACCTGCACCGCTG 3’ 




Wnt9a Fw: 5’ CAGCACTACCAATGAAGCCA 3’ 
Rv: 5’ CCTCGGCCACAACAAATACT 3’ 







Wnt9b Fw: 5’ CTACGCTATGACACGGCTGT 3’ 
Rv: 5’ GTACTTGCTGGGCCGGCAGA 3’ 




Wnt10a Fw: 5’ AAAGTCCCCTACGAGAGCCC 3’ 
Rv: 5’ CAGCTTCCGACGGAAAGCTT 3’ 




Wnt10b Fw: 5’ CGGCTGCCGCACCACAGCGC 3’ 
Rv: 5’ CAGCTTGGCTCTAAGCCGGT 3’ 




Wnt11 Fw: 5’ GCCATGAAGGCCTGCCGTAG 3’ 
Rv: 5’ GATGGTGTGACTGATGGTGG 3’ 




Wnt16 Fw: 5’ CCCTCTTTGGCTATGAGCTG 3’ 
Rv: 5’ CATGCCGTACTGGACATCAT 3’ 




Axin2 Fw: 5’ GGCCCAGAGCAAGAGAGGTATC 3’ 
Rv: 5’ ACGCACGATTTCCCTCTCAGC 3’ 




!-Actin Fw: 5’ GAACAACAGCGTTGTCTCCA 3’ 
Rv: 5’ TGGGGAGGTAGCCACATAAG 3’ 









2.3 Tissue preparation 
2.3.1 Tissue collection and fixation 
Embryos were collected between E12.5 and E18.5 and pups between P1 and P21. 
Heads from embryos up to E15.5 and brains dissected from E16.5-E18.5 embryos 
were immersion fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) 
overnight at 4°C.  
2.3.2 Transcardial perfusion 
All postnatal mice were transcardially perfused prior to tissue fixation. Mice were 
terminally anaesthetised with sodium pentobarbital delivered via IP injection. The 
thoracic cavity was opened, exposing the heart, and perfusion was carried out 
through the left cardiac ventricle with 5-10 ml PBS followed by 5-10 ml 4% 
PFA/PBS. Tissue of interest was dissected and then immersion fixed overnight in 4% 
PFA.  
2.3.3 Tissue preparation and sectioning 
After fixation, embryonic and postnatal tissue for wax embedding was washed and 
dehydrated through increasing concentrations of ethanol prior to embedding in 
paraffin wax using an automated tissue processor (Tissue-Tek, Sakura). 10 µm serial 
sections were cut on a microtome and mounted on Superfrost plus slides (BDH). 
Tissue for in situ hybridisation and frozen immunohistochemistry was fixed as above 
before being cryoprotected in 30% sucrose/PBS overnight and then embedded in a 
1:1 solution of 30% sucrose/OCT (Raymond A Lamb Ltd) and snap frozen on dry 






2.4 Histological analysis 
2.4.1 DAB immunohistochemsitry 
For immunohistochemistry with a diaminobenzidine (DAB) chromogenic end point, 
sections were dewaxed in xylene before being rehydrated through decreasing 
concentrations of ethanol to PBS. Antigen retrieval was achieved by microwaving 
sections at full power in 10 mM citrate buffer (pH6.0) for five minutes followed by 
15 minutes at medium power. Slides were left to cool for 20 minutes and washed in 
0.1% Triton-X (Sigma)/PBS (PBST) before blocking in 10% normal goat serum 
(NGS) in PBST. Primary antibody incubations were carried out overnight at 4°C 
with antibodies diluted in blocking solution and then washed in PBST (primary 
antibodies used and their concentrations are detailed in Table 2.3). Secondary 
antibody incubation was carried out using species-specific biotin-conjugated 
antibodies (goat anti-mouse IgG and goat anti-rabbit IgG, 1:200 Dako) for one hour 
at room temperature. After a further PBST wash, bound antibody was revealed after 
incubation for one hour with an ABC kit (Vector), followed by a DAB and hydrogen 
peroxide reaction using the DAB detection kit (Vector) for 1-3 minutes. Following 
DAB reaction certain slides were counterstained with Harris-haematoxylin for 30 
seconds (Thermo Shandon). After staining, slides were washed and dehydrated 
through increasing concentrations of ethanol and xylene prior to mounting under 
coverslips in DPX mounting solution (BDH).  
2.4.2 Fluorescent immunohistochemistry 
For immunofluorescent staining, wax sections were rehydrated as above, while 
frozen sections were air-dried and washed in PBS. Antigen retrieval was carried out 
as above for wax sections, alternatively frozen sections (if antigen retrieval was 
carried out) were microwave heated on a medium setting for five minutes followed 
by gently simmering for 15 minutes. Blocking and primary antibody incubation was 
carried out in an identical manner to that for DAB immunohistochemsitry. For 
double immunofluorescence, primary antibodies raised in two different species were 




the secondary antibody used. Primary antibodies were then detected using species 
specific secondary antibodies conjugated to Alexa fluor-488 or -568 dyes (goat anti-
rabbit, goat anti-mouse, donkey anti-goat, donkey anti-rabbit, donkey anti-mouse, 
1:200, Molecular Probes) for 1 hour at room temperature. Nuclei were 
counterstained with TOPRO3 (1:1000, Molecular Probes), washed in PBS and 
mounted under coverslips in Vetashield hardest (Vectorlabs) or ProLong Gold 
(Invitrogen). Appropriate controls were used in all cases by incubating sections with 
all but the primary antibodies. No staining was observed under these conditions. 
2.4.3 RNA in situ hybridisation 
In situ hybridisation on frozen section was performed as described previously 
(Wallace and Raff, 1999). LacZ and Axin2 antisense riboprobes (Fotaki et al., 2011b) 
were obtained in plasmid DNA from V. Fotaki (University of Edinburgh). Plasmid 
cloning and purification was undertaken as described above. 10 µg Axin2 plasmid 
DNA was linearised by restriction digest with Kpn1 (New England Biolabs) and !-
gal was linearised with Not1 (Promega) in a 200 µl reaction with 1X restriction 
digest buffer (New England Biolabs, Promega) and nuclease free H2O at 37°C for 
three hours. Successful digestion was confirmed by gel electroporesis on a 1% 
agarose gel and the linear product was purified using a standard phenol-chloroform 
isoamyl alcohol (PCIA) DNA precipitation protocol (Appendix 2). DIG-UTP 
labelled RNA probes were then transcribed and labelled from 1 µg purified linear 
plasmid DNA using a T7 (LacZ) or T3 (Axin2) RNA polymerase (Roche) with a 
DIG-UTP RNA labelling kit (Roche) following the manufacturers instructions. 
Labelled probes were purified by digestion with DNaseI (Roche) at 37°C for 15 
minutes followed by precipitation of the probe with LiCl in absolute ethanol at -20°C 
overnight. Precipitate was isolated by centrifugation and then resuspended in 50 µl 
nuclease free H2O and stored at -20°C.  
 
Frozen sections for in situ hybridisation were brought to room temperature in a 
sealed container (to minimise RNA degradation from condensation on slides) for 30 
minutes. DIG-labelled RNA probes were diluted (Axin2 1/20, lacZ 1/50) in 




diluted probe was then diluted a further 1/100 in hybridisation buffer and applied to 
sections. Slides were covered with coverslips and incubated overnight at 65°C in a 
humidified box. Slides were washed three times in wash buffer (Appendix 3) at 65°C 
for 30 minutes followed by two washes in MABT (Appendix 3) at room temperature 
for 30 minutes. Sections were then blocked for 2-4 hours at room temperature in 
blocking solution (Appendix 3) before applying a 1:1500 dilution of sheep anti-DIG 
antibody (BM) in blocking solution and incubating overnight at 4°C. Following 
antibody incubation slides were washed in MABT five times for 20 minutes each and 
then equilibrated in pre-staining buffer (Appendix 3) for 10 minutes before being 
developed in NBT/BCIP staining buffer (Appendix 3) in the dark at room 
temperature until a stain was observed. Slides were then washed in PBS and mounted 
under coverslips with Aquamount (BDH). In all experiments, some sections were 
treated without any probe to control for background staining.  
2.4.4 Microscopy and image analysis 
A Leica brightfield microscope connected to a Leica DFC 480 digital camera was 
used to capture images of DAB labelled sections. A Leica brightfield microscope 
connected to a Leica DFC360Fx camera was used to capture images of fluorescently 
labelled sections. High resolution fluorescent microscopy was carried out using an 
inverted Zeiss LSM510 confocal system in the IMPACT facility, School of 
Biomedical Sciences. Images were processed for analysis and presentation using 
Photoshop CS4 (Adobe) or ImageJ (v10.2). Occasionally brightness and contrast of 
images were adjusted to improve clarity. In all images that were adjusted, changes 




Table 2.3 - Primary antibody details and suppliers 
 





!-catenin Mouse Monoclonal 1:500  BD Biosciences 
!-galactosidase Rabbit Polyclonal 1:1000 (wax) 
1:500 (frozen) 
Molecular Probes 
!-galactosidase Mouse Monoclonal 1:100 DSHB* 
BrdU Mouse Monoclonal 1:50 BD Biosciences 
Calbindin Mouse Monoclonal 1:500 Swant 
Caspase3 Mouse Monoclonal 1:50 New England 
Biosciences 
GFP Goat Polyclonal 1:400 Abcam 
GFP Rabbit Polyclonal 1:1000 Abcam 
Nestin Mouse Monoclonal 1:50 DSHB* 
NeuN Mouse Monoclonal 1:500 Millipore 
GFAP Rabbit Polyclonal 1:400 Sigma 
Pax2 Rabbit Polyclonal 1:200 Covance 
PCNA Mouse Monoclonal 1:500 Abcam 
s100! Mouse Monoclonal 1:500 Abcam 
Sox9 Rabbit Polyclonal 1:1000 Millipore 
 
*DSHB developed under the auspices of the NICHD and maintained by the University of 




2.5 Organotypic culture methods 
2.5.1 Tissue preparation 
Organotypic slice culture procedures generally followed those of Anderson et al. 
(Anderson et al., 1997). Embryos were dissected at E18.5 in 1X Kreb’s buffer on ice. 
Brains were removed and placed into 1X Kreb’s buffer with 10 mM HEPES buffer 
(Invitrogen), Gentamicin (Sigma) and Penicillin-Streptomycin (Invitrogen). The 
MHB regions were microdissected and embedded in molten 4% LMP agarose 
(Seakem)/PBS at 43°C with stirring and solidified on ice. Tissue was sectioned 
sagitally on a vibratome (Leica) at a thickness of 300µm.  Slices were collected into 
1X Kreb’s buffer with HEPES and antibiotics and held on ice prior to culturing.  
2.5.2 Culturing technique 
Collected vibratome slices were transferred to 13 mm, 8 µm nucleopore 
polycarbonate membranes (Whatman) floating on 2 ml of 10% FCS (Gibco) and 
0.5% glucose (Sigma) supplemented MEM (Gibco) with Penicillin-Streptomycin in a 
7cm Petri dish. The time this was done was taken as T0. Explants were allowed to 
recover at 37°C with 5% CO2 for one hour before media was replaced with serum-
free Neurobasal medium (Gibco) supplemented with 2% B-27 (Sigma), glucose, L-
glutamine and Penicillin-Streptomycin (T0 + 1).  
2.5.3 Small molecule administration 
Small molecules for activation or inhibition of the Wnt/!-catenin signalling pathway 
(Table 2.4) were dissolved to a stock concentration of 10 mM in DMSO (Sigma) and 
stored at -80°C for long term or -20°C for short term storage. Working solutions 
were prepared at varying concentrations in pre-warmed Neurobasal medium plus 
supplements so that DMSO never had a final concentration of  >1%. After explant 
slices were equilibrated in Neurobasal medium plus supplements for three hours, the 
medium was replaced with that containing the particular small molecule (T0 + 3). 




2.5.4 Processing of slices for analysis 
At T0 + 25, BrdU was added to the culture medium (final concentration 10 mg/ml) 
before the end point at T0 + 27. For histological analysis slices were lifted from the 
membranes and immersion fixed in 4% PFA/PBS overnight at 4°C. Slices were then 
washed in PBS before cryoprotecting in 30% Sucrose at 4°C for 2-4 hours and 
embedding in a 1:1 solution of 30% sucrose/OCT and snap freezing on dry ice. 
Slices were then further sectioned at 14µm on a cryostat. For RNA extraction and 
qRT-PCR, slices were lifted from the membranes and the agarose was removed in 
cold, sterile PBS before the slice was snap frozen on dry ice.  
 
2.6 Statistical analysis 
The extent of statistical analysis performed in this thesis was limited to direct 
comparison of two individual groups. Thus, the student’s T-test was used, assuming 
unequal variance and normal distribution unless otherwise stated. Analyses were 
performed and charts prepared using Prism 4 (GraphPad). Specific quantitation 
methods used for each experiment are detailed in the methods sections of the 





Table 2.4 - Small molecule Wnt/"-catenin pathway modulators used 
 
Compound Full name Pathway effect Source Reference 
BIO 6-bromoindirubin-
3’-oxime 
Activator Sigma (Sato et al., 2004) 
 
 
CHIR CHIR99021 Activator Cambridge 
Biosciences 






Inhibitor of Wnt 
production – 2 
Inhibitior Sigma (Chen et al., 2009) 
XAV 
 
XAV939 Inhibitor Sigma (Huang et al., 2009) 
iCRT3 Inhibitor of !-
catenin responsive 
transcription 







3 In vivo analysis of Wnt/!-catenin signalling during 
cerebellum development 
3.1 Introduction 
A number of developmental signalling pathways have been identified that direct 
cerebellum development, however a role for the Wnt/!-catenin signalling pathway 
has only been partially resolved – despite a number of functions having been defined 
in development of the cortex (Kalani et al., 2008; Munji et al., 2011; Mutch et al., 
2009; Wexler et al., 2009). In order to understand how the Wnt/!-catenin signalling 
pathway contributes to development of the cerebellum, I first sought to identify 
where and when its activity is present. However, the complexity of the Wnt/!-catenin 
signalling pathway presents a number of challenges in approaching a spatio-temporal 
analysis such as this.  
 
The Wnt/!-catenin pathway is only a small part of a large signal transduction 
network. 19 known Wnt ligands bind in a myriad of different permutations with 10 
different Fz receptors and LRP5/6 co-receptors and then go on to signal through 
three interacting pathways – of which the Wnt/!catenin pathway is one (van 
Amerongen and Nusse, 2009). In addition, downstream gene expression directed by 
the Wnt/!-catenin pathway is entirely context dependent (i.e. different cell types at 
different developmental stages will respond to a Wnt/!-catenin signal with the 
expression of different downstream target genes). Combined, the complexity of this 
signalling network means there is no universal read-out for Wnt/!-catenin signalling 
in the form of an endogenous gene or protein that can be readily used to identify 
active signalling domains. A generally accepted exception to this is the protein 
Axin2, which is routinely used as a marker for Wnt/!-catenin signalling. Axin2 
encodes a negative feeback inhibitor of the Wnt/!-catenin signalling pathway and is 
a direct target of TCF/LEF-mediated transcription (Jho et al., 2002). Unlike other 
downstream Wnt/!-catenin target genes Axin2 is peculiar in that it does not appear to 




catenin activity. However, it remains an endogenous Wnt/!-catenin target and is 
therefore subject to a certain degree of regulation that raises concern about its ability 
to report Wnt/!-catenin signalling in all contexts. 
 
To address this, a number of different transgenic reporter mice have been generated 
that express an easily detectable protein (usually !-gal) in cells transducing a Wnt/!-
catenin signal. The first of these was the TOPGAL line (DasGupta and Fuchs, 1999), 
which expresses !-gal under control of a minimal promoter (c-fos) and three 
TCF/LEF binding sites. Similar mice have been generated with the same construct 
theme, including the BAT-gal line (Maretto et al., 2003), the TCF/Lef-LacZ line 
(Mohamed et al., 2004) and the BATLacZ line (Nakaya et al., 2005) – the key 
differences being the minimal promoters used and the number of TCF/LEF binding 
sites regulating expression of the reporter gene. While a number of limitations exist 
for the use of artificial reporter systems such as these (Barolo, 2006), as long as due 
caution is exercised in interpretation of results they can provide an efficient and 
convenient method for identifying sites of Wnt/!-catenin signalling activity.  
 
3.2 Aims and experimental design 
The aims for this chapter were to: 
1. Identify the regional localisation of Wnt/!-catenin signalling activity in 
the developing cerebellum. 
2. To determine the cell lineages responding to Wnt/!-catenin signalling 
during development. 
 
To address these aims I utilised the BAT-gal reporter mouse line (Maretto et al., 
2003) and performed a series of immunohistochemistry and in situ hybridisation 
experiments for the !-gal reporter protein, its encoding mRNA LacZ and an 
independent Wnt/!-catenin target Axin2 at the following time points: E12.5, E14.5, 
E18.5, P1, P5, P10 and P21. These time points were chosen as they cover the key 




of the key signalling domains, a series of double immunofluorescence experiments 
for the !-gal reporter protein and markers of the main cerebellar cell lineages were 
performed in order to determine the identity of cells expressing the !-gal reporter 
protein and thus responding to a Wnt/!-catenin signal. Lastly, a follow up 
experiment was performed using RT-PCR on RNA extracted from dissected 
cerebellum at E18.5 onwards to identify the Wnt ligands expressed. 
 
3.3 Analysis of Wnt/!-catenin signalling in the embryonic 
cerebellum 
3.3.1 !-gal protein expression at E12.5  
Serial sagittal sections of E12.5 cerebellum tissue were analysed for expression of 
the !-gal reporter protein. DAB immunohistochemistry revealed diffuse expression 
centred around the IsO at the anterior end of the cerebellar anlage and the RL to the 
posterior (Fig. 3.1A-B). From these two key signalling centres !-gal expression 
spreads in an apparent gradient, with staining stronger towards the pial surface. This 
pattern was consistent for both medial (Fig. 3.1A) and lateral (Fig. 3.1B) sections, 
although the diffuse nature of the staining is more apparent medially while laterally 
the staining becomes more restricted to the anterior and posterior ends of the 
cerebellum revealing a void of !-gal expression within the VZ. In addition, !-gal 
expression is also observed in the dorsal monolayer of cells making up the surface of 
the CP (Fig. 3.1B), compared to the ventral surface of the CP which shows no 
evidence of !-gal expression. However, the ventral surface of the CP leads into the 
LRL and DHB, which display patchy expression of the !-gal reporter protein.  
Medial
A
Figure 3.1 - Expression of the BAT-gal reporter and Wnt/!-catenin target gene 
Axin2 in the E12.5 cerebellum. 
DAB immunohistochemsitry for !-gal on medial (A) and lateral (B) sagittal sections 
of E12.5 cerebellum revealed expression at the isthmis organizer (IsO) and the upper 
rhombic lip (URL). !-gal protein was validated as a Wnt/!-catenin reporter by in situ 
hybridisation for its encoding LacZ mRNA (C-D) and independent Wnt/!-catenin 
downstream target Axin2 (E-F) on matched sections. Both of these revealed similar, 
although not identical, expression patterns. Scale bar = 100 "m. (CP = choroid 































3.3.2 LacZ mRNA expression at E12.5  
As the !-gal protein may persist in cells after transcription of the BAT-gal transgene 
has ceased, immunohistochemsitry for !-gal may stain cells that are no longer 
transducing a Wnt/!-catenin signal. Therefore, analysis of LacZ mRNA (the coding 
sequence for the !-gal protein) was carried out to test whether the !-gal expression 
pattern identified reliably reflects transcription of the BAT-gal transgene. In situ 
hybridisation analysis using riboprobes for LacZ mRNA was undertaken on sagittal 
sections of E12.5 cerebellum matched to those analysed with !-gal 
immunohistochemistry (Fig. 3.1C-D). Consistent with the observations made with !-
gal immunohistochemistry, LacZ mRNA expression was observed at the Iso in the 
anterior and the RL in the posterior of the cerebellar anlage, with a notable void in 
staining observed along the ventricular zone and internally between the two domains. 
This pattern was consistent between both medial (Fig. 3.1C) and lateral (Fig. 3.1D) 
sections. However, it is clear that the LacZ mRNA represents a slightly more 
restricted pattern than the !-gal protein (compare Fig. 3.1A-B with Fig. 3.1C-D). 
Particularly in the medial region, the extent of !-gal protein expression appears 
considerably more widespread than LacZ mRNA. Another clear difference between 
!-gal protein and LacZ mRNA expression patterns is observed within the dorsal 
monolayer of cells lining the CP. While !-gal protein is expressed in this cell 
population from the RL to the midpoint of the CP, LacZ mRNA expression is 
markedly more restricted and does not extend quite so far around. Taken together, 
these results show a minor disparity between !-gal protein expression and LacZ 
mRNA expression indicative of perdurance of the protein in certain cells beyond the 
cessation of Wnt/!-catenin signal transduction.  
3.3.3 Axin2 mRNA expression at E12.5 
As an independent verification that the BAT-gal reporter expression observed 
through !-gal immunohistochemistry and LacZ in situ hybridisation represents bona 
fide Wnt/!-catenin signalling activity, in situ hybridisation was performed with 




sections matched to those used for BAT-gal reporter expression analysis revealed 
Axin2 expression in the key domains identified as Wnt/!-catenin responsive areas 
(Fig. 3.1E-F). Namely, the RL and IsO – thus supporting the BAT-gal expression 
identified in these regions as genuine. However, several notable differences are 
obvious when the two expression profiles are compared (compare Fig. 3.1A-D with 
Fig. 3.1E-F). 
 
Firstly, Axin2 appears to be expressed in a much more diffuse gradient than !-gal or 
LacZ. For example, the RL displays strong expression of Axin2, which gradually 
decreases along the ventricular surface in an anterior direction, a pattern not mirrored 
by !-gal or LacZ expression. The expression of Axin2 appears to spread further away 
from the RL than !-gal or LacZ, and also appears to spread along the ventral surface, 
while !-gal and LacZ are not expressed as strongly in the VZ. This is particularly 
evident in lateral sections (Fig. 3.1B,D,F). Secondly, the LRL and dorsal hindbrain 
also display strong expression of Axin2 (Fig. 3.1F), which is not consistent with the 
pattern of !-gal or LacZ observed (Fig. 3.1 B,D). Axin2 is expressed in a gradient 
from the ventral CP through the LRL and into the DHB, while !-gal and LacZ are 
expressed more sporadically throughout this region and in no clear gradient. Finally, 
there is also some disparity between the expression of Axin2 and the BAT-gal 
reporter at the IsO. While !-gal and LacZ are both expressed at the IsO and in a large 
region of cerebellar tissue immediately posterior to the IsO, Axin2 expression is 
markedly more restricted. The Axin2 expression at the IsO is not as strong as that 
observed at the RL, and is not expressed as abundantly in the anterior cerebellum as 
!-gal or LacZ.  
3.3.4 !-gal protein expression at E14.5  
I next examined sections of E14.5 cerebellum for expression of the !-gal reporter 
protein.  By E14.5 the cerebellum has grown in size, and the fate of cells being 
generated at the two germinal centres have changed. DAB immunohistochemistry on 
sagittal sections revealed an expression similar, but not identical, to that observed at 




cerebellar tissue immediately posterior to it, and at the RL (Fig. 3.2A). However, a 
number of differences can be observed between the expression patterns at E14.5 and 
E12.5.   
 
Firstly, expression of !-gal along the VZ appears more restricted at E14.5, except for 
the region immediately anterior to the RL and posterior to the IsO, indicating that the 
cell types being generated along most of the length of the VZ at this time point are 
not doing so in response to a Wnt/!-catenin signal. This is particularly evident in 
coronal sections of the E14.5 cerebellum, which shows the medial-lateral extent of 
the VZ in each of the cerebellar hemispheres with !-gal staining being restricted to 
the RL, which lies at the lateral edges in this plane of section (Fig. 3.2B). In addition, 
!-gal expression at the anterior and posterior limits of the cerebellum (the IsO and 
RL respectively) appears generally more restricted than at E12.5, with less diffuse 
staining within the cerebellar anlage. At the RL, while some diffuse expression was 
observed anterior to the URL at E12.5, the expression at E14.5 is restricted to the 
URL and spreads in a specific dorsal and anterior direction away from the URL – 
likely representing GPCs migrating away from the URL on the pial surface forming 
the early EGL.  
 
Double immunofluorescence for !-gal and PCNA – a DNA binding protein involved 
in DNA replication and cell division (Hall, 1990) that marks cells in mitotically 
active germinal centres – confirms the expression of !-gal within the URL and in the 
EGL (Fig. 3.2C-D).  Fluorescent immunohistochemsitry for PCNA clearly identifies 
the VZ, URL and EGL. !-gal expression is expectedly restricted to the IsO and RL. 
Closer magnification of the URL reveals the extent of colocalisation between !-gal 
and PCNA in this region (Fig. 3.2D).   
A
Figure 3.2 - Expression of the BAT-gal reporter and Wnt/!-catenin target gene 
Axin2 in the E14.5 cerebellum.
At E14.5 immunohistochemsitry on sagittal sections (A) revealed !-gal expression at 
the IsO, RL and early EGL (arrowheads). Coronal sections (B) confirmed the lack of 
!-gal  expression along the medial-lateral extent of the VZ. Double 
immunofluorescence for !-gal  and PCNA (C) confirmed the expression pattern 
observed. Higher magnification confirmed the presence of !-gal+ cells in the URL 
and early EGL (D). In situ hybridisation for LacZ (E) and Axin2 (F) showed a similar 
although not identical expression pattern. Scale bars: A,C,E-F = 100 "m, B = 500 


































3.3.5 LacZ mRNA expression at E14.5 
Analysis of LacZ mRNA expression at E14.5 by in situ hybridisation revealed a 
pattern that was clearly more restricted than that observed for the !-gal protein (Fig. 
3.2E), again likely reflecting the perdurance of the !-gal protein. Importantly though, 
the key domains identified through !-gal expression at E14.5 were readily 
identifiable as expressing LacZ, namely, the IsO, RL and early EGL. The URL in 
particular shows very clear staining that is restricted to that domain and does not 
extend into adjacent cerebellar tissue, with the exception of the bifurcated pattern 
with expression observed in the early EGL and most posterior region of the VZ. In 
addition, staining for LacZ mRNA ceases at the posterior end of the URL while the 
!-gal protein can be detected extending along the dorsal surface of the CP (Fig. 
3.2A). Light DAB staining for !-gal is also observed within the cerebellar anlage, 
which is absent from the LacZ staining observed, again, likely reflecting perdurance 
of !-gal protein. In comparison to the LacZ expression pattern observed at E12.5, 
expression at E14.5 appears much more restricted to the anterior and posterior limits 
of the cerebellum, with less spreading of LacZ expression into the cerebellar anlage.  
3.3.6 Axin2 mRNA expression at E14.5 
Axin2 mRNA expression at E14.5 was analysed by in situ hybridisation in order to 
test the validity of the !-gal and LacZ expression patterns observed (Fig. 3.2F). 
Importantly, Axin2 mRNA expression is observed in the key domains identified 
through !-gal and LacZ expression – the IsO and RL – supporting the conclusion that 
these areas are sites of active Wnt/!-catenin signalling. However, there are several 
notable differences between the expression of LacZ/!-gal and Axin2 at E14.5. 
Consistent with observations made at E12.5, the LRL at E14.5 displays sporadic 
expression of LacZ (Fig. 3.2E) whereas Axin2 expression appears much more 
widespread from the ventral limit of the CP and across the extent of the LRL with an 
abrupt boundary at the DHB (Fig. 3.2F). In addition to this clear difference, Axin2 
does not appear to be expressed quite so markedly within the forming EGL 
compared to the obvious expression of !-gal and LacZ in this region. Instead Axin2 




3.4 Analysis of Wnt/!-catenin signalling in the perinatal 
cerebellum 
3.4.1 !-gal protein expression at E18.5  
The cerebellum undergoes a number of obvious morphological changes between 
embryonic (E12.5-E14.5) and perinatal (E18.5-P1) stages. One notable difference is 
the extension of the EGL around the entire pial surface of the cerebellum and its 
expansion to a layer several cells thick, a result of the layer having begun extensive 
proliferation. The ballooning of the anlage and the initiation of the fissures that will 
eventually lead to the mature folia is also noticeable as terminally differentiated GCs 
begin to migrate internally from the EGL to the early IGL. Consistent with the 
significant changes to cerebellar morphology at E18.5, !-gal immunohistochemsitry 
revealed a strikingly different expression pattern than that observed at the earlier 
time points.  
 
While the early forming EGL at E14.5 showed expression of !-gal (Fig. 3.2A), the 
more advanced EGL at E18.5 did not (Fig. 3.3A). Scattered !-gal+ cells can be 
observed at the posterior limit of the EGL (site of the former URL) but they become 
increasingly rare along the length of the EGL in an anterior direction. This is 
confirmed by double immunofluorescence for !-gal and PCNA on matched sections 
(Fig. 3.3B-C). PCNA labels the highly mitotic EGL and very few !-gal+ cells can be 
observed within the layer (Fig. 3.3B). Higher magnification of the anterior EGL 
reveals the lack of !-gal expression within the layer (Fig. 3.3C). Interestingly, !-gal 
expression is observed abundantly within the developing cerebellum at E18.5 (Fig. 
3.3A-B), compared to embryonic stages where it appeared limited to the anterior and 
posterior limits of the cerebellum. Double immunofluorescence with PCNA reveals 
both !-gal+/PCNA- and !-gal+/PCNA+ cell populations (Fig. 3.3C), likely 
reflecting different states of mitotic activity within the !-gal+ cell population at this 
time point.  
Figure 3.3 - Expression of the BAT-gal reporter and Wnt/!-catenin target gene 
Axin2 in the E18.5 cerebellum.
DAB immunohistochemistry for !-gal on E18.5 sagittal sections (A) revealed 
widespread expression, including predominant staining in the VZ and velem 
medullaris. A similar pattern is observed with double immunofluorescence for !-gal 
and PCNA (B), which confirms the lack of !-gal in the EGL (C) and the presence at 
the VZ (D) under high magnification. In situ hybridisation for LacZ (E) revealed a 
similar expression pattern to !-gal, with notable expression at the VZ and within the 
developing cerebellum. This pattern was not seen with in situ hybridisation for Axin2 
(F) wich displayed a much fainter and more homogenous expression pattern. Scale 





















The most striking observation at E18.5 was the expression of !-gal within the VZ 
(Fig. 3.3A), a region with less !-gal expression at earlier time points. Expression can 
be observed extending along the entire length of the VZ from the IsO, the velum 
medullaris (VM - the thin stretch of cells that joins the IsO to the VZ) to the posterior 
limit of the EGL. An active germinal centre, the VZ expresses PCNA along its length 
(Fig. 3.3B), although double immunofluorescence for !-gal and PCNA reveals a 
mosaic !-gal expression pattern along the length of the VZ, with a mixture of !-gal+ 
and !-gal- cell types in the cell layer and in the cells radiating away from the VZ.  
3.4.2 LacZ expression at E18.5 
Reflecting the pattern of !-gal protein expression observed at this time point, in situ 
hybridisation for LacZ on matched sections revealed a notable lack of staining within 
the EGL, abundant staining along the length of the VZ and scattered staining within 
the cerebellum itself (Fig. 3.3E). This confirms that the !-gal+ cells identified 
through immunohistochemistry at this time point are actively transducing a Wnt/!-
catenin signal.  
3.4.3 Axin2 expression at E18.5 
In situ hybridisation for Axin2 revealed a fainter and more homogenous expression 
pattern (Fig. 3.3F). Consistent with the !-gal and LacZ expression patterns observed, 
Axin2 was present along the VZ. However, staining was also observed at low levels 
within the EGL and very faintly throughout the cerebellum. Overall the expression of 
Axin2 is not entirely consistent with the marked !-gal or LacZ expression observed at 
E18.5.  
3.4.4 !-gal expression at P1 
The rapid growth of the perinatal cerebellum is evident in the dramatic increase in 
size between E18.5 and P1, particularly with regards to the more developed extent of 
foliation. !-gal immunohistochemistry on sagittal sections at this time point revealed 
a similar pattern of !-gal expression to that observed at E18.5. The most obvious 




expression along the length of the VZ and the widespread expression of !-gal+ cells 
within the cerebellum (Fig. 3.4A). Double immunofluorescence with !-gal and 
PCNA confirmed the lack of !-gal+ cells within the EGL (Fig. 3.4B-C), and also 
demonstrated the mitotic heterogeneity of !-gal+ cells inferior to the EGL (i.e. there 
was a mixed population of !-gal+/PCNA- and !-gal+/PCNA+ cell types). The VZ 
also shows a similar pattern of !-gal expression to E18.5 with clear expression 
observed along the length of the VZ cell layer – reflecting the potential of a 
continued role for Wnt/!-catenin signalling in development of this area from E18.5. 
Double immunofluorescence with PCNA to help identify the VZ showed a reduction 
in expression at the VZ, consistent with a reduction in proliferation of this region. 
There was also a more heterogenous cell population compared to E18.5 – with a 
greater mix of PCNA+, !-gal+, and PCNA+/!-GAL+ cells both at the VZ and 
radiating away from the the VZ.  
3.4.5 LacZ expression at P1 
In situ hybridisation for LacZ mRNA at P1 (Fig. 3.4E) confirmed the !-gal 
expression pattern observed (Fig. 3.4A-D). No LacZ expression was observed within 
the EGL, whereas expression was observed within the VZ and internally within the 
cerebellum. However, while the !-gal immunohistochemistry revealed quite a 
widespread pattern of expression within the cerebellum, LacZ appeared more 
restricted to the PCL, which can be seen clearly as a layer that internally outlines the 
developing folia.  Thus, while LacZ and !-gal appear similar, there are minor 
discrepancies between the two expression patterns at this age.  
3.4.6 Axin2 expression at P1 
In situ hybridisation for Axin2 at P1 (Fig. 3.4F) revealed a pattern similar to that 
observed at E18.5. Namely, the general expression pattern appeared faint and 
widespread to the point that identifying clear Axin2 expressing domains was difficult. 
Thus, at this time point there is a clear discrepancy between the expression of Axin2 
and !-gal/LacZ.  
Figure 3.4 - Expression of the BAT-gal reporter and Wnt/!-catenin target gene 
Axin2 in the P1 cerebellum.
DAB immunohistochemistry for !-gal on P1 sagittal sections (A) revealed 
widespread expression, including predominant staining in the VZ and VM. A similar 
pattern is observed with double immunofluorescence for !-gal and PCNA (B), which 
confirms the lack of !-gal in the EGL (C) and the presence at the VZ (D) under high 
magnification. In situ hybridisation for LacZ (E) revealed a similar albeit more 
restricted expression pattern to !-gal, with notable expression at the VZ and within 
the developing cerebellum. This pattern was not seen with in situ hybridisation for 
Axin2 (F), which displayed a much fainter and more homogenous expression pattern. 




















3.4.7 Analysis of !-gal and VZ derived lineage markers at E18.5-P1 
In order to determine the lineage of cells expressing the !-gal reporter protein during 
this perinatal period I tested sections from both E18.5 and P1 cerebellum for 
expression of the interneuron marker Pax2 and glial marker Sox9. The transcription 
factor Pax2 is expressed in committed cerebellar interneuron progenitors after their 
exit from the ventricular zone and prior to their terminal differentiation (Maricich 
and Herrup, 1999), while Sox9 is expressed in VZ progenitors (Kordes et al., 2005; 
Pompolo and Harley, 2001) and subsequently in cells that have become restricted to 
the glial lineage (Kordes et al., 2005; Sottile et al., 2006). Combined, these two 
markers cover the binary nature of cells generated at the VZ at this time point (i.e. 
neuronal or glial). Double immunofluorescence for !-gal and Pax2 at E18.5 (Fig. 
3.5A) and P1 (Fig. 3.5B) revealed that, despite the extensive expression of both 
markers, in no event was there evidence for !-gal expression within the Pax2+ cell 
population. In contrast, double immunofluorescence for !-gal and Sox9 at E18.5 
(Fig. 3.5C) and P1 (Fig. 3.5D) revealed that all !-gal+ cells express Sox9. These data 
suggest that of the cell lineages generated at the VZ perinatally, the !-gal reporter 
protein is expressed within multipotent progenitors and/or those restricted to the glial 
lineage.   
Figure 3.5 - Analysis of !-gal and VZ derived lineage markers at E18.5-P1.  
Double immunofluorescence for !-gal and interneuron marker Pax2 (A-B) revealed 
intermingled expression of !-gal (filled arrowheads) and Pax2 (empty arrowheads), 
but no colocalisation of the two was observed in any cell at E18.5 (A) or P1 (B). 
Analysis of !-gal and glial marker Sox9 (C-D) revealed extensive expression of Sox9 
at both E18.5 (C) and P1 (D), and that all !-gal+ cells also expressed Sox9 (white 
arrows), suggesting the !-gal+ cell population consists of glia or glial progenitors. 







































3.5 Analysis of Wnt/!-catenin signalling during postnatal 
development 
3.5.1 !-gal expression at P5  
By P5 the cerebellum continues to produce vast quantities of granule neurons from 
the EGL resulting in the expansion of the cerebellum to the extent that all 10 folia are 
identifiable. The laminar structure is also more evident at this stage as the mature cell 
types of the cerebellum become differentiated and assume their terminal positions in 
the WM, IGL, PCL and ML. The VZ becomes greatly reduced in size as the anterior 
and posterior limits of the cerebellum come together and the WM generates the 
remaining populations of VZ-derived cell lineages. Sagittal sections of P5 BAT-gal 
cerebellum were analysed with DAB immunohistochemistry for the expression of !-
gal. In both medial (Fig. 3.6A) and lateral (Fig. 3.6B) regions of the cerebellum, !-
gal expression was most clearly observed in the PCL outlining the internal aspects of 
the folia and within the WM. Higher magnification confirmed the presence of !-gal+ 
cells within the PCL and WM (Fig. 3.6C), but !-gal+ cells could also be seen in 
other cell layers. The IGL contained !-gal+ cells (although not to the same extent as 
the PCL and WM), as did the ML. The EGL, consistent with earlier ages analysed, 
was void of !-gal expression.  
3.5.2 LacZ/Axin2 expression at P5 
In situ hybridisation for LacZ on matched sections at P5 (Fig. 3.6D) revealed a 
similar expression pattern to !-gal immunohistochemistry, with a lack of staining in 
the EGL and expression observed in all other cell layers. However, the staining 
appeared more diffuse and not as clearly restricted to the PCL and WM as !-gal. 
This was also seen with in situ hybridisation for Axin2 (Fig. 3.6E), which was 
expressed in a pattern similar to that seen at P1 with considerable widespread faint 
staining observed throughout the cerebellum making it difficult to discern Axin2 
expressing regions clearly.  
Figure 3.6 - Expression of the BAT-gal reporter and Wnt/!-catenin target gene 
Axin2 in the P5 cerebellum.
DAB immunohistochemistry for !-gal on medial (A) and lateral (B) sagittal 
cerebellum sections revealed a widespread expression pattern with no clear 
anterior-posterior differences. Higher magnification (C) allowed the identification of 
!-gal+ cells wtihin the WM (demarcated by the dashed line), rarely within the IGL 
and predominating within the PCL. The EGL was void of !-gal expression.  In situ 
hybridisation for LacZ (D) showed a more restricted pattern of expression, while 
Axin2 (E) showed a fainter and more homogenous expression pattern. Scale bars: 

































3.5.3 Analysis of !-gal and lineage markers at P5 
The P5 cerebellum is undergoing extensive growth in all key cell layers and as 
Wnt/!-catenin signalling is commonly associated with cell growth and proliferation I 
sought to determine if the !-gal expression pattern identified at P5 correlated with 
proliferation. Double immunofluorescence for !-gal and PCNA on sagittal sections 
at P5 revealed extensive PCNA expression through all cell layers, although 
particularly within the EGL, PCL and WM (Fig. 3.7A). However, while !-gal 
expression was particularly clear within the PCL and WM, very few !-gal+/PCNA+ 
cells were observed. These results provide little evidence for a correlation between 
Wnt/!-catenin signalling and proliferation in the P5 cerebellum, despite the high 
amount of growth occurring at this time point in the Wnt/!-catenin responsive 
regions identified. 
 
As PCNA is not widely co-localised with expression of !-gal, I next looked at a 
number of markers to determine if the !-gal+ cells identified were of a particular cell 
lineage. The !-gal+ cells in the IGL, PCL and ML would be consistent with 
migratory post-mitotic granule cells, exiting the EGL towards their final destination 
in the IGL. However, double immunofluorescence between !-galactosidase and 
NeuN, a marker for post-mitotic granule cells (Mullen et al., 1992), did not reveal 
any cellular colocalisation between the two proteins in any sections analysed (Fig. 
3.7B). Thus, Wnt/!-catenin signalling appears unlikely to be directly involved in the 
migration of post-mitotic granule cells at this stage. 
 
The presence of !-gal+ cells within the WM, IGL and PCL would also be consistent 
with the pattern of multipotent glial/interneuron progenitors or lineage restricted 
glia/interneurons. Thus, colocalisation between Pax2 or Sox9 and !-gal would 
indicate which lineage was responding to a Wnt/!-catenin signal. Consistent with 
perinatal observations, in no case were !-gal and Pax2 observed to colocalise to the 
same cells (Fig. 3.7C). However, !-gal was evident exclusively within the Sox9+ cell 




involved in the development of the interneuron population at this stage but rather is 
active in the multipotent progenitors or in the restricted glial lineage.  
3.5.4 !-gal/LacZ expression at P10  
By P10 the cerebellum has undergone extensive proliferation and terminal 
differentiation of the various cell types is advanced – resulting in a fully laminated 
and foliated structure comparable with the adult cerebellum. However, the EGL still 
remains at P10 and continues to proliferate and produces GCs until approximately 
P21. In addition, WM progenitors are still actively generating cells of the 
GABAergic interneuron and glial lineages. !-gal DAB immunohistochemsitry on 
sagittal sections of the P10 cerebellum  (Fig. 3.8A-B) revealed an expression pattern 
that was both reduced and restricted compared to that seen at earlier time points, 
likely reflective of the more advanced stage of development. Both medial (Fig. 3.8A) 
and lateral (Fig. 3.8B) sections displayed a consistent pattern of !-gal expression 
predominating within the PCL and WM. This was confirmed at higher magnification 
(Fig. 3.8C), which clearly shows !-gal+ cells residing in the PCL. Similar to the 
expression pattern observed at P5, !-gal+ cells can also be observed sporadically 
within the IGL and ML. Consistent with previous ages, no !-gal expression was 
observed within the EGL.  
 
In situ hybridisation for LacZ mRNA revealed a similar pattern (Fig. 3.8D) - albeit 
more restricted - indicating that the !-gal protein detected at the PCL is still being 
produced from an actively transcribed BAT-gal transgene. This observation supports 
the conclusion that these cells are still actively transducing a Wnt/!-catenin signal 
but the restricted nature of LacZ expression compared to !-gal is consistent with the 
perdurance of !-gal protein in certain cells. In situ hybridisation for Axin2 was also 
undertaken but no staining above background levels was detected (data not shown).   
Figure 3.7 - Analysis of !-gal and cerebellar lineage markers at P5. 
Double immunofluorescence for !-gal and PCNA (A) revealed the presence of !
-gal+ cells within the PCL and WM (filled arrowheads, layers demarcated by dashed 
lines). Although !-gal+ cells were often observed in close proximity to proliferating 
PCNA+ cells (unfilled arrowheads) very few !-gal+/PCNA+ cells were observed. 
Double immunofluorescence for !-gal and NeuN (B) showed !-gal+ cells (filled 
arrowheads) located outwith the IGL, which displays abundant NeuN expression. 
Double immunofluorescence for !-gal and postmitotic interneuron marker Pax2 (C) 
showed the close proximity of !-gal+ (filled arrowheads) cells to Pax2+ cells (empty 
arrowheads) in the PCL, although no double-labelled cells were observed in any 
sections. Analysis with glial marker Sox9 revealed extensive nuclear colocalisation 
between the two proteins (white arrows, D). Images counterstained with TOPRO3. 















Figure 3.8 - Expression of the BAT-gal reporter in the P10 cerebellum.
DAB immunohistochemistry for !-gal on medial (A) and lateral (B) sagittal 
cerebellum sections at P10 revealed a widespread expression pattern with no clear 
anterio-posterior differences. !-gal+ cells can be observed throughout the section,  
including the DCN (B). Higher magnification (C) allowed the identification of !
-gal+ cells sporadically within the IGL but predominating within the PCL. The EGL 
was void of !-gal expression.  In situ hybridisation for LacZ (D) showed a more 
restricted pattern of expression, although clear expression was observed within the 
PCL (arrowheads). Scale bars: A-B = 500 "m, C-D = 100 "m. Vermis and 






























3.5.5 Analysis of !-gal and lineage markers at P10  
Double immunofluorescence of !-gal and a number of different markers was used to 
determine the cell type of the !-gal+ cells observed in the P10 cerebellum. 
Expression of PCNA at this time point illustrates the continued proliferation of GPCs 
in the EGL (Fig. 3.9A) and interestingly the presence of mitotic cells within the PCL 
– consistent with the location of !-gal+ cells observed (Fig. 3.8C). However, as was 
observed at P5, in no sections analysed was there evidence for colocalisation 
between PCNA and !-gal, indicating that the Wnt/!-catenin signal driving 
expression of the BAT-gal transgene is not a mitogenic signal at this stage.  
 
Double immunofluorescence between !-gal and NeuN (Fig. 3.9B) or Pax2 (Fig. 
3.9C) was also undertaken to test whether the !-gal+ cells identified were of the 
granule or interneuron lineages respectively. Consistent with results obtained from 
analysis of !-gal expression at P5, no colocalisation between !-gal and NeuN or 
Pax2 was identified, despite the frequent presence of !-gal+ cells in close proximity 
to NeuN+ or Pax2+ cells. This supports the earlier conclusion that Wnt/!-catenin 
signalling is not directly involved in the maturation of the interneuron or granule cell 
lineages.  
Figure 3.9 - Analysis of !-gal and cerebellar cell lineage markers at P10.
Double immunofluorescence for !-gal and PCNA (A) revealed the presence of !
-gal+ cells (filled arrowheads) in close proximity to PCNA+  cells (empty 
arrowheads) although no double-positive cells were observed in any sections. The 
same pattern was seen between !-gal and NeuN (B) and Pax2 (C). Interestingly, !
-gal+ cells were seen clustered around Calbindin+ Purkinje cells (D) within the PCL, 
a location consistent with Bergmann glia. Double immunofluorescence with !-gal 
and glial markers s100! (E) and Sox9 (F) confirmed the identity of the !-gal+ cells 






















The localisation of !-gal+ cells to the PCL could also be consistent with either 
Purkinje cells or Bergmann glia. To test the first hypothesis, double 
immunofluorescence for !-gal and Calbindin (Fig. 3.9D), a Purkinje cell marker only 
expressed at detectable levels from P10, was undertaken. !-gal+ cells can be clearly 
identified clustered around Purkinje cells, but in no event were Calbindin+ Purkinje 
cells identified with !-gal expression. The location of !-gal+ cells clustered around 
Purkinje cells would be consistent with Bergmann glia. This was tested by carrying 
out double immunofluorescence between !-gal and s100! or Sox9, both markers for 
Bergmann glia and other astrocytes (Landry et al., 1989). These experiments 
revealed extensive colocalisation between the two markers and !-gal (Fig. 3.9E-F), 
supporting the conclusion that the !-gal+ cell population identified within the P10 
PCL consists largely of Bergmann glia. However, the !-gal+ cell population only 
represents a small proportion of the s100!+ or Sox9+ cell populations. Therefore the 
BAT-gal reporter is only active in a subset of Bergmann glia at P10.   
3.5.6 !-gal expression at P21  
By P21 the morphological development of the cerebellum is largely complete, with 
minor numbers of interneurons still being generated in the WM and the remnants of 
the EGL migrating through the ML into the IGL. Development of the cellular 
circuitry within the cerebellum is the remaining process, which proceeds well into 
adulthood. DAB immunohistochemsitry for !-gal at this time point revealed an 
expression pattern similar to that observed at P10, although notably more restricted 
with !-gal+ cells predominating in the PCL but also detectable sporadically within 
the IGL, WM and DCN (Fig. 3.10A-B). There were no differences observed between 
medial (Fig. 3.10A) and lateral (Fig. 3.10B) sections and the localisation of !-gal+ 
cells to the PCL was consistent across a single section (i.e. no anterior to posterior 
differences were observed). Higher magnification confirmed the presence of !-gal+ 
cells within the PCL (Fig. 3.10C), with limited !-gal expression observed within the 
WM, IGL and ML.  
Figure 3.10 - Expression of the BAT-gal reporter in the P21 cerebellum.
DAB immunohistochemistry for !-gal on medial (A) and lateral (B) sagittal 
cerebellum sections at P21 revealed a restricted expression pattern with !-gal+ cells 
discernable within the PCL and DCN, with no apparent difference from anterior to 
posterior. Higher magnification (C) allowed the clear identification of !-gal+ cells 
within the PCL, as well as sporadic expression noted within the IGL. Scale bars: A-B 





























Importantly, in situ hybridisation for LacZ did not reveal detectable levels of the 
transcript in any of the sections analysed (data not shown), indicating that active 
transcription of the BAT-gal transgene has likely reduced to undetectable levels by 
this time point but that detectable levels of the !-gal protein persist. In situ 
hybridisation for Axin2 at P21 also revealed no staining above background levels 
(data not shown). 
3.5.7 Analysis of !-gal and cell fate markers at P21 
By P21 there is little remaining proliferation within the cerebellum, with most of the 
cell types having terminally differentiated. Few PCNA+ can be observed scattered in 
the PCL or WM, although double immunofluorescence for PCNA and !-gal did not 
reveal any colocalisation (data not shown) consistent with earlier time points and 
supporting the conclusion that the Wnt/!-catenin activity at this stage is not 
mitogenic. As the last remaining GCs and interneurons are produced, the expression 
of NeuN and Pax2 is evident. However double fluorescence immunohistochemistry 
revealed no colocalisation between !-gal and NeuN (Fig. 3.11A) and Pax2 (Fig. 
3.11B). Consistent with the location identified through !-gal DAB detection and 
with the observations at P10, !-gal+ cells were identified on the fringes of the NeuN 
positive IGL (Fig. 3.11A) and present around Calbindin positive Purkinje cells 
identified with double immunofluorescence for Calbindin and !-gal (Fig. 3.11C). 
Double immunofluorescence for !-gal and s100! revealed a similar pattern of !-gal 
expression in a small subset of s100!+ Bergmann glia as that seen at P10, supporting 
the conclusion that the remaining !-gal+ cells at P21 are largely Bergmann glia.  
Figure 3.11 - Analysis of !-gal and cerebellar cell lineage markers at P21. 
Double immunofluorescence for  !-gal and NeuN (A), Pax2 (B) and Calbindin (C) 
confirm the PCL localisation of !-gal+ cells (filled arrowheads) and demonstrate that 
they do not express markers of interneurons, granule neurons or PCs respectively. 
Colocalisation with glial marker s100! confirms the identity of these cells as 
Bergmann glia. Images counterstained with TOPRO3. Scale bar = 50 "m.
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3.5.8 RT-PCR analysis of Wnt ligand expression during cerebellum 
development 
As expression analysis of the BAT-gal transgene suggested active Wnt/!-catenin 
signalling at all time points analysed, I next carried out RT-PCR on RNA extracted 
from dissected cerebellum at E18.5, P1, P5, P10 and P21 (the small size of the 
embryonic cerebellum prohibited dissection at earlier time points) to determine 
which Wnt ligands were expressed and could be responsible for driving expression 
of the reporter*. Genes for analysis were selected based on published evidence (Hall 
et al., 2000; Lucas and Salinas, 1997; Salinas et al., 1994) or by Wnt ligands 
identified in the developing cerebellum according to the Allen Brain Atlas 
(http://www.brain-map.org). !-actin was used as a positive control for these 
experiments and was present in all samples (Fig. 3.12). As a general measure of 
Wnt/!-catenin activity over this developmental series Axin2 expression was analysed 
and found to be present at all time points, although apparently reduced at P21, 
supporting the activity of the Wnt/!-catenin pathway at these time points.  
 
A number of Wnt ligands showed differential expression patterns throughout the 
developmental series, including Wnt3, 7a and 11 which all appeared to increase from 
E18.5 to P21. Wnt 7b and 9a both appeared to decrease between P1 and P21, while 
Wnt1 was only identified at E18.5. Consistent levels of expression were observed by 
Wnt5a across the whole series and a more sporadic expression pattern was observed 
by Wnt2b, 6, 10b and 16. No expression of Wnt2, 3a, 4 or 10a was identified (Fig. 
3.12).  
                                                
* These experiments were carried out by myself and two BSc (hons) project students: 
Eimhear Lusbey and Mark Pringle.  






















Figure 3.12 - RT-PCR analysis of Wnt ligand expression during cerebellum 
development.
An array of Wnt ligands were examined by RT-PCR for their expression at defined 
stages during cerebellum development, revealing a pattern of differential expression 
at each time point. The expression of Axin2 confirms Wnt/!-catenin signalling 
activity at each time point. !-actin was used as a positive control, while reactions 







The aim of this chapter was to investigate the distribution of Wnt/!-catenin 
signalling during development of the cerebellum. This was undertaken from E12.5 to 
P21 primarily using the BAT-gal Wnt reporter mouse strain (Maretto et al., 2003). 
The specific roles played by Wnt/!-catenin signalling during development of the 
cerebellum are not yet well characterised. Here, I provide evidence for a specific and 
dynamic spatio-temporal pattern of Wnt/!-catenin signalling through different stages 
of cerebellum development (summarised in Fig. 3.13).  
3.6.1 Validity of the BAT-gal transgene as an accurate reporter of Wnt/!-
catenin signalling activity in the developing cerebellum 
Before the results of this chapter can be interpreted, the validity of the BAT-gal 
transgenic reporter as a method of identifying bona fide Wnt/!-catenin signalling 
regions needs to be discussed in light of the data presented. The BAT-gal reporter 
mouse has been widely cited as a tool to study the role of Wnt/!-catenin signalling in 
the developing CNS (Backman et al., 2005; Bluske et al., 2009; Fancy et al., 2009; 
Fotaki et al., 2011a; Ivaniutsin et al., 2009; Laine et al., 2010; Liu et al., 2010; 
Machon et al., 2007; Mazumdar et al., 2010; Mutch et al., 2009; Selvadurai and 
Mason, 2011) but there are inherent limitations to the model that need to be taken 
into consideration.  
 
Most downstream Wnt/!-catenin target genes display a tightly regulated and context 
specific expression pattern – likely the result of a complex set of cooperative 
regulatory elements directing expression to the right cell types at the right times 
(Barolo and Posakony, 2002). Transgenic reporters used to detect Wnt/!-catenin 
signalling (e.g. BAT-gal, TOPGAL, BATlacZ, TCF/Lef-LacZ) all express a target 
gene with a deliberately simplistic upstream regulatory mechanism consisting of a 
minimal promoter coupled to multimerized TCF/LEF binding sites – the rationale 
behind this being that reporter gene expression should be activated in all contexts 




regulatory construction of these reporters they cannot be considered good 
mechanistic models for how a Wnt/!-catenin signal is natively transduced (Barolo, 
2006). Thus, while a reporter may be expressed in a similar pattern to native Wnt/!-
catenin target genes, it is not being done so in the same way and as a result could 
cause expression that is inconsistent with Wnt/!-catenin signaling in certain 
contexts.  
 
Because of this, a number of investigators choose to use Axin2 expression as a 
marker for Wnt/!-catenin signalling instead of a transgenic reporter, either by 
analysing its endogenous mRNA expression or with available knockin Axin2 reporter 
models (Lustig et al., 2002). Axin2 encodes a negative feedback inhibitor of the 
Wnt/!-catenin signalling pathway and is a direct target of TCF/LEF-mediated 
transcription. Unlike other downstream Wnt/!-catenin targets, Axin2 has an upstream 
regulatory sequence similar to that utilised by reporter models, with eight high-
affinity TCF binding sites (Jho et al., 2002) that allows it to be expressed much more 
widely than the more tightly regulated Wnt/!-catenin target genes. Despite this, 
Axin2 is still subject to the sort of native regulation that controls the expression of 
Wnt/!-catenin target genes (although obviously not as much as other targets). Thus, 
expression of Axin2 may not indicate true levels of Wnt/!-catenin signalling in all 
contexts.  
 
Combined, these caveats support the fact that no simple and consistent method of 
reporting Wnt/!-catenin signalling exists and the available tools need to be 
considered based on the context being investigated. A recent publication reached this 
conclusion after comparing BAT-gal, TOPGAL and Axin2LacZ models in both 
developmental and pathological contexts in the lung (Al Alam et al., 2011). These 
authors noted differential expression patterns between all three reporters, and that the 
utility of each depended on whether one was investigating the up- or down-





In the context of the data presented in this chapter the BAT-gal reporter also shows 
differential expression to Axin2, although the key Wnt/!-catenin signalling domains 
and cell lineages identified are consistent. In situ hybridisation for LacZ and Axin2 at 
E12.5 and E14.5 (Fig. 3.1-2) revealed a similar expression pattern, with the key 
domains of the URL and IsO showing expression of both genes. However, notable 
differences were observed. Axin2 showed a clear gradient of expression from the 
URL and LRL, particularly evident at E12.5, while the BAT-gal transgene was 
expressed more sporadically. The gradient of Axin2 expression, compared to the 
more binary expression of LacZ, is likely attributable to the more subtle regulation of 
Axin2 compared to the artificial BAT-gal transgene. This conclusion is supported by 
similar published observations made analysing BAT-gal expression in the cortex and 
thalamus (Bluske et al., 2009; Machon et al., 2007). In both these cases expression of 
the BAT-gal reporter was identified in the same domains as Axin2 expression, 
although Axin2 exhibited a much smoother gradient of expression while the BAT-gal 
reporter was expressed in a patchier and more mosaic manner.    
 
Another important discrepancy between the two Wnt/!-catenin detection methods 
observed was the lack of detectable Axin2 expression in postnatal cerebellum tissue 
where there was clear LacZ expression (Fig. 3.4,6,8,10). However, inability to detect 
expression of a gene by in situ hybridisation does not necessarily mean it is not 
present, as it could persist below the limits of detection with the given methodology. 
This is supported by the observation that Axin2 is detected by RT-PCR from E18.5 to 
P21 (Fig. 3.12). In addition, the fallibility of Axin2 as a marker for Wnt/!-catenin 
signalling activity means that we cannot rule out activity of the pathway if Axin2 is 
not expressed. That said, this result is a clear limitation of these data and needs to be 
taken into consideration during further interpretation.  
 
Finally, as considerable analysis has been undertaken utilising 
immunohistochemsitry for the !-gal protein rather than LacZ mRNA, it is pertinent 
to discuss discrepancies between these two detection methods for the BAT-gal 
reporter. A number of observations were made where cells were shown to express 




persist in cells beyond the point where the cell has ceased to transduce a Wnt/!-
catenin signal. At E14.5 cells in the CP were identified with !-gal but not LacZ 
expression (compare Fig. 3.2A with Fig. 3.2E), however the URL showed expression 
of both, consistent with the idea that !-gal+ cells migrating away from the URL and 
no longer responding to a Wnt/!-catenin signal may still contain detectable levels of 
the protein. In addition, the pattern of !-gal expression appeared more widespread at 
postnatal stages, compared to LacZ expression. By P21 LacZ expression was not 
detectable, while considerable expression of the !-gal protein was observed (Fig. 
3.8). This likely represents the perdurance of !-gal protein in a certain proportion of 
!-gal+ cells identified, although it does not affect the conclusion that Wnt/!-catenin 
signalling was present during development of the identified cells.  
 
The limitations of the BAT-gal reporter model obviously need to be taken into 
consideration. However, it is clear that there is no consistent method for universally 
identifying Wnt/!-catenin responding cells and as discussed different methods 
should be employed depending on the context. In the data presented here, differential 
expression between the detection methods (!-gal immunohistochemsitry, LacZ in 
situ hybridisation and Axin2 in situ hybridisation) exists, but the identification of key 
Wnt/!-catenin responding domains and cell lineages is consistent.  
3.6.2 BAT-gal reporter expression at the embryonic IsO is consistent with this 
being a Wnt/!-catenin responsive signalling centre 
Early patterning of the midbrain-hindbrain region is dependent on molecular signals 
released from the IsO. Formed at an expression boundary between Gbx2 and Otx2 
(Simeone, 2000), the IsO is identified genetically through the expression of Fgf8, 
Wnt1 and En1, all of which act in a positive feedback loop (Adams et al., 2000; 
Davis and Joyner, 1988; McMahon et al., 1992; Reifers et al., 1998). The importance 
of these genes in patterning the surrounding tissue, including the cerebellum, is 
evident when their expression is perturbed in mouse models which display severe 
patterning defects (Basson et al., 2008; McMahon and Bradley, 1990; Thomas and 




is therefore consistent with the observation that the BAT-gal reporter is expressed in 
this region and in the surrounding tissue at all embryonic ages analysed (Fig. 3.1, 
3.2, 3.3). In addition to its role as a morphogenic signalling centre, the IsO is also a 
germinal centre that provides both the cell types and molecular signals required for 
fusion of the two cerebellar hemispheres (Louvi et al., 2003). A role for Wnt/!-
catenin signalling in this process is demonstrated by recent evidence where loss of 
Jbn, a protein that has been shown to facilitate nuclear translocation of !-catenin 
(Lancaster et al., 2009), causes cerebellar midline fusion defects associated with a 
decrease in Wnt/!-catenin activity at the IsO and anterior-medial ventricular zone 
(Lancaster et al., 2011).  
3.6.3 BAT-gal reporter expression at the embryonic RL is consistent with the 
early generation of GPCs but not their further development 
Analysis of BAT-gal reporter expression at E12.5 and E14.5 revealed the RL as a 
Wnt/!-catenin signalling centre in both cases (Fig. 3.1-2) and the early EGL at E14.5 
(Fig. 3.2). The rhombic lip gives birth to projection neurons of the deep cerebellar 
nuclei from E10.5 to E12.5 (Fink et al., 2006) followed by GPCs and unipolar brush 
cells from E12.5 onwards (Englund et al., 2006; Machold and Fishell, 2005; Wang et 
al., 2005). Because the projection neurons of the deep cerebellar nuclei are born prior 
to our analysis and the unipolar brush cells migrate along a different path than the 
dorsal stream that forms the EGL, I concluded that the BAT-gal reporter expression 
observed is limited to GPCs. This indicates a potential role for Wnt/!-catenin 
signalling in the initial specification of GPCs at E12.5 and their early migration at 
E14.5. Consistent with this, a number of studies have identified expression of Wnt1 
at the RL (Davis and Joyner, 1988; Dymecki and Tomasiewicz, 1998; Fischer et al., 
2007; Nichols and Bruce, 2006; Wilkinson et al., 1987) and its ablation from this 
domain may contribute to the patterning defects in the Wnt1 knockout mouse models 
(McMahon and Bradley, 1990; Thomas and Capecchi, 1990). Due to the consistency 
between the known expression pattern of Wnt1, and its important role in 
development of this area, it is possible that Wnt1 activity is responsible for the active 
Wnt/!-catenin signalling at the RL in addition to the IsO. However, it remains to be 





While active Wnt/!-catenin signalling was identified in the early migrating GPCs 
(Fig. 3.2), this was lost in the GPCs observed in the EGL during later stages of 
development. By E18.5, BAT-gal expression within the EGL was minimal and from 
P1 onwards, it was undetectable (Fig. 3.3-4). These data are consistent with a role for 
Wnt/!-catenin signalling during early specification of GPCs but not in their further 
migration or proliferation. Taken together with the fact that proliferation of this cell 
population during late embryogenesis and early post natal development is driven by 
Shh secreted by neighbouring Purkinje cells (Dahmane and Ruiz i Altaba, 1999; 
Wechsler-Reya and Scott, 1999), these results suggest that while Wnt/!-catenin 
signalling plays a role in the early specification of the GPC cell population at the 
embryonic rhombic lip, it does not appear to be involved in the continued 
development of these cells in the EGL. Interestingly, recent evidence shows that 
dysregulation of the Wnt/!-catenin pathway in GPCs through conditional Apc 
knockout (thereby constitutively activating the pathway) leads to a reduction in 
production of mature GCs and a severe reduction in cerebellar size as a result 
(Lorenz et al., 2011). This supports the necessity to keep Wnt/!-catenin signal 
transduction tightly regulated even in non-Wnt/!-catenin responsive cell lineages. 
 
Prior to maturation of terminally differentiated GCs, they undergo migration across 
the presumptive ML from the EGL to the IGL. A first glance, the pattern of !-gal+ 
cell distribution within the postnatal cerebellum resembles the pattern that would be 
expected if the reporter were active in these cells. However, the absence of NeuN 
expression in any of the !-gal+ cells observed from P5-P21 demonstrates that this is 
not the case (Fig. 3.7,9,11). NeuN is abundantly expressed in most classes of neurons 
(Mullen et al., 1992) and has been identified in all stages of post-mitotic granule cell 
development (Weyer and Schilling, 2003). Thus, the lack of NeuN expression in !-




3.6.4 BAT-gal reporter expression at the embryonic LRL is consistent with 
this region as a key Wnt/!-catenin signalling centre and possible site for 
medulloblastoma origin 
The LRL is a region that recent evidence suggests may be a site for the origin of Wnt 
subgroup medulloblastoma (Gibson et al., 2010). This conclusion was based on gene 
expression analysis which suggested the region expressed a high number of Wnt/!-
catenin target genes compared to surrounding areas. Constitutive activation of the 
Wnt/!-catenin pathway in progenitors present in this region leads to a migration 
defect that eventually manifests as a tumour when tumour suppressor TP53 is 
additionally knocked out. While it is somewhat controversial that the LRL is the site 
of origin for Wnt subtype medulloblastoma, the fact that the LRL was identified as a 
highly Wnt/!-catenin responsive region does support their conclusion. The data 
presented in this chapter demonstrate the activity of the Wnt/!-catenin signalling 
pathway in the LRL through both the expression of the BAT-gal reporter and Wnt/!-
catenin target gene Axin2, supporting the conclusions of Gibson et al (2010) that the 
LRL is a Wnt/!-catenin responsive region and potential site for the origin of Wnt 
subgroup medulloblastoma. 
3.6.5 BAT-gal reporter expression at the perinatal VZ supports a role for 
Wnt/!-catenin in regulating progenitors from this region 
At E18.5, many !-gal+ cells were seen in the ventricular zone (Fig. 3.3-4), whereas 
at earlier stages they were less abundant (Fig. 3.1-2). This indicates that Wnt/!-
catenin signalling is active in cell lineages originating at the ventricular zone from 
this time point. Purkinje cells are amongst the first cell lineage generated at the 
ventricular zone. They arise at the onset of cerebellar neurogenesis between E10.5 
and E12.5 (Altman and Bayer, 1997; Hashimoto and Mikoshiba, 2003). The 
interneuron lineage can then be detected by the expression of Pax2 in scattered cells 
at the ventricular zone from E13.5 to E17.5 (Maricich and Herrup, 1999) from where 
they migrate dorsally into the white matter of the early cerebellum as Pax2+ lineage 
restricted progenitors (Maricich and Herrup, 1999; Weisheit et al., 2006). 




through the expression of S100!, BLBP and Sox9 (Hachem et al., 2007). The early 
Bergmann glial population is hypothesised to exit the ventricular zone at E14.5 and 
follow a migratory path behind Purkinje cells (Yamada and Watanabe, 2002). Birth 
of the remaining cerebellar glial populations follows from this point.  
 
The data presented here suggests that the cell populations born and migrating away 
from the ventricular zone between E18.5 and P1 could be doing so in response to a 
Wnt/!-catenin signal. Based upon the timing of known cell populations arising from 
the ventricular zone, we can conclude that Wnt/!-catenin signalling is active in the 
multipotent VZ progenitors that are responsible for generating both the interneuron 
and glial lineages. However, the identity of the !-gal+ cells within the E18.5 and P1 
cerebellum is less clear. Due to the fact that multipotent VZ progenitors and glial 
lineage restricted WM progenitors display the same molecular markers (i.e. GFAP, 
Nestin, Sox9) it cannot be concluded whether these !-gal+ cells identified are 
lineage restricted (i.e. glial or interneuron) or not.  The key finding from the data 
presented above (Fig. 3.5) is that the lineage restricted interneurons do not express !-
gal, leading to the conclusion that Wnt/!-catenin signalling is active in multipotent 
progenitors and potentially within the glial lineage.  
 
RT-PCR analysis of the E18.5 and P1 cerebellum revealed the expression of a 
number of different Wnt ligands (Fig. 3.12). Wnt1, known to be involved in early 
cerebellum development (see above refs), is identified at E18.5 but not P1, 
suggesting a possible residual role into late embryonic development.  
3.6.6 BAT-gal reporter expression in the postnatal cerebellum is consistent 
with a role for Wnt/!-catenin signalling in developing Bergmann glia 
Further to the identification of !-gal+ cells at the ventricular zone, a population of !-
gal+ cells was also observed within all other layers of the cerebellum (excluding the 
EGL) from E18.5 through to P21. Lack of colocalisation between !-galactosidase 
and Pax2, NeuN and Calbindin at all postnatal stages analysed (Fig. 3.7,9,11) ruled 




Purkinje cell types respectively. The remaining alternative is that the !-gal+ cell 
population identified within the developing cerebellum are glia. Oligodendrocytes 
are thought to arise from extra-cerebellar tissue (Grimaldi et al., 2009), while velate 
and fibrous astrocytes arise from progenitors at the VZ or progenitors that have 
delaminated to the presumptive WM (Milosevic and Goldman, 2002; Milosevic and 
Goldman, 2004). Bergmann glia are thought to follow a slightly different 
developmental path. Rather than arising during gliogenesis from WM progenitors 
like the rest of the astrocyte lineage, a population of early Bergmann glia arise from 
the ventricular zone and migrate in close proximity to - and remain developmentally 
intertwined with - Purkinje cells (Yamada and Watanabe, 2002). This wave of 
migration occurs from E14.5 onwards, and by E18.5 these glia come to lie in a 
pattern similar to that seen for some of the !-gal+ cell population identified, 
outlining the developing folia inferior to the EGL. A !-gal+ cell population in this 
pattern was seen at all postnatal stages, although the number of labelled cells appears 
to decrease with age. Anatomical location of !-gal+ cells throughout postnatal 
development and colocalisation of !-gal with glial markers Sox9 and s100! at P5 
(Fig. 3.7), P10 (Fig. 3.9) and P21 (Fig. 3.11) strongly supports the conclusion that 
the developing Bergmann glia population is responding to a Wnt/!-catenin signal. 
Consistent with this, a recent study revealed that dysregulated Wnt/!-catenin 
signalling, through loss of Apc, lead to a disruption of Bergmann glia cell structure 
resulting in the eventual degeneration of the neighbouring PC population (Wang et 
al., 2011).  
 
Interestingly, the lack of !-galactosidase expression at the ventricular zone at E14.5 
indicates that Wnt/!-catenin signalling is not involved in the birth of the Bergmann 
glia but may be potentially involved in its further development and maturation. This 
is consistent with the post-mitotic development of Bergmann glia occurring 
alongside dendritogenesis and synaptogenesis of Purkinje cells (Yamada et al., 2000; 
Yamada and Watanabe, 2002; Yuasa, 1996) and suggests a possible role for Wnt/!-
catenin in this process. However, the presence of !-gal+ cells at the VZ of E18.5 and 




generated at this time point, or that the generation of additional cell lineages is also 
regulated by a Wnt/!-catenin signal.  
 
RT-PCR analysis for the expression of Wnt ligands during postnatal cerebellum 
development revealed the presence of several ligands that could be responsible for 
driving the expression of the BAT-gal reporter (Fig. 3.12). Wnt3, 7a and 7b were all 
identified in the postnatal cerebellum. Wnt3 and 7a have both been shown to be 
expressed in PCs and GCs respectively and, alongside Wnt7b are known to regulate 
axon remodelling, dendritogenesis and synapse formation (Hall et al., 2000; Lucas 
and Salinas, 1997; Rosso et al., 2005; Salinas et al., 1994). Importantly though, they 
have also been shown to regulate these processes independent of Wnt/!-catenin 
signalling (Ciani et al., 2004; Purro et al., 2008; Rosso et al., 2005). The lack of 
postnatal BAT-gal reporter expression in the GCs or PCs is consistent with this, 
although the possibility remains that the ligand expressed by these cells could be 
bound by the neighbouring !-gal+ Bergmann glia and cause activation of the 
reporter. In addition to these known Wnt ligands identified, Wnt2b, 5a, 6, 9a, 9b, 
10b, 11 and 16 were all identified with varying post natal expression patterns. These 
ligands have been shown to play a role in numerous developmental processes in a 
number of organs (see http://www.stanford.edu/group/nusselab/cgi-bin/wnt/mouse 
for a summary of Wnt ligands involved in organogenesis). However, a role for these 
ligands signalling through the Wnt/!-catenin pathway in cerebellar development (or 
even CNS development) remains to be determined.  
3.6.7 Summary 
Cerebellum development is anatomically well defined, though the molecular 
mechanisms that govern the generation of the complexity observed in the adult 
cerebellum remain to be fully resolved. In this chapter I have presented a spatio-
temporal description of Wnt/!-catenin signalling activity during cerebellum 
development that both supports and extends previous published findings. From the 
data presented in this chapter I conclude that there are potential roles for Wnt/!-
catenin signalling at the embryonic RL, the perinatal VZ and in the developing 















Figure 3.13 - Summary of Wnt/!-catenin activity during cerebellum 
development from E12.5 to P21.
Based on expression analysis of the BAT-gal reporter allele throughout cerebellum 
development, a dynamic pattern of Wnt/!-catenin was revealed. Initially expression 
was observed at the RL and the IsO at E12.5 and E14.5. By E18.5 expression had 
shifted to the VZ and in cells radiating from that centre, while expression in the 
granule lineage had ceased. During postnatal stages the expression becomes 





4 Analysis of Wnt/!-catenin signalling 
dysregulation in cerebellar slice culture 
4.1 Introduction 
The novel expression of the BAT-gal reporter observed perinatally and postnatally 
suggests a number of possible roles for Wnt/!-catenin signalling in cerebellum 
development. The identification of the VZ and its tangentially radiating progeny as 
cells with high Wnt/!-catenin activity leads to the hypothesis that Wnt/!-catenin 
signalling could play a role in the regulation of VZ progenitors and in the cell 
lineages they give rise to. While a role for Wnt/!-catenin signalling in this process 
has not yet been observed, a number of hypotheses can be generated based on the 
understanding of the function of Wnt/!-catenin signalling elsewhere in the CNS.  
 
Within the cortex, a growing body of literature suggests multiple roles for Wnt/!-
catenin signalling in regional specification and regulation of the radial dimension by 
controlling progenitor and transit amplifying cell proliferation and differentiation. 
The ventricular zone in the developing cortex contains a population of radial glia that 
divide asymmetrically to produce either terminally differentiated neurons, IPCs or 
additional radial glial cells. IPCs then divide to produce two terminally differentiated 
neurons, thus amplifying the neurogenic pool (Molyneaux et al., 2007). A role for 
Wnt/!-catenin signalling has been identified in this process based on published 
evidence that shows a reduction in cortical neurogenesis after inhibition of the 
pathway (Zhou et al., 2006). Conversely, activation of the pathway promotes 
expansion of the developing cortex (Chenn and Walsh, 2002; Ivaniutsin et al., 2009). 
These findings support a role for Wnt/!-catenin signalling in regulating self-renewal 
of the radial glial population, where inhibition causes increased cell cycle exit and 
hence fewer neurons, and activation promotes radial glial self-renewal and an 
increased neurogenic pool. In addition, the Wnt/!-catenin pathway has also been 





These multiple roles of Wnt/!-catenin signalling in regulating self-renewal and 
differentiation in the cortex support the hypothesis that a similar mechanism could be 
responsible for the regulation of VZ progenitors and their progeny. To address this, a 
loss-of-function/gain-of-function approach was attempted using small molecule 
activation/inhibition of the Wnt/!-catenin pathway in organotypic cerebellar slice 
culture. Organotypic slice culture has been used successfully to study numerous 
aspects of cerebellar developmental biology (Choi et al., 2005; Dusart et al., 1997; 
Fink et al., 2006; Ghoumari et al., 2000; Li et al., 2006). Despite the limitations of a 
2D culture system such as this, it presents an opportunity to generate useful pilot data 
to guide future in vivo experiments.   
 
The use of small molecules to activate or inhibit cellular signalling pathways is an 
effective tool to generate pilot data before expensive and time consuming genetic 
manipulation is undertaken. The nature of the Wnt/!-catenin pathway presents an 
attractive target for small molecule dysregulation: it is a biochemically well-
characterised pathway with multiple positive and negative regulatory components 
available for targeting. Wnt ligands are cysteine-rich secreted glycoproteins that act 
in an autocrine, paracrine or juxtacrine manner. A Wnt ligand binds and activates the 
Frizzled-LRP5/6 transmembrane receptor complex and activates a downstream 
cystoplasmic cascade that results in the dissociation of the !-catenin destruction 
complex – consisting of APC, GSK3!, Axin and CK1. Dissociation of this complex 
allows for the cytoplasmic accumulation and nuclear translocation of !-catenin 
where it activates a transcriptional response with TCF/LEF cotranscription factors. In 
this chapter, I investigated the effectiveness of several small molecules that activate 
or inhibit the Wnt/!-catenin pathway by targeting different components.  
 
Inhibition of GSK3! stops the phosphorylation of !-catenin by the destruction 
complex and allows cytoplasmic accumulation and nuclear translocation to occur. 6-
bromoindirubin (a component of Tyrian purple dye found in molluscs) and its 
synthetic derivative 6-bromoindirubin-3’-oxime (BIO) were shown to be potent 
inhibitors of GSK3! and when applied to Xenopus embryos resulted in ectopic 




extended to both mouse and human cells (Sato et al., 2004) and has since become 
routine for in vitro activation of Wnt/!-catenin signalling. However, indirubins are 
known to cross-react with numerous kinases in addition to GSK3! (Meijer et al., 
2003; Zhen et al., 2007). A more selective GSK3! inhibitor CHIR99021 (CHIR) has 
also been identified (Ring et al., 2003) and has been shown to activate the Wnt/!-
catenin pathway in vitro as a result (Ying et al., 2008).  
 
Considerably more research has been undertaken in the identification of inhibitors of 
Wnt/!-catenin signalling due to the potential clinical applications to Wnt-dependent 
cancer (e.g. colon cancer). Numerous high throughput drug screens have identified a 
number of small molecules that cause effective inhibition of the Wnt/!-catenin 
pathway. Inhibitor of Wnt production-2 (IWP2) was identified in one such screen as 
an inhibitor of the acyltransferase Porcn. Porcn is required for palmitoylation of the 
Wnt ligand prior to secretion (Willert et al., 2003) and disruption of this process by 
IWP2 leads to a reduction in secreted Wnt ligand alongside downstream Wnt/!-
catenin activity in vitro (Chen et al., 2009). An additional screen identified a 
tankyrase inhibitor XAV939 (XAV) that acts downstream of Wnt production by 
stabilising the !-catenin destruction complex (Huang et al., 2009). These authors 
demonstrate that tankyrase 1 and 2 bind directly to Axin and target it for 
ubiquitination, thereby providing a mechanism for the homeostatic regulation of 
Axin levels. Disruption of this process leads to an upregulation of Axin, which then 
reduces the amount of cytoplasmic !-catenin available for Wnt/!-catenin signal 
transduction. A further small molecule screen utilising RNAi knockdown of 
upstream components identified several small molecules that target the !-catenin-
TCF/LEF transcription complex independent of !-catenin stabilisation (Gonsalves et 
al., 2011). These inhibitors of !-catenin responsive transcription (iCRT) were shown 
to inhibit the expression of Wnt/!-catenin target genes while cytoplasmic function of 
!-catenin remained unaffected. While clinical applications were the primary 
objective of the screens that identified these small molecules, they present a useful 




4.2 Aim and experimental design 
The aim of the work carried out in this chapter was to characterise the early effects of 
Wnt/!-catenin pathway dysregulation on development of the E18.5 cerebellum ex 
vivo in order to generate pilot data on its possible function. To address this, E18.5 
BAT-gal+ cerebellums were cultured in the presence of GSK3! inhibitors BIO or 
CHIR, Porcn inhibitor IWP2, Tankyrase inhibitor XAV or !-catenin transcriptional 
inhibitor iCRT3 for 24 hours (Fig. 4.1A). BrdU was also added to the culture for the 
final two hours to give a measure of proliferation. Slices were then analysed for 
expression of Wnt/!-catenin pathway activation, proliferation, apoptosis and cell fate 
by immunohistochemistry or qRT-PCR (Fig. 4.1B).  
 
In order to quantitate the expression of the different markers analysed by 
immunohistochemistry, counting frames were placed in four defined regions of the 
section (Fig. 4.1B): three along the anterior-posterior extent of the EGL, and one 
ventrally covering the VZ and the area immediately dorsal to it. The frames placed 
along the EGL were further partitioned to generate defined quantitation for the EGL 
and the internal component inferior to the EGL. Quantitation involved generating a 
labelling index for each of the markers by counting all Topro+ cells and then all cells 
expressing the marker being analysed in the ventral, internal and EGL regions. Two 
sections from each slice were quantitated for each marker and averaged to give a 
value for an individual slice. One slice was analysed from three individual animals in 
each experimental group (n=3). For qPCR, three slices were analysed for each 
experimental group (n=3). Quantitated immunohistochemistry or qRT-PCR from 
treated slices in all cases were compared to the relevant DMSO treated control using 
an unpaired two-tailed T-test and a P value of less than 0.05 was considered 
significant.  
















Figure 4.1 - Experimental design for ex vivo analysis of Wnt/!-catenin signalling 
in the E18.5 cerebellum.
(A) E18.5 brains were dissected and embedded in agarose before being sectioned on 
a vibratome into 300 !m thick slices. The explant slices were grown in culture for 24 
hr in the presence of small molecule activators or inhibitors of the Wnt/!-catenin 
pathway. (B) Individual slices were then fixed, frozen and sectioned further on a 
cryostat. Two sections were tested with immunohistochemistry and quantitated for 
the expression of various markers at four defined regions that include the EGL, 
interior and ventral regions in a slice taken from three animals (n=3). Alternatively, 














4.3 Establishement of a cerebellar slice culture protocol 
4.3.1 Culture length and tissue preparation optimisation 
In order to determine the culturing parameters, slices were cultured for between 24 
and 96 hours and gross morphology was examined. In addition, two methods of post-
culture processing were compared: tissue freezing followed by cryosectioning (Fig. 
4.2A,C,E,G) and wax embedding followed by microtome sectioning (Fig 
4.2B,D,F,H). Frozen tissue sections after 24 hours ex vivo had a normal morphology 
with an easily definable EGL (Fig. 4.2A). However, by 48 hours ex vivo this was lost 
as the EGL appeared less organised and was not as easy to differentiate from the cell 
layer inferior to it (Fig. 4.2C). This was also observed after 72 hours ex vivo (Fig. 
4.2E) and by 96 hours ex vivo the morphology was significantly disrupted with a 
thickened EGL and a disruption to cell density within the internal region (Fig. 4.2G). 
Due to the loss of morphology from 48 hours onwards, I decided to limit my analysis 
to slices examined after 24 hours ex vivo. The changes to cell density and the 
disorganisation of the cell layers from 48 hours onwards would have prohibited 
accurate quantitation of cell numbers. Similar morphological features were observed 
with sections analysed after wax preparation. After 24 hours ex vivo the laminated 
structure of the cerebellum was clear (Fig. 4.2B). This became less evident with each 
additional day ex vivo (Fig. 4.2D,F,H). However, the cell sparse nature of the 
cerebellum after 24 hours ex vivo appeared to result in tearing between the ventral 
and dorsal aspects of the section when the wax preparation was used. Due to this, I 
reasoned that the frozen preparation was preferable for retaining the cellular 
morphology of the slice. 
4.3.2 Dose response for small molecules targeting the Wnt/!-catenin pathway 
A number of small molecules were trialled in the ex vivo cerebellar slice culture 
paradigm. Initially, a dose response was performed for each using concentrations 
based on published evidence or covering a broad range. The effect of the different 
concentrations was judged non-quantitatively by the extent of BrdU label retention 




compared to DMSO treated control slices (Fig. 4.3A). Wnt/!-catenin pathway 
activator BIO has been shown to be effective at concentrations between 5-20 µM in 
ex vivo culture experiments (Fliniaux et al., 2008; Kuure et al., 2007; Laine et al., 
2010) so I conducted a dose response at 5 µM (Fig. 4.3B), 10µM (Fig. 4.3C) and 20 
µM (Fig. 4.3D). While a 5 µM concentration of BIO appeared to result in an increase 
in BrdU label retention, a concentration of 20 µM showed increased expression of 
the BAT-gal reporter, thus both these concentrations of BIO were selected for further 
analysis. No published evidence was found for the use of CHIR in an explant culture 
system, although it has been shown to be effective in vitro at a concentration of 3 µM 
(Ying et al., 2008). Thus, I trialled 0.5 µM (Fig. 4.3E), 5 µM (Fig. 4.3F) and 50 µM 
(Fig. 4.3G) concentrations. While none of the slices analysed contained the BAT-gal 
reporter transgene, a marked change in BrdU label retention was clear at 50 µM (Fig. 
4.3G) therefore this concentration was selected for further analysis.  
 
Wnt/!-catenin pathway inhibitors IWP2 and XAV have both been shown to inhibit 
the pathway in organotypic kidney culture (Karner et al., 2010; Karner et al., 2011) 
at concentrations of 5 µM and 200 µM respectively, although XAV has also been 
shown to function in vitro at a concentration of 1 µM. Thus I performed a dose 
response using a range from 0.5 µM-50 µM for IWP2 (Fig. 4.3H-J) and a higher 
range of 1 µM-100 µM for XAV (Fig. 4.3K-M). At no dose tested was a clear 
difference in BrdU label retention or !-gal expression evident, therefore the highest 
dose (50 µM and 100 µM for IWP2 and XAV respectively) was selected for further 
analysis. Finally, iCRT3 has only recently been identified (Gonsalves et al., 2011) so 
no published evidence for its use in an explant culture system exists. As it was shown 
to be effective in a number of different in vitro settings at concentrations between 25 
µM and 100 µM (Gonsalves et al., 2011) I performed a dose response covering the 
same range (Fig. 4.3N-P). No change to the expression of !-gal was evident, 
although reduced BrdU label retention was observed in all cell layers from a 
concentration of 50 µM, therefore this dose was selected for further analysis.  
Figure 4.2 - Optimisation of culture length and tissue processing technique.
Explant slices from E18.5 cerebellum were cultured for 24 (A-B), 48 (C-D), 72 (E-F) 
or 96 (G-H) hours and then frozen (A,C,E,G) and analysed with TOPRO3 or wax 
















Figure 4.3 - Small molecule dose response.
Immunohistochemistry for BrdU and !-gal was undertaken on explant cerebellum 
slices cultured in the presence of DMSO (A) or varying concentrations of BIO 
(B-D), CHIR (E-G), IWP2 (H-J), XAV (K-M) or iCRT3 (N-P) in order to determine 
the extent of action on BAT-gal reporter expression and proliferation and select the 
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4.4 Inhibition of Wnt/!-catenin signalling was not successful in this 
cerebellar slice culture system 
Despite the negligible changes observed with the doses of Wnt/!-catenin pathway 
inhibitors tested initially (Fig. 4.3), I hypothesised that closer investigation might 
reveal an effect that would justify further analysis. To test this, I cultured explant 
cerebellum slices from entire E18.5 BAT-gal+ litters and treated each with either 50 
µM IWP2, 100 µM XAV or 50 µM iCRT3. !-gal expression was still evident in 
slices treated with IWP2 (Fig. 4.4B), XAV (Fig. 4.4C) or iCRT3 (Fig. 4.4D). 
However, as results in the previous chapter suggest the !-gal protein may persist for 
a period after pathway activity has ceased, I analysed the expression of Wnt/!-
catenin downstream target Axin2 by qPCR. This experiment showed no change in the 
level of Axin2 between any of the treatment groups and the DMSO treated control 
slices (Fig. 4.4F). The likely explanation for these data are the limitations of the 
relatively short culture period in the presence of the small molecules. Due to the 
constraints of the culture system and the requirement for a clear morphology for 
accurate quantitation of cell numbers no further experiments were carried out using 
the Wnt/!-catenin pathway inhibitors.  
DMSO
Figure 4.4 - Small molecule induced Wnt/!-catenin pathway inhibition was not 
successfull in the culture setting. 
E18.5 BAT-gal+ cerebellum slices were cultured in the presence of DMSO (A), 50 
!M IWP2 (B), 100 !M XAV (C) or 50 !M iCRT3 (D). Expression of "-gal was 
analysed by immunohistochemistry and compared. Expression of Axin2 was 
analysed by qRT-PCR (F) and each of the treated groups (black bars) was compared 
to the DMSO control group (white bar) by a T-test. No signficant difference was 










































4.5 Activation of Wnt/!-catenin signalling in cerebellar slice 
culture 
4.5.1 Small molecule inhibition of GSK3! activates the Wnt/!-catenin 
pathway in cerebellar slice culture 
Analysis of !-gal expression in BAT-gal+ E18.5 cerebellum slices cultures for 24 
hours ex vivo revealed an expression pattern identical to that observed at E18.5 in 
vivo (see Chapter 3). !-gal expression was detected along the VZ and spread 
throughout the internal region of the slice (Fig. 4.5A). Quantitation of !-gal 
expression calculated by counting !-gal+ cells and expressing that as a proportion of 
total cell number in the EGL, internal and ventral regions reflected this observation 
(white bars in Fig. 4.5E). Only 1.4% (±0.4%) of cells within the EGL expressed !-
gal, while 9.9% (±1.6%) and 19.4% (±3.1%) of cells within the internal and ventral 
regions were !-gal+ respectively (Fig. 4.5E).  
 
Treatment of slices with 5 µM BIO for 24 hours did not appreciably increase the 
expression of !-gal (Fig. 4.5B). This is evident in the quantitation of !-gal+ cells 
(compared red bars with white bars in Fig. 4.5E). 5 µM BIO treatment resulted in 
3.1% (±1.3%) of EGL cells, 15.0% (±3.8%) of internal cells and 18.6% (±3.1%) of 
ventral cells expressing !-gal, a result which was not significantly different to that 
observed in DMSO treated slices. Treatment with 20 µM BIO did result in a notable 
increase in the expression of !-gal (Fig. 4.5C). This was particularly evident in the 
EGL and internal region compared to the DMSO treated control. Quantitation 
reflected this (compare orange bars with white bars Fig. 4.5E). The proportion of !-
gal+ cells within the EGL rose to 17.2% (±1.2%), within the internal region to 17% 
(±1.3%) and within the ventral region to 20.7% (±3.8%). These differences were 
significant between the 20 µM and DMSO treated slices within the EGL and internal 
regions, though not the ventral region – likely reflecting the existing Wnt/!-catenin 
activity in that region. Pathway activation with CHIR showed an even more 




within all cell layers in the slice (Fig. 4.5D). The proportion of !-gal+ cells was 
increased in all cell layers (compare blue bars with white bars Fig. 4.5E). !-gal+ 
cells made up 32.1% (±2.3%), 25% (±4%) and 31.3% (±4.4%) of the EGL, internal 
and ventral regions respectively.  
 
These data are supported by qPCR for Axin2, which was used as an independent 
validation for Wnt/!-catenin pathway activation (Fig. 4.5F). Relative expression of 
Axin2 compared to EIF4A2 was not significantly increased by slice treatment with 5 
µM BIO, however it was after treatment with 20 µM and further still with 50 µM 
CHIR. This pattern is consistent with that observed for the proportion of !-gal+ cells 
in the whole cerebellum (last group Fig. 4.5E), which consisted of pooled results 
from the EGL, internal and ventral regions. Combined, these data are consistent with 
activation of the Wnt/!-catenin signalling pathway in E18.5 cerebellum slices treated 
ex vivo with small molecules inhibiting GSK3!.  
DMSO
Figure 4.5 - GSK3! inhibition activates the Wnt/!-catenin signalling pathway.
E18.5 BAT-gal+ cerebellum slices were cultured in the presence of DMSO (A), 5 
!M BIO (B), 20 !M BIO (C) or 50 !M CHIR (D). Expression of "-gal was analysed 
by immunohistochemistry and quantitated (E) by counting the total proportion of "
-gal+ cells in each of the defined regions. Comparisons were made between each of 
the treatment groups and the DMSO control group for each region by T-test. 
Expression of Axin2 was analysed by qRT-PCR (F) and each of the treated groups 
(black bars) was compared to the DMSO control group (white bar) by a T-test. (n=3, 
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4.5.2 Wnt/!-catenin pathway activation in cerebellar slice culture increases 
proliferation 
As Wnt/!-catenin is often associated with proliferation, the next set of experiments 
sought to determine the effects of Wnt/!-catenin pathway activation on proliferation 
within the cultured slices. BrdU was added to the cultures two hours prior to fixation 
and the amount of BrdU label retained by cells within the slices gives an indication 
of the number of cells in S-phase, which can be used to approximate proliferation. 
The DMSO treated control slices showed considerable BrdU label retention within 
the EGL, consistent with the proliferative nature of this region, and less in the 
internal and ventral regions of the slice (Fig. 4.6A). The number of BrdU+ cells was 
counted and expressed as a proportion of total cells, to give a BrdU labelling index 
(LI) of untreated proliferation levels of 22.5% (±1.5%) in the EGL, 6.7% (±2.8%) in 
the internal region and 5.9% (±1.3%) in the ventral region (white bars in Fig. 4.6E). 
 
In slices treated with 5 µM and 20 µM BIO (Fig. 4.6B-C) an increase in the BrdU LI 
was observed in all cell layers (compare red/orange bars with white bars Fig. 4.6E). 
The BrdU LI was increased to 28.2% (±2.8%) and 24% (±4.3%) for 5 µM and 20 
µM concentrations respectively in the EGL, while in the internal region the BrdU LI 
was 13.4% (±2.6%) and 12% (±1.8%) respectively. The BrdU LI in the ventral 
region was increased to 14.1% (±1.9%) and 13.8% (±4.5%) respectively. These 
changes were significant in all cases except for the increase in BrdU LI in the EGL 
of slices treated with 20 µM BIO. CHIR treatment revealed a slightly different 
picture of BrdU label retention (Fig. 4.6D, blue bars Fig 4.6E). Notably, the BrdU LI 
in the EGL was significantly reduced to 16% (±1.4%). In contrast, the BrdU LI in the 
internal and ventral regions were significantly increased to 15.1% (±3.2%) and 16% 
(±3.1%) respectively. Similar to what was observed with the expression of !-gal, 
BrdU label retention in CHIR treated cerebellum slices appears to become 
homogenous between regions, with the differences between the EGL, internal and 
ventral regions becoming less evident. These data support the conclusion that 
increased Wnt/!-catenin pathway activity results in an increase in proliferation in 




of BrdU label retention are different between BIO and CHIR treated slices and that 
proliferation does not increase in a similar pattern to that seen with expression of !-
gal or Axin2.   
 
In order to test if the increase in proliferation is a direct result of activated Wnt/!-
catenin signalling within individual cells, the number of !-gal+ BrdU+ cells were 
analysed by double immunofluorescence and expressed as a proportion of total !-
gal+ cells (Fig. 4.6F). Within the EGL, the low proportion of !-gal+ cells in DMSO 
treated control combined with an even smaller proportion that were BrdU+ (5.4% 
±5.9%) created a high amount of variation within the sample group. However, the 
EGL of slices treated with 5 µM or 20 µM BIO showed a significantly higher 
proportion of BrdU+ !-gal+ cells: 31% (±5.6%) and 38.5% (±4.6%) respectively. 
This was not evident in CHIR treated slices, which only showed an increase to 
11.6% (±1.5%). Within the internal region, only the 20 µM BIO treated slices 
showed a significant increase in the proportion of BrdU+ !-gal+ cells to 28.8% 
(±6.5%). Treatment with 5 µM BIO resulted in an increase to 24.8% (±7%) and 
treatment with CHIR resulted in an increase to 18.9% (±4.9%) compared to the 
control treated level of 12.6% (±4.4%). Within the ventral region, 5 µM BIO 
treatment showed a significant difference, with 22% (±1.4%) of !-gal+ cells also 
being BrdU+ compared to 5.4% (±7.5%) of cells in control treated slices. 20 µM 
BIO and CHIR treated slices were not significantly different, although showed an 
increase to 19.9% (±6.7%) and 14.2% (±2.9%) respectively. These data do not 
provide conclusive evidence for a cell autonomous or non-autonomous affect on 
proliferation of Wnt/!-catenin pathway activation.  
DMSO
Figure 4.6 - Wnt/!-catenin pathway activation induces proliferation ex vivo.
E18.5 BAT-gal+ cerebellum slices were cultured in the presence of DMSO (A), 5 
!M BIO (B), 20 !M BIO (C) or 50 !M CHIR (D) and treated with BrdU two hours 
prior to fixation. Expression of BrdU was analysed by immunohistochemistry and 
quantitated (E) by counting the total proportion of BrdU+ cells in each of the defined 
regions (generating a LI). A BrdU LI was generated for the !-gal+ cell population (F) 
in the same way but using double immunofluorescnece for BrdU and !-gal. 
Comparisons were made between each of the treatment groups and the DMSO 
control group for each region by T-test (n=3, error bars = SEM, *=p<0.05, 
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4.5.3 Wnt/!-catenin pathway activation in cerebellar slice culture does not 
affect apoptosis 
Wnt/!-catenin signalling is known to be an important regulator of cell survival and 
apoptosis, although whether it acts to promote cell survival (Chen et al., 2001; He et 
al., 2004; You et al., 2002) or apoptosis (Kim et al., 2000; Olmeda et al., 2003) 
appears to be context dependent (Benchabane and Ahmed, 2009). To test how 
activation of Wnt/!-catenin signalling in cerebellar slice culture affects apoptosis, I 
analysed the expression of cleaved Caspase 3 (Casp3), a pro-apoptotic protein 
(Jänicke et al., 1998), by immunohistochemistry in slices treated with 5 µM or 20 
µM BIO, 50 µM CHIR or DMSO.  
 
In control DMSO treated slices (Fig. 4.7A), Casp3 can be observed throughout the 
slice though it appears to predominate in the internal and ventral regions rather than 
within the EGL. Quantitation of Casp3+ cells per µm2 confirms this observation 
(white bars Fig. 4.7E). Comparison with Casp3 expression in slices treated with 5 
µM BIO (Fig. 4.7B), 20 µM BIO (Fig. 4.7C) or 50 µM CHIR (Fig. 4.7D) did not 
reveal any obvious differences. Quantitation of Casp3+ cell numbers did not result in 
any significant differences between DMSO control or treated slices in any of the 
regions analysed, or in the cerebellum slice as a whole (Fig. 4.7E). These data show 
that activation of Wnt/!-catenin signalling in cerebellum slice culture neither 
promotes or inhibits apoptosis.  
DMSO
Figure 4.7 - Wnt/!-catenin pathway activation has no effect on apoptosis.
E18.5 cerebellum slices were cultured in the presence of DMSO (A), 5 !M BIO (B), 
20 !M BIO (C) or 50 !M CHIR (D). Apoptosis was analysed by 
immunohistochemistry for Casp3 and quantitated (E) by counting the total Casp3+ 
cells in each of the defined regions and expressing this in terms of area. Comparisons 
were made between each of the treatment groups and the DMSO control group for 
each region by T-test (n=3, error bars = SEM). No significant differences were 






































4.5.4 Wnt/!-catenin pathway activation in cerebellar slice culture restricts the 
expression of interneuron lineage progenitor marker Pax2 
As I have previously identified the activity of wnt/!-catenin signalling at the 
perinatal VZ (Chapter 3), I reasoned that ectopic activation of the pathway may 
disrupt the generation of cell lineages arising from there. The interneuron lineage is 
first identified by the expression of Pax2 (Maricich and Herrup, 1999), which is 
transiently activated in lineage restricted interneuron progenitors born from 
multipotent VZ or WM progenitors before their terminal differentiation and 
maturation (Milosevic and Goldman, 2002; Milosevic and Goldman, 2004) – a 
process that begins embryonically and continues until adulthood. In order to examine 
the effects of Wnt/!-catenin activation on development of the interneuron 
population, I analysed the expression of Pax2 in treated and control slices and 
quantitated the proportion of Pax2+ cells in the previously defined regions (with the 
exception of the EGL, since no Pax2+ cells are observed there).  
 
Control DMSO treated slices showed a pattern of widespread Pax2 expression within 
the internal and ventral regions of the cerebellum (Fig. 4.8A), consistent with cells of 
the early interneuron population born at the VZ and migrating radially throughout the 
cerebellum. Quantitation of Pax2+ cells revealed a higher proportion ventrally (21% 
(±2.2%)) compared to the internal region (14% (±1.7%)) (white bars fig. 4.8E), 
consistent with Pax2 expression being activated initially and then lost during later 
development as the cells migrate away from the VZ. Treatment of slices with 5 µM 
BIO (Fig. 4.8B) did not result in any observable difference in expression of Pax2. 
Quantitation of the proportion of Pax2+ cells demonstrated 11.5% (±2%) internally 
and 15.5% (±5.7%) ventrally (red bars Fig. 4.8E), which were not significantly 
different to the proportion of Pax2+ cells observed in these regions in the DMSO 
treated control slices. Treatment with 20 µM BIO showed an interesting restriction of 
Pax2 expression within the internal region (Fig. 4.8C) compared to the DMSO 
treated control slices, with the limits of Pax2 expression not reaching as far towards 
the EGL. However, quantitation revealed that 8.5% (±3%) of cells internally and 




different from the control (orange bars Fig. 4.8E). Treatment of the slices with CHIR 
resulted in a similar pattern of Pax2 expression (Fig. 4.8D) to that observed with 20 
µM BIO treatment. Namely, the expression of Pax2 did not extend as far towards the 
EGL as the control slices. This observation is consistent with quantitation that 
showed 18.4% (±1.8%) of cells in the ventral region were Pax2+, a result that was 
not significantly different from control slices, while internally the proportion of 
Pax2+ cells was significantly reduced with only 9.2% (±0.7%) of cells expressing 
Pax2.  
 
These results support the conclusion that the expression of Pax2 ventrally, and thus 
the generation of Pax2+ interneurons, is not affected by activation of the Wnt/!-
catenin signalling pathway. However, the extent of Pax2+ expression within the 
cerebellum is affected. Pax2 expression displays a more restricted pattern in slices 
treated with 20 µM BIO or 50 µM CHIR, resulting in significantly fewer Pax2+ cells 
towards the periphery of the CHIR treated slices.  
DMSO
Figure 4.8 - Wnt/!-catenin pathway activation restrictes the expression of 
interneuron lineage marker Pax2.
E18.5 cerebellum slices were cultured in the presence of DMSO (A), 5 !M BIO (B), 
20 !M BIO (C) or 50 !M CHIR (D). Expression of Pax2 was analysed by 
immunohistochemistry and quantitated (E) by counting the total proportion of Pax2+ 
cells in each of the defined regions. Comparisons were made between each of the 
treatment groups and the DMSO control group for each region by T-test (n=3, error 
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4.5.5 Wnt/!-catenin pathway activation in cerebellar slice culture inhibits the 
expression of Sox9 
The other key cell lineage generated from the VZ at E18.5 is the glial lineage. Glia 
become lineage restricted upon delamination from the VZ or from multipotent WM 
progenitors and migrate radially in a similar fashion to the interneuron lineage. Sox9 
is expressed in cells at the VZ progenitors during this period (Kordes et al., 2005; 
Pompolo and Harley, 2001) and is known to have a function in glial/neuronal fate 
determination in other systems (Stolt et al., 2003). Interestingly, Sox9 expression is 
also maintained in mature glia of the cerebellum (Kordes et al., 2005; Sottile et al., 
2006). As Wnt/!-catenin signalling is active at the VZ, I reasoned that it could play a 
role in regulation of the glial lineage and that its modulation could therefore alter the 
expression of Sox9.  
 
DMSO treated control E18.5 cerebellum slices (Fig. 4.9A and white bars Fig. 4.9E) 
revealed a Sox9 expression pattern consistent with previously published evidence 
(Kordes et al., 2005; Pompolo and Harley, 2001). Expression of Sox9 within the 
EGL is minimal, with only 3.3% (±0.5%) of cells Sox9+. Expression is more 
widespread within the internal and ventral regions, with 25.5% (±3.2%) and 37.1% 
(±3.4) of cells expressing Sox9 respectively. This is consistent with a high 
expression of Sox9 along the VZ and in cells radiating out from it. Treatment of 
slices with 5 µM BIO did not affect the expression of Sox9 (Fig. 4.9B). 
Immunohistochemistry revealed expression along the VZ and within the internal 
region consistent with that observed in control slices treated with DMSO. 
Quantitation of Sox9+ cell numbers (red bars, Fig. 4.9E) was consistent with this, 
with 2.5% (±0.3), 26.3% (±2.4) and 30.4% (±3.6) of cells within the EGL, internal 
and ventral regions respectively expressing Sox9. These values were not 
significantly different from those observed in control slices.  
 
Treatment with 20 µM BIO resulted in an apparent reduction in Sox9 expression 
(Fig. 4.9C and orange bars Fig. 4.9E). While the low expression within the EGL was 




internal region appeared reduced. Quantitation revealed a significant reduction in 
Sox9 expression within the internal region to 16.1% (±3%). Ventrally the proportion 
of Sox9+ cells was reduced to 25% (±1%), a significant reduction from what was 
observed with control slices. The most striking result was observed in slices treated 
with CHIR (Fig. 4.9D). A clear reduction in the expression of Sox9 is evident along 
the VZ and within the internal region. Quantitation of Sox9+ cell numbers revealed a 
significant reduction in all regions compared to the DMSO treated control slices 
(blue bars Fig. 4.9E). No Sox9+ cells were observed within the EGL, while only 
2.5% (±0.5%) of cells within the internal region were Sox9+. Within the ventral 
region the proportion of Sox9+ cells was reduced to 9.6% (±6.1%).  
 
These data are supported by qRT-PCR analysis for the expression of Sox9 in the 
cultured slices (Fig. 4.9F). These experiments confirmed the significant reduction in 
Sox9 expression after treatment with CHIR and are consistent with the significant 
reduction in Sox9+ cells observed in the slice as a whole (Fig. 4.9E). While qRT-
PCR analysis of slices treated with 5 µM BIO or 20 µM BIO did not reveal a 
significant difference with control slices, a general trend was evident that is 
consistent with the number of Sox9+ cells observed in the slice as a whole.  
Combined, these data support the conclusion that activation of the Wnt/!-catenin 
signalling pathway in E18.5 cerebellum slices ex vivo causes a reduction in the 
expression of Sox9 with greater pathway activation (as seen with CHIR in Fig. 4.5) 
leading to a greater reduction in Sox9 expression.  
DMSO
Figure 4.9 - Wnt/!-catenin pathway activation reduces expression of VZ 
progenitor and astrocyte marker Sox9.
E18.5 cerebellum slices were cultured in the presence of DMSO (A), 5 !M BIO (B), 
20 !M BIO (C) or 50 !M CHIR (D). Expression of Sox9 was analysed by 
immunohistochemistry and quantitated (E) by counting the total proportion of Sox9+ 
cells in each of the defined regions. Comparisons were made between each of the 
treatment groups and the DMSO control group for each region by T-test. Sox9 
mRNA expression was analysed by qRT-PCR (F). Comparisons were made between 
each of the treatment groups and the DMSO control group by T-test (n=3, error bars 
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4.5.6 Wnt/!-catenin pathway activation in cerebellar slice culture inhibits the 
expression of GFAP 
Similar to Sox9, GFAP is expressed in the VZ monolayer and also in mature 
Bergmann glia and astrocytes (Levitt and Rakic, 1980; Nolte et al., 2001; Yuasa, 
1996). Based on the finding that activated Wnt/!-catenin signalling affects the 
expression of glial marker Sox9, I sought to determine the effects on an additional 
glial marker GFAP. Immunohistochemistry for GFAP on DMSO treated control 
slices revealed a pattern of high expression ventrally, with considerable expression 
along the ventricular zone and glial processes evident radiating away from the VZ 
towards the pial surface of the cerebellum (Fig. 4.10A). This is consistent with 
expression of GFAP in the VZ progenitors. Treatment with 5 µM BIO (Fig. 4.10B), 
20 µM BIO (Fig. 4.10C) or 50 µM CHIR (Fig. 4.10D) all revealed a considerable 
restriction of GFAP staining in the cerebellum. While clear staining was observed 
along the length of the VZ in control slices, this was not evident in any of the treated 
slices. The staining appeared patchier and less intense. In addition, the extent of 
staining radiating from the VZ into the internal region was notably reduced. GFAP in 
control slices can be observed almost reaching the EGL in places, whereas this was 
not observed in any of the treated slices.  
 
As GFAP is a cytoplasmic protein, cell numbers were unable to be quantified. 
However, the qualitative reduction in GFAP immunoreactivity was consistent with 
qRT-PCR data, which revealed a significant reduction in GFAP expression after 
treatment with 20 µM BIO and 50 µM CHIR (Fig. 4.10F). These data support the 
conclusion that activation of the Wnt/!-catenin signalling pathway in E18.5 
cerebellum slices affects the expression of glial markers at the VZ and within the 
developing cerebellum.  
DMSO
Figure 4.10 - Wnt/!-catenin pathway activation reduces expression of VZ 
progenitor and astrocyte marker GFAP.
E18.5 cerebellum slices were cultured in the presence of DMSO (A), 5 !M BIO (B), 
20 !M BIO (C) or 50 !M CHIR (D). Expression of GFAP was analysed by 
immunohistochemistry. GFAP mRNA expression was analysed by qRT-PCR (F). 
Comparisons were made between each of the treatment groups and the DMSO 

















































The aim of this chapter was to establish an ex vivo culture system to characterise the 
early effects of small molecule mediated Wnt/!-catenin pathway modulation on 
perinatal cerebellum development. In particular, I sought to gain insight into the 
function of Wnt/!-catenin signalling at the VZ, as I had previously identified this as 
a domain of Wnt/!-catenin activity (Chapter 3). The results presented in this chapter 
demonstrate that activation of the Wnt!-catenin signalling pathway ex vivo in E18.5 
cerebellum slices results in a general increase in proliferation, no change to apoptosis 
and importantly affects the expression of markers for VZ progenitors and their 
progeny. 
4.6.1 Limitations of the experimental system and analysis 
Before the observations made in this chapter can be discussed, there are a number of 
limitations to the experiments and analyses carried out that need to be addressed. The 
most obvious of these was the short length of time that slices could be grown in 
culture. The cerebellum undergoes considerable growth at E18.5, with expansion of 
the GPC population within the EGL causing a dramatic increase in the extent of 
foliation by P1. The restrictions of the agarose surrounding the slice and the two-
dimensional nature of the culture mean that cell migration is unable to proceed 
normally and thus the morphology of the cerebellum is notably disrupted from 48 
hours ex vivo onwards to the extent that the individual layers (i.e. EGL vs the internal 
region) could not be accurately defined. Thus, experiments were limited to 24 hours 
ex vivo.  
 
While small molecule upregulation of the Wnt/!-catenin signalling pathway was 
successfully achieved after 24 hours ex vivo, this was not the case for inhibitors of 
the pathway (Fig. 4.4). All of the small molecules used have been shown previously 
to be effective in vitro and ex vivo in some cases at dosages within the range tested in 
these experiments (Chen et al., 2009; Gonsalves et al., 2011; Huang et al., 2009; 
Karner et al., 2010; Karner et al., 2011). Hence, it is likely that 24 hours was not 




Further experiments are therefore required to optimise this culture paradigm in order 
to test inhibition of the Wnt/!-catenin signalling pathway.  
 
Another limitation was the small number (n=3) of samples used for the analysis. The 
amount of confocal microscopy and manual cell counting required for the 
quantitation of cell numbers expressing !-gal, BrdU, Casp3, Pax2 and Sox9 for each 
of the treatment groups meant that undertaking this on a sample size of greater than 
three would not have been realistic within the time frame of this project. Thus, it is 
conceivable that some of the effects observed may not be entirely representative of a 
larger population of cultured slices.  
 
Lastly, while the small molecules used to activate the Wnt/!-catenin pathway caused 
an upregulation of both the BAT-gal reporter and independent Wnt reporter Axin2 
(Fig. 4.5), the possibility of non-specific action causing some of the observed effects 
cannot be excluded. Firstly, GSK3! is known to be involved in a number of cellular 
processes and signalling pathways independent of the Wnt/!-catenin signalling 
pathway. Evidence suggests that alternative GSK3! substrates include Creb (Grimes 
and Jope, 2001), Nfat (Beals et al., 1997; Neal and Clipstone, 2001), Neurogenin-2 
(Ma et al., 2008), Smad1 (Fuentealba et al., 2007) and c-Jun (de Groot et al., 1993). 
Secondly, it is important to reiterate the fact that BIO is known to act on other 
kinases other than GSK3! (Meijer et al., 2003; Zhen et al., 2007). Taken together, 
the published evidence argues that multiple cellular pathways are being affected in 
this culture system. A necessary follow up experiment to provide confidence that the 
findings from this chapter are a result of activated Wnt/!-catenin signalling alone is 
to use an independent method of pathway activation (i.e. genetic or molecular 
targeting of another component of the destruction complex).  
4.6.2 GSK3! inhibition successfully activates Wnt/!-catenin signalling ex vivo 
The data presented in this chapter confirm that inhibition of GSK3! results in the 
activation of Wnt/!-catenin signalling in cerebellar slice culture ex vivo (Fig. 4.5). 




number of in vitro and ex vivo settings (Meijer et al., 2003; Sato et al., 2004; Ying et 
al., 2008). Here I have demonstrated the success of GSK3! inhibition as an activator 
of Wnt/!-catenin signalling in the context of organotypic cerebellar slice culture. 
Without GSK3! inhibition expression of the BAT-gal reporter was observed 
primarily along the VZ and within the internal region – consistent with the 
observations made in Chapter 3. Treatment with a high concentration of BIO or 
CHIR resulted in a significant increase in BAT-gal reporter expression, which was 
particularly evident in the regions that had low levels of Wnt/!-catenin activity 
(primarily the EGL). This suggests that cells within all key domains in the E18.5 
cerebellum are competent to transduce a Wnt/!-catenin signal. qRT-PCR for 
endogenous Wnt/!-catenin target gene Axin2 on RNA extracted from whole slices 
validated these findings.  
4.6.3 Wnt/!-catenin activation is mitogenic but does not affect apoptosis 
Activation of the Wnt/!-catenin signalling pathway is often associated with an 
increase in proliferation. This is largely due to observations from mice (Megason and 
McMahon, 2002; Yamaguchi et al., 1999) and Drosophila (Giraldez and Cohen, 
2003) where loss of Wnt/!-catenin signalling causes a reduction in tissue growth. In 
addition, induction of Wnt/!-catenin signalling in cancer has been shown to increase 
proliferation. Consistent with this, cell cycle regulators c-myc and cyclin-D1 have 
been identified as targets of the pathway in colon cancer (He et al., 1998; Shtutman 
et al., 1999). In cerebellum slices treated with BIO (at either concentration tested) or 
CHIR, a significant increase in BrdU label retention was observed in all layers 
except the EGL (Fig. 4.6E). This is likely due to the already high levels of 
proliferation within the EGL. Interestingly, the addition of CHIR to the slices 
resulted in a decrease in the BrdU LI within the EGL – supporting a potential 
inhibitory role of Wnt/!-catenin signalling on the generation of GPCs (a process 
known to be primarily driven by Shh signalling) with a high concentration of a 
specific GSK3! inhibitor as opposed to BIO which is known to act on other kinases. 




reduced BrdU LI in the EGL of CHIR treated slices (i.e. whether the observation is a 
result of slower cell cycling or premature terminal differentiation).  
 
Within the other regions analysed, BIO or CHIR treatment both resulted in an 
increased BrdU LI. However, the BrdU LI observed between the different treatments 
did not reflect the progressive increase in Wnt/!-catenin activity previously observed 
from 5 µM BIO to 20 µM BIO and then 50 µM CHIR (Fig. 4.5). Instead, the BrdU 
LI within the internal and ventral regions after any treatment appeared similar, 
suggesting a possible limit to the capacity for proliferation as a response to Wnt/!-
catenin induced proliferation in the culture conditions. However, further experiments 
would be needed to test this.  
 
If the increase in BrdU label retention observed after all three small molecule 
treatments were being driven in a cell autonomous fashion by increased Wnt/!-
catenin signalling, then we would also expect to see an increase in the proportion of 
!-gal+ cells that are BrdU+ above control levels. This is the case for all three regions 
measured. However, the three treatments show quite different patterns. In addition, 
the variation within sample groups means that the increases observed in most cases 
are not significantly different. Thus, while it is clear that activation of the Wnt/!-
catenin signalling pathway in cerebellar slice culture increases proliferation, these 
data are not sufficient to support the conclusion that it is driving increased 
proliferation in a consistently cell-autonomous manner.  
 
Alongside an increase in proliferation, it could be hypothesised that an increase in 
cell survival (i.e. a reduction in apoptosis) would also be observed. However, no 
effects on apoptosis were observed in any of the treated slices, suggesting that no 
change in cell survival occurs as a result of Wnt/!-catenin pathway activation in 
E18.5 cerebellum slice culture (Fig. 4.7). This is consistent with the opposing and 
context dependent evidence of Wnt/!-catenin signalling both promoting cell survival 
(Chen et al., 2001; He et al., 2004; You et al., 2002) and apoptosis (Kim et al., 2000; 




4.6.4 Wnt/!-catenin activation affects VZ cell fate markers 
The previous identification of Wnt/!-catenin signalling at the perinatal VZ suggests 
a potential role in regulating the genesis of the two lineages generated in this region 
at this time point: interneurons and glia. The dual and opposing roles of Wnt/!-
catenin signalling driving self renewal of radial glia (Chenn and Walsh, 2002; 
Ivaniutsin et al., 2009; Zhou et al., 2006) or promoting the differentiation of IPCs 
down the neuronal lineage (Hirabayashi et al., 2004; Munji et al., 2011) supports a 
potential role for Wnt/!-catenin signalling in regulating the behaviour of VZ 
progenitors and the lineages that are derived from them. To test this hypothesis I 
analysed the expression of interneuron fate marker Pax2, which labels lineage 
restricted early born interneurons (Maricich and Herrup, 1999; Milosevic and 
Goldman, 2002; Milosevic and Goldman, 2004), alongside GFAP and Sox9, which 
label the VZ progenitors and their glial restricted progeny (Kordes et al., 2005; Levitt 
and Rakic, 1980; Nolte et al., 2001; Pompolo and Harley, 2001; Sottile et al., 2006; 
Yuasa, 1996).  
 
If Wnt/!-catenin signalling were driving the production of the interneuron lineage, it 
could be hypothesised that an increase in activity of the pathway would promote 
more cells to enter the lineage and express Pax2. However, these results suggest the 
opposite: that increased Wnt/!-catenin pathway activity inhibits the expression of 
Pax2 (Fig. 4.8). This decrease, however, was only observed in the internal region of 
the cerebellum, nearer to the EGL than the VZ. These data support the conclusion 
that activation of the Wnt/!-catenin signalling pathway affects the expression of 
Pax2 in differentiating interneurons, rather than during their genesis at the VZ, and 
leads to the hypothesis that Wnt/!-catenin signalling may promote the early 
differentiation of interneurons from Pax2+ progenitors.  
 
Conversely, if Wnt/!-catenin signalling were driving the production of glia or 
promoting the expansion of the VZ progenitor pool, then one would expect an 
expansion of the glial population as a result of activation of the pathway. The 




in the developing Bergmann glia population supports this. However, this was again 
not the case (Fig. 4.9-10). Activation of the Wnt/!-catenin pathway by 20 µM BIO 
or 50 µM CHIR resulted in a significant reduction in the expression of Sox9 within 
the internal and ventral regions of the slice. In particular, treatment with CHIR 
caused a marked reduction of Sox9 expression along the length of the VZ (Fig. 
4.9D). Expression of GFAP was also observed by immunohistochemistry and qRT-
PCR in all treated slices. Initially, these data are contrary to the hypothesis that 
Wnt/!-catenin signalling promotes the production of glia in the developing 
cerebellum. However, the possibility of a strong negative feedback mechanism being 
promoted by the dysregulation of the Wnt/!-catenin signalling pathway could 
explain this inconsistency. Analysis of these markers after inhibition of the pathway 
would certainly help resolve the function of Wnt/!-catenin signalling in cerebellum 
development and, as pointed out, is a significant limitation to the data presented in 
this chapter.  
4.6.5 Summary 
The aim of this chapter was to investigate the early effects of Wnt/!-catenin pathway 
dysregulation on development of the E18.5 cerebellum and to generate pilot data on 
its function. While the limitations of the culture system discussed make it difficult to 
draw any meaningful conclusions beyond the immediate observations made within 
this chapter, it is clear that activation of the Wnt/!-catenin signalling pathway has a 
profound effect on the development of cell lineages arising from the VZ – suggesting 
a potential role for Wnt/!-catenin signalling in regulating the behaviour of VZ 
progenitors and the lineages they generate. An analysis of dysregulated Wnt/!-
catenin signalling in vivo is now required to both support these findings and extend 







5 Genetic activation of Wnt/!-catenin signalling 
during cerebellum development in vivo 
5.1 Introduction 
Work presented in the previous two chapters confirms the presence of Wnt/!-catenin 
activity during cerebellum development and indicates a potential role in regulating 
cell behaviour at the VZ and in the lineages arising from there. In order to investigate 
this potential role further I used a genetic approach to constitutively activate the 
pathway during cerebellum development.  
 
In addition to utilising standard gene knockout mouse models, the rapid uptake in 
Cre/lox inducible gene targeting in developmental biology over the past decade has 
presented a useful tool to probe the function of different signalling pathways during 
brain development. The bacteriophage-P1 cre gene codes for a Cre-recombinase 
enzyme that efficiently recombines DNA between two LoxP sites. By floxing an 
integral sequence of a particular gene and using a Cre under the control of a tissue 
specific promoter it is possible to carry out spatio-temporal specific gene ablation 
(Sauer, 1998). Furthermore, the generation of a Cre-recombinase fused to a mutant 
form of the estrogen receptor (ER) ligand binding domain (CreER) allows for more 
precise temporal regulation of Cre activation by the addition of tamoxifen to the 
system (Hayashi and McMahon, 2002).  
 
A number of mouse models have been generated that utilise this technology to study 
developmental signalling pathways during cerebellum development, but little has 
been revealed about the nature of Wnt/!-catenin signalling.  Constitutive activation 
of Wnt/!-catenin signalling in GPCs (Lorenz et al., 2011) utilising a Math1-Cre 
(Matei et al., 2005) addition transgene expressed in GPCs crossed to a floxed Apc 
allele (Miclea et al., 2009) revealed severe developmental abnormalities in GC 
generation. The reduced cerebellum size and disrupted cytoarchitecture observed was 




observed in the anterior of the cerebellum – suggesting uneven Math1-Cre 
expression across the GPC population. That said, this study reveals a potential link 
between Wnt/!-catenin signalling and neuronal differentiation, although only in the 
granule lineage. Gibson et al (Gibson et al., 2010) generated mice with a 
constitutively active Ctnnb1lox(ex3) allele (Harada et al., 1999) under the control of an 
addition BLBP-Cre transgene, expressed in MHB progenitors (including the VZ, RL 
and LRL) from E10.5 (Hegedus et al., 2007). While no abnormalities were observed 
in the cerebellum from these mice, the analysis was limited to proliferation (Ki67) 
and apoptosis (TUNEL) markers. Importantly, a developmental analysis of cells 
arising from the VZ and RL was not carried out. Thus, the conclusions we can draw 
from this study about the role of Wnt/!-catenin signalling during cerebellum 
development are limited. Combined, these limited studies do not provide a functional 
explanation for the role of Wnt/!-catenin signalling during cerebellum development 
consistent with what has been presented in the previous two chapters. An explanation 
for Wnt/!-catenin signalling at the VZ and in the developing glial population in 
particular is lacking.  
 
5.2 Aims and experimental design 
The aim of the work presented in this chapter was to investigate the functional 
consequences of Wnt/!-catenin pathway activation in vivo during cerebellum 
development. To this end, I used a combination of mouse models to remove Apc 
function (and thus constitutively activate the pathway) during cerebellum 
development and investigated the effects. Initially the Apcmin mouse (Moser et al., 
1990) was used as it contains a loss-of-function Apc allele and as mutations in human 
APC are known to predispose to medulloblastoma (Hamilton et al., 1995), I 
hypothesised that mice with the Apcmin mutation may also develop cerebellar 
abnormalities in addition to intestinal neoplasia. Thus, I collected cerebellum tissue 
from Apcmi/+ mice and analysed the histology for any signs of gross pathology that 





Secondly, I sought to use a conditional genetic approach to remove both Apc alleles 
in a defined cell type at defined points in development. To achieve this, a mouse line 
containing a Nestin-CreERT2 (hereinafter referred to as Nestin-Cre) addition 
transgene (Carlén et al., 2006) was obtained in order to target recombination of a 
floxed Apc allele (Shibata et al., 1997) in the Nestin+ progenitor population at 
different stages of cerebellum development. As Nestin is expressed in both the VZ 
and RL progenitor domains (Dahlstrand et al., 1995; Zimmerman et al., 1994), 
utilising this Cre-recombinase line allowed the targeting of Apc mutations to all 
progenitors in order to investigate the effects of Wnt/!-catenin pathway activation in 
all cell lineages during development. The approach I took with these experiments 
was to first cross the Nestin-Cre onto a Rosa26 eYFP (R26YFP) reporter line 
(Srinivas et al., 2001) to validate the Cre-recombinase activity at different points 
during development (Fig. 5.1A). Secondly, I crossed the Nestin-Cre line onto a line 
carrying an Apclox allele (Shibata et al., 1997) that contains two LoxP sites and a 
Neomycin cassette flanking exon 14 of the mouse Apc gene. Tamoxifen induced 
Cre-recombinase activation in mice homozogous for the Apclox allele should generate 
non-functional APC protein after recombination of exon 14 in the cell types targeted 
(Fig. 5.1B).  
 
Finally, I sought to upscale and optimise these experiments for a full analysis by 
generating triple transgenic animals with Nestin-Cre+/- ; Apclox/lox ; R26YFP+/- 
genotype (Fig. 5.1C). To achieve this I generated mice homozygous for both the 
Apclox and R26YFP alleles, crossed these to Nestin-Cre+/- ; Apclox/lox mice and treated 
the offspring with tamoxifen. The aim of this set of experiments was to optimise the 
tamoxifen dosage that gave the highest Cre-recombinase induction as measured by 
YFP expression and to enable Apclox/lox cells to be tracked over a developmental time 
course.  
Figure 5.1 - Breeding strategy and  experimental summary. 
In order to test the expression of the Nestin-Cre transgene, heterozygous mice were 
crossed to mice homozygous for the R26YFP reporter. Offspring were treated with 
tamoxifen (Tmx) at defined points and analysed for YFP expression (A). Nestin-Cre 
mice were then crossed to mice carrying the Apclox allele and offspring were treated 
with Tmx in order to validate Wnt/!-catenin pathway activation in Nestin-Cre 
expressing cells (B). Finally, the R26YFP reporter allele was crossed onto the 
conditional knockout line in order to scale up the experiments and quantitate the 
extent of Nestin-Cre induction (C). 
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5.3 Analysis of the Apcmin mouse cerebellum revealed no pathology 
The Apcmin mouse model of intestinal neoplasia was identified after an 
ethylnitrosourea (ENU) screen generated a mutant mouse predisposed to multiple 
intestinal neoplasia (Min) (Moser et al., 1990). Linkage analysis and DNA 
sequencing revealed a point mutation in the Apc gene was responsible (Su et al., 
1992). As the Apcmin mutation causes intestinal polyposis throughout the intestinal 
tract in young adult mice the oldest age possible for analysis was 13 weeks, beyond 
this point the neoplasia normally develops to a point that requires the animals to be 
culled for humane reasons. Sagittal sections from Apc+/+ (Fig. 5.2A-B) and Apcmin/+ 
(Fig. 5.2C-D) mice (n=3 of each) were stained with hematoxylin in order to identify 
any histological differences. However, no sections analysed revealed any differences 
in gross morphology or lamination of the Apcmin/+ cerebellum (Fig. 5.2C-D). In 
addition, no obvious ectopic growth that would be consistent with a preneoplastic 
lesion was identified. These data support the conclusion that the required second hit 
of the Apc gene necessary for constitutive activation of the Wnt/!-catenin pathway is 
a considerably rare event in the cerebellum and would likely require a high number 
of animals to be observed before any effects of pathway activation could be 
observed.  
Figure 5.2 - The Apcmin mouse cerebellum shows no evidence of gross pathology.
Sagittal cerebellum sections from 13 week old Apc+/+ (A-B) and Apcmin/+ (C-D) mice 
were stained with Hematoxylin and Eosin and examined for evidence of gross 
pathology. No obvious differences were observed between the two groups. Scale bars 


























5.4 Nestin-Cre induction of an Apclox/lox mutation 
In order to constitutively activate the Wnt/!-catenin pathway in vivo I utilised an 
inducible Nestin-Cre addition transgene (Carlén et al., 2006) and a floxed Apc allele 
(Shibata et al., 1997) to remove APC function in the progenitor population at defined 
stages during cerebellum development.  
5.4.1 Nestin is expressed at key stages during cerebellum development 
I first sought to validate the expression pattern of Nestin by immunohistochemistry at 
various stages in early cerebellum development. At E14.5, Nestin can be observed 
along the length of the VZ (Fig. 5.3A). At higher magnification Nestin fibres can be 
observed radiating out from the VZ (Fig. 5.3B). Outside of the VZ Nestin expression 
remains relatively low. By E18.5 considerable Nestin expression can be observed 
throughout the cerebellum, with Nestin fibres evident extending from the EGL down 
into the tissue (Fig. 5.3C). Nestin is also evident within the developing cerebellum, 
although appears stronger in the anterior (Fig. 5.3D). At P1 the expression appears 
more restricted. Nestin fibres can be seen extending from the EGL into the PCL (Fig. 
5.3E), and also within WM (Fig. 5.3F). This pattern is also seen at P5, though 
appears considerably more restricted (Fig. 5.3G-H). These data support the continued 
































Figure 5.3 - Nestin is expressed in the developing cerebellum.
Sagittal cerebellum sections from E14.5 (A-B), E18.5(C-D), P1 (E-F) and P5 (G-H) 
mice were tested by immunohistochemistry for the expression of Nestin. Scale bars = 





5.4.2 Induction of the Nestin-Cre transgene activates a R26YFP reporter 
While Nestin expression is evident in the developing cerebellum, the Nestin-Cre 
transgene is an artificial construct driven by a single Nestin enhancer element 
(Kawaguchi et al., 2001; Zimmerman et al., 1994), thus the dynamics of its 
expression are unlikely to be entirely consistent with that of endogenous Nestin. For 
this reason, I next sought to validate the activity of the Nestin-Cre transgene. To do 
this I crossed heterozygous Nestin-Cre mice with homozygous R26YFP reporter 
mice to generate offspring that were heterozygous for both Nestin-Cre and R26YFP. 
These litters were treated with established concentrations of tamoxifen at two 
embryonic and two postnatal time points to induce the Cre-recombinase and thereby 
activate expression of the R26YFP reporter. Expression of YFP was then analysed by 
immunohistochemistry.  
 
Induction of Cre-recombinase activity at E13.5 by a single injection of 10 mg 
tamoxifen to a pregnant mother followed by a chase of three days resulted in a 
mosaic activation of the R26YFP reporter throughout the developing cerebellum 
(Fig. 5.4A). YFP expression was observed in numerous patches along the VZ, in 
cells apparently radiating out from the VZ, and also in scattered cells in the anterior 
EGL and immediately below it. No YFP expression was observed in the posterior 
EGL. A slightly later embryonic induction (E15.5) with the same dose followed by a 
three day chase resulted in a similar pattern of expression (Fig. 5.4B), with YFP 
expression again observed along the VZ and in cells radiating outward towards the 
EGL. Again, a notable lack of YFP expression was observed in the EGL. SC 
injections of tamoxifen postnatally also resulted in detectable YFP expression. 
Injections at P1 (1.5 mg) followed by a two day chase resulted in expression 
predominating in the PCL with scattered expression throughout the WM and 
occasionally in the EGL (Fig. 5.4C). SC tamoxifen injection at P5 followed by a four 
day chase gave a similar pattern of R26YFP expression, with YFP detected almost 
exclusively in the PCL and WM, with scattered expression through the IGL. No 
expression was observed in the EGL (Fig. 5.4D). Combined, these data confirm the 




the restriction of the reporter expression compared to the expression of endogenous 
Nestin protein suggests Nestin-Cre is not active in all Nestin expressing cells at the 
dosages of tamoxifen used. In particular, Nestin expression at P1 and P5 was 
observed throughout the PCL and WM while expression of the R26YFP reporter 
appeared considerably more restricted.   
5.4.3 Potential linkage between the Nestin-Cre and Apc alleles caused difficulty 
in generating the Nestin-Cre Apclox/lox mouse model 
To constitutively activate Wnt/!-catenin signalling in the Nestin-Cre expressing cells 
during cerebellum development I crossed the Nestin-Cre line to the Apclox line. 
However, a number of crosses were required to obtain Nestin-Cre+/- ; Apclox/lox 
individuals and the genotype ratios obtained indicated a potential linkage between 
the Nestin-Cre and Apc alleles. Offspring from three separate pairs were genotyped 
and the observed genotype frequencies were compared to the expected genotype 
frequencies (Table 5.1). In all three crosses carried out, the Nestin-Cre allele and the 
Apclox alleles from the two parents rarely ended up in the same offspring (i.e. the 
Nestin-Cre and Apc alleles appear to segregate together more often than would be 
expected). A two-tailed Chi2 test to analyse the difference between the observed and 
expected offspring genotypes revealed a significant difference in all three crosses. 
This suggests that the aberrant segregation of the two alleles observed is likely the 
result of them both being present on the same chromosome, though far enough apart 
that several rare offspring were obtained with the Nestin-Cre+/- ; Apclox/lox genotype 
required for further breeding.  
Figure 5.4 - R26YFP reporter expression induced after tamoxifen induction of 
Nestin-Cre activity. 
Nestin-Cre+ ; R26YFP+ animals were injected with tamoxifen in utero or early 
postnatally to induce Nestin-Cre activity at E13.5 (A), E15.5 (B), P1 (C) and P5 (D). 
Expression of the R26YFP reporter was analysed by immunohistochemistry between 
two and four days later on sagittal cerebellum sections.Scale bar = 100 !m. Folia 
identified by roman numerals. 
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Chi2 / P value 
Cre+/- Apclox/+   Cre+/ Apclox/lox- 1 3.25 (25%)  
x Cre+/-Apclox/+ 7 3.25 (25%)  
Cre-/- Apclox/lox Cre-/-Apclox/lox 4 3.25 (25%)  
 Cre-/-.Apclox/+ 1 3.25 (25%) 7.62 / 0.019 (3df) 
Cre+/- Apclox/+   Cre+/ Apclox/lox- 0 4.75 (12.5%)  
x Cre+/-Apclox/+ 11 4.75 (12.5%)  
Cre-/- Apclox/+ Cre+/-Apc+/+ 7 9.5 (25%)  
 Cre-/- Apclox/lox- 8 9.5 (25%)  
 Cre-/-Apclox/+ 11 4.75 (12.5%)  
 Cre-/-Apc+/+ 1 4.75 (12.5%) 25.05 / 0.00136 (5df) 
Cre+/- Apclox/+   Cre+/-Apclox/+ 3 14.75 (25%)  
x Cre+/-Apc+/+ 31 14.75 (25%)  
Cre-/- Ap+/+ Cre-/-Apclox/+ 20 14.75 (25%)  






5.4.4 Nestin-Cre ; APClox/lox mutant mice display ectopic !-catenin, confirming 
activation of the Wnt/!-catenin pathway 
Once adequate numbers of Nestin-Cre+/- ; Apclox/lox males were obtained I began a 
series of proof of principle experiments to test the activity of the Nestin-Cre 
transgene on the Apclox allele at defined embryonic and postnatal stages of 
development.  Nestin-Cre+/- ; Apclox/lox males were crossed to Apclox/lox females in order 
to generate offspring that were either Nestin-Cre+/- ; Apclox/lox for analysis or Nestin-
Cre-/- ; Apclox/lox as controls. These offspring were treated with tamoxifen 
embryonically by a gavage delivered to the pregnant mother, or by early postnatal 
SC injection.  
 
10 mg of tamoxifen in total was delivered (in 200 µl corn oil) to E14.5 pregnant 
Apclox/lox females that had been set up in timed matings with Nestin-Cre+/- ; Apclox/lox 
males. The embryos were first collected at E18.5 and sagittal sections taken from the 
resulting Cre+ and Cre- embryos were analysed by immunohistochemsitry for the 
ectopic localisation of !-catenin as a marker for loss of APC (as APC is an 
abundantly expressed cytoplasmic protein, detecting its lack of expression in few 
cells spread amidst a high number of APC+ cells was too difficult). While no effect 
was observed in the Cre- sections (Fig. 5.5A), a small proportion of cells were 
identified in the Cre+ embryos, particularly along the VZ, that displayed ectopic 
nuclear localisation of !-catenin protein (Fig. 5.5B-C). This indicated that Cre-
mediated recombination of the Apclox/lox allele had occurred and that the Wnt/!-
catenin pathway had become upregulated as a result.  
 
In order to analyse the long term consequences of Wnt/!-catenin pathway activation 
in the cerebellum at this stage, a second litter was left to term and then analysed after 
six weeks postnatal growth. Initially, a cresyl violet (CV) stain was carried out on 
sagittal sections and gross morphology of the Cre- (Fig. 5.5D) and Cre+ (Fig. 5.5E) 
cerebellums were compared, although no obvious differences were observed between 




revealed a lack of ectopic expression (Fig. 5.5F-G) in the Cre+ cerebellums. These 
data suggest that the complement of mutant cells generated by E18.5 have either died 
out by this time point, or that recombination of the Apclox allele was not successful in 
this litter.  
 
1.5 mg tamoxifen (delivered in 50 µl corn oil) was injected SC to each pup from the 
same cross at P1. Animals were then culled and cerebella dissected at P10. Sagittal 
sections from each Cre- (Fig. 5.6A) and Cre+ (Fig. 5.6B) cerebellum were then 
analysed by immunohistochemistry for the expression of !-catenin. These 
experiments revealed ectopic expression of !-catenin throughout each lobe of the 
cerebellum (Fig. 5.6B-C), with particularly extensive expression within the 
developing ML and PCL – consistent with the glia and interneuron populations. 
However, in an additional litter analysed after six weeks postnatal development no 
differences were observed at the gross morphological level between the Cre- (Fig. 
5.6D) and Cre+ (Fig. 5.6E) cerebellums, nor was there any evidence for ectopic 
expression of !-catenin (Fig. 5.6F-G). Again, this could be due to either the death of 
the mutant cells generated earlier, or the failure of recombination to take place.  
 
Interestingly, in a litter that was allowed to develop for six months one of the Cre+ 
animals developed intestinal adenomas and was subsequently culled. Sagittal 
sections from the dissected cerebellum of this animal were compared to a Cre- 
littermate (Fig. 5.7A) and a small amount of ectopic !-catenin localisation was 
observed (Fig. 5.7B-C). These results indicate that in this individual Cre-mediated 
recombination of the Apclox allele was successful, though this either occurred in a 
small proportion of cells or the survival of the mutant cells was limited. Indeed, no 
developmental defects were observed in these sections alongside the ectopic !-
catenin expression. Multiple intestinal adenomas were present in this animal, 
predominating in the distal portion of the large intestine. The Cre- littermate showed 
normal large intestine morphology and !-catenin expression (Fig. 5.7D,F), while the 
Cre+ adenoma displayed extensive disorganisation and ectopic !-catenin expression 




communication – Dr. O. Faluyi, Queens Medical Research Institute, University of 
Edinburgh, UK).  
 
Induction of Apclox recombination was also tested at an additional postnatal time 
point. 1.5 mg tamoxifen was injected SC (in 50 µl corn oil) to a P5 litter, which was 
then left until P21 before analysis. At this point animals were culled and the 
cerebella dissected and processed. Immunohistochemistry for !-catenin in Cre- (Fig. 
5.8A) and Cre+ animals (Fig. 5.8B-C) revealed a number of cells with ectopic 
nuclear !-catenin throughout the layers of the cerebellum, although again 
predominance in the PCL and ML was evident. This is likely the result of the glia 
and interneuron progenitors being the remaining Nestin expressing cells at P5. An 
additional litter was treated with tamoxifen at P5 and left until six weeks. While no 
gross morphological differences were observed between Cre- (Fig. 5.8D) and Cre+ 
individuals (Fig. 5.8E), immunohistochemistry for !-catenin revealed considerable 
ectopic expression (Fig. 5.8F-H).  
 
The limited data obtained from these experiments confirm the activity of the Nestin-
Cre transgene on the Apclox allele during cerebellum development from the 
observation of ectopic !-catenin expression shortly after induction of the Cre-
recombinase at E14.5, P1 and P5. However, a number of inconsistencies were 
observed in the full data set. Namely, no expression of !-catenin was observed after 
six weeks in the cerebellum of animals injected with tamoxifen at E14.5 or P1, while 
this was observed in animals injected at P1 after six months and after six weeks and 
six months in animals injected with tamoxifen at P5. These confounding results 
suggest that the protocol for Cre induction by tamoxifen injection was not 
consistently successful and warranted a more thorough optimisation of these 
experiments in order to draw any solid conclusions from the data.  
Figure 5.5 - Nestin-Cre induced loss of APC at E14.5 led to ectopic accumulation 
of !-catenin.
Nestin-Cre+ ; Apclox/lox x Nestin-Cre- ; Apclox/lox crosses were set up and pregnant 
females were injected with Tmx at E14.5. Resulting Cre- (A) and Cre+ (B) embryos 
were identified and ectopic accumulation of !-catenin was observed in the Cre+ 
embryos (B-C). An additional litter was left to develop normally for six weeks 
(D-G), but no gross pathology was observed (D-E) through cresyl violet (CV) stain-
ing. No ectopic accumulation of !-catenin was observed (F-G). Scale bars = 100 "m 







































































6  weeks PN (Tmx P1)
Figure 5.6 - Nestin-Cre induced loss of APC at P1 led to ectopic accumulation of 
!-catenin.
Pups from Nestin-Cre+ ; Apclox/lox x Nestin-Cre- ; Apclox/lox crosses were injected with 
Tamoxifen at P1. Cre- (A) and Cre+ (B) animals were identified at P10 and ectopic 
accumulation of !-catenin was observed in sagittal sections from Cre+ embryos 
(B-C). An additional litter was left to develop normally for six weeks (D-G), but no 
gross pathology was observed (D-E). No ectopic accumulation of !-catenin was 
observed either (F-G). Scale bars = 100 "m (A-B, F-G), 500 "m (D-E). 
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Figure 5.7 - Nestin-Cre induced loss of APC at P1 led to ectopic accumulation of 
!-catenin and intestinal adenoma after six months in one case.
Nestin-Cre- ; Apclox/lox (A,D,F) and Nestin-Cre+ ; Apclox/lox (B,E,G) pups were injected 
with tamoxifen at P1. Ectopic accumulation of !-catenin was observed in the 
cerebellum of one Cre+ animal (B-C) after six months. The same animal developed 
an intestinal adenoma (E) which displayed considerable disorganisation and ectopic 
accumulation of !-catenin (G) compared to the epithelia of a Cre- intestine (F). Scale 
















































































Figure 5.8 - Nestin-Cre induced loss of APC at P5 led to ectopic accumulation of 
!-catenin.
Pups from Nestin-Cre+ ; Apclox/lox x Nestin-Cre- ; Apclox/lox crosses were injected with 
Tamoxifen at P5. Cre- (A) and Cre+ (B) animals were identified at P21 and ectopic 
accumulation of !-catenin was observed in sagittal sections from Cre+ embryos 
(B-C). An additional litter was left to develop normally for six weeks (D-G), but no 
gross pathology was observed (D-E). However, ectopic accumulation of !-catenin 
was observed (F-H) throughout the cerebellum. Scale bars = 100 "m (A-B, F-G), 







5.4.5 Generation of a Nestin-Cre+ ; Apclox/lox ; R26YFP+ triple transgenic model 
for experimental optimisation 
In order to investigate the phenotype of constitutive Wnt/!-catenin activation in the 
developing cerebellum, I next sought to optimise the induction protocol by creating 
triple transgenic mice with the Nestin-Cre, Apclox and R26YFP alleles. To obtain 
mice with this genotype, I generated Apclox/lox ; R26YFP+/+ double homozygous 
animals and crossed them with the previously generated Nestin-Cre+/- ; Apclox/lox 
animals. With these mice generated, I planned to quantify the extent of 
recombination (by counting YFP+ cells in the tamoxifen treated cerebella) with 
different tamoxifen doses at the different time points. In addition, I investigated the 
use of 4-hydroxy (4-OH) tamoxifen – the metabolically active form of the drug 
(tamoxifen itself requires processing in the liver for conversion to its active state).  
 
Initially, Nestin-Cre+/- ; Apclox/lox males were crossed to Apclox/lox ; R26YFP+/+ females 
and the offspring were treated with 10.5 mg or 12 mg of tamoxifen by gavage 
delivered to the pregnant mother at E14.5 or E16.5 respectively. In addition, P1 stage 
pups were injected SC with either 1.5 mg tamoxifen or 0.05 mg 4-OH tamoxifen. 
Offspring induced embryonically were collected at E18.5 for analysis and offspring 
induced at P1 were collected for analysis at P7 (Fig. 5.9A). The cerebellum of Cre+ 
individuals (approximately half the total offspring) were sectioned and analysed by 
immunohistochemistry for YFP and !-catenin expression. In addition, the cortex of 
these animals was collected and DNA extracted in order to test for presence of the 
recombined Apc allele (Apc") by PCR.  
 
These experiments revealed that in all cases little to no YFP or ectopic !-catenin 
expression was observed (Fig. 5.9B-C) in stark contrast to the induction of YFP or 
ectopic expression of !-catenin observed previously (Fig. 5.4-5.7). In no case was 
the Apc" allele identified. A total of 37 Cre+ individuals (out of a total of 72 
individuals) were treated with tamoxifen in the four dosing regimes, none of which 
displayed any YFP expression above one or two rare cells per section. To confirm 




separate experiment was carried out where the offpsing from an Emx1-Cre x 
R26YFP cross were treated with 10.5 mg tamoxifen by gavage to the pregnant 
mother at E14.5 followed by analysis at E18.5. In all Cre+ individuals from this 
experiment, considerable induction of the YFP reporter was evident throughout the 
cortex (the region of Emx1 expression) (Fig. 5.9D-E). This confirmed that both the 
reporter transgene and the tamoxifen preparation were functional and that the lack of 
YFP expression or ectopic !-catenin expression observed is likely due to loss of 
Nestin-Cre transgene function.   
Figure 5.9 - Loss of Nestin-Cre activity despite effectiveness of tamoxifen 
preparation on other models.  
To optimise the tamoxifen induction protocol, a R26YFP reporter was crossed onto 
Nestin-Cre ; Apclox/lox animals and a series of tamoxifen or 4-hydroxy (OH) tamoxifen 
injections were carried out at E14.5, E16.5 and P1 followed by analysis at E18.5 or 
P7 (A). Only rarely were YFP+ cells observed in sagittal sections taken from these 
animals (white arrows B-C, representative images). The tamoxifen preparation was 
trialed on an independent Cre line (EMX1Cre), which revealed expected expression 
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The aim of this chapter was to investigate the consequences of constitutively 
activating the Wnt/!catenin pathway in vivo at defined points during development. 
To address this I utilised existing mouse models with targeted mutations to the Apc 
gene. Results from these experiments revealed either a lack of aberrant phenotype, or 
were unsuccessful.  
5.5.1 The Apcmin mouse does not model medulloblastoma 
The Apcmin mouse contains a point mutation in the Apc gene resulting in a truncated 
and non-functional protein being produced (Moser et al., 1990; Su et al., 1992). Mice 
heterozygous for the Apcmin allele exhibit loss of heterozygosity (LOH) and develop 
intestinal polyposis and eventual multiple adenomas after 10 weeks. As such, they 
are frequently used to model the human condition FAP. As FAP patients are 90 times 
more likely to develop medulloblastoma than the general population (Hamilton et al., 
1995) I reasoned that early preneoplastic lesions may be evident in the cerebellum of 
mice with the Apcmin mutation. However, no such lesions nor any gross 
developmental defects were evident. This is most likely due to the requirement for 
Apc LOH in order for Wnt/!-catenin signalling to become constitutively active. 
While the continuous turnover of cells within the intestinal crypts allows for the 
gradual accumulation of mutation (such as the second hit required for Apc LOH), the 
limited amount of cell division during cerebellum development in comparison means 
that this event would be exceedingly rare. Thus, a large cohort of mice would have to 
be analysed in order to find any abnormality resulting from Apc LOH in the 
cerebellum. In addition, as the Wnt subgroup of paediatric medulloblastoma is 
known to be less aggressive and to develop relatively late in childhood (Kool et al., 
2008) it is also possible that the timescale for these experiments was not long enough 




5.5.2 Attempts to constitutively activate the Wnt/!-catenin pathway during 
cerebellum development mediated by the Nestin-Cre transgene were not 
successful 
Conditional gene targeting allows for the effects of a gene knockout to be studied in 
a spatio-temporal specific manner. In this context, I chose a Nestin-CreERT2 
trasngene (Carlén et al., 2006) to knockout the Apc gene (Shibata et al., 1997) in the 
cerebellum progenitor population (Dahlstrand et al., 1995; Zimmerman et al., 1994) 
at defined stages in cerebellum development. Thus, while a full knockout of Apc 
function would not be viable, this approach would allow a functional investigation 
on the consequences of Wnt/!-catenin pathway activation in progenitors at different 
stages of development.  
 
Initially, validation of the Nestin-Cre trasngene using a R26YFP reporter allele 
revealed widespread expression of the reporter following tamoxifen induction at 
E13.5 or E15.5 (Fig. 5.4) throughout the cerebellum. Furthermore, reporter activation 
was observed after postnatal induction at both P1 and P5, albeit in a more restricted 
manner consistent with the expression of endogenous Nestin (Fig. 5.2). Combined, 
these experiments provided the rationale for using the Nestin-Cre trasngene to 
knockout Apc function at these stages of cerebellum development. Proof of principle 
experiments testing the conditional knockout of Apc at E14.5, P1 and P5 revealed 
ectopic accumulation of !-catenin after a period of four to 15 days (Fig. 5.5-5.8). 
However, inconsistencies were evident between experimental groups after attempts 
to leave injected animals for periods of six weeks to six months. To resolve these, 
and to launch a more thorough investigation of the functional effects of conditional 
Apc knockout in the developing cerebellum, I carried out further breeding in order to 
generate Nestin-Cre Apclox/lox R26YFP transgenic animals. However, experiments 
carried out on animals at this point revealed an almost complete loss of Nestin-Cre 
activity. From these data I conclude that attempts to optimise and scale up the 
experiments resulted in a heritable loss of Nestin-Cre function and thus alternative 




6 Activation of Wnt/!-catenin signalling in vivo 
using in utero electroporation 
6.1 Introduction 
The aim of the work presented in the previous chapter was to investigate the 
functional consequences of Wnt/!-catenin pathway activation in vivo at defined 
stages during cerebellum development. Attempts to address this aim using an 
inducible genetic knockout mouse model were not successful and due to the time 
constraints of generating further mouse models I decided to pursue in utero 
electroporation as an alternative method of in vivo genetic manipulation. Briefly, the 
technique involves exposing embryos in utero and microinjecting DNA into the 
embryonic tissue of interest followed by passing a current through the tissue with 
external electrodes so that the DNA is taken into cells within the region (Saito and 
Nakatsuji, 2001).  
 
There are a number of examples of in utero electroporation being used as a technique 
for studying cerebellum development that demonstrate its advantages over traditional 
genetic approaches. Core to this is the ability to more precisely control the spatio-
temporal extent of the genetic change being introduced by choosing when a DNA 
injection is carried out and defining the region to take up the DNA by positioning the 
electrodes accordingly. This has allowed a descriptive fate map of the brain stem 
nuclei to be generated by targeting a YFP encoding plasmid to the LRL and 
following the migration of YFP+ cells over a developmental window (Kawauchi et 
al., 2006). This approach has also been used to investigate the role of different 
transcription factors and signalling pathways in the generation of LRL derived 
lineages (Dipietrantonio and Dymecki, 2009; Gibson et al., 2010; Kalinovsky et al., 
2011). Of particular interest is the study by Gibson et al. that demonstrated LRL cells 
with activated Wnt/!-catenin signalling were unable to migrate appropriately and 





In addition to targeting mutations to the LRL, in utero electroporation has also been 
used in gain/loss of function experiments to study development from the VZ 
(Grimaldi et al., 2009) and URL (Kawauchi and Saito, 2008). Grimaldi et al. used in 
utero electroporation to demonstrate the role of Ascl1 in the generation of 
GABAergic interneurons from the VZ by electroporating Ascl1 expression vectors to 
induce overexpression of the gene. Kawauchi and Saito demonstrated that Bar-class 
homeobox transcription factors Mbh1 and Mbh2 lie downstream of GPC marker 
Math1 and are required for differentiation of GCs from GPCs by electroporating 
constructs to over or under express all three genes (Kawauchi and Saito, 2008). 
These studies highlight the ease of gene transfer with multiple constructs to study a 
developmental process without resorting to time consuming and costly generation of 
multiple knockout mouse models. Combined, these studies highlight the ease, 
efficiency, specificity and ability to target multiple genes using in utero 
electroporation in order to study cerebellum development, making it a feasible 
alternative method to address the aims that were not successfully achieved in the 
previous chapter.   
 
6.2 Aims and experimental design 
As with the previous chapter, the aim of the work presented here was to investigate 
the functional consequences of Wnt/!-catenin pathway activation in vivo during 
cerebellum development. To achieve this I conducted a series of experiments using 
in utero electroporation to deliver Cre-reombinase encoding DNA directly to the 
progenitors surrounding the fourth ventricle of Apclox/lox  and Apclox/+ embryos. Some 
embryos carrying the R26YFP reporter allele were also generated in order to better 
track the extent of electroporation (these cases are specified in the proceeding 
sections). This was followed by an analysis of the effects over a developmental 
window from E14.5 to E18.5.  
 
E13.5 was chosen as the time point for electroporation as a compromise between two 




shaped space with a simple surrounding tissue. Early in development (between 
E10.5-E12.5) it takes up considerable space and is easily identifiable from a dorsal 
view of the MHB region. However, it becomes progressively restricted in size during 
development and becomes obscured under the growing cerebellar anlage, making 
access for injection more difficult. Another confounding factor is the thickness of the 
uterine wall. During early embryogenesis (from conception to E12.5) the thickness 
of the uterus makes it difficult to visualise the gross anatomy of each embryo, 
whereas from E13.5 onwards this becomes much easier. Thus, I chose E13.5 as the 
best time point to carry out electroporations as the uterine wall is thin enough to see 
the embryo yet the fourth ventricle is large enough to allow access for the injection 
procedure. In addition, electroporation at E13.5 enabled the plasmid to be targeted to 
the VZ at a relatively early period of cerebellum development, allowing the effects of 
Wnt/!-catenin pathway activation to be observed in the multiple cell lineages that 
develop from that point onwards.  
 
pCAG-Cre-IRES2-EGFP plasmid DNA (Woodhead et al., 2006) containing coding 
sequence for Cre-recombinase and GFP was injected (>1.5 µg/µl) in a solution 
containing Fast Green dye into the fourth ventricle of the exposed E13.5 embryos 
(Fig. 6.1A). Accumulation of the dye in the fourth ventricle was used to judge the 
success of the injection. Electrodes were then placed over the MHB region on a 
medial-lateral axis with the positive electrode on the right so that the negatively 
charged DNA would only be taken up by cells surrounding the right side of the 
ventricle (Fig. 6.1B). While orientation of the positive electrode directly over the 
right cerebellar hemisphere would potentially lead to a more successful plasmid 
uptake in the VZ, orienting the electrodes along the medial-lateral axis is more 
reproducible and also allowed for electroporation of cells within the LRL and DHB. 
Analysis was carried out on the cerebellum and HB tissue from Apclox/lox and Apclox/+ 
embryos at E14.5, E15.5, E16.5 and E18.5 (Fig. 6.1C). Initially I sought to determine 
the extent of electroporation based on the expression of GFP and the activation of 
Wnt/!-catenin signalling based on the ectopic expression of !-catenin. A more 
thorough comparison between the two genotypes was carried out at E18.5 in order to 
allow a reasonable amount of time for any effects to manifest.  
Figure 6.1 - Experimental procedure
Apclox/lox males were crossed to Apclox/+ females and embryos were injected in the 4th 
ventricle with Cre-GFP plasmid (A) before being electroporated (B). Embryos were 





Cre-GFP injected into 4th ventricle of 
E13.5 ApcLox/Lox and ApcLox/+ embryos
Electroporation across medial-lateral axis
(35 v, 50 ms on, 950 ms off, x5)
Deletion of Apc in Cre-GFP 
expressing cells in Cb and DHB
Analysis at E14.5, 15.5, 16.5 and 18.5














6.3 Early effects of Cre-GFP electroporation to E13.5 Apclox/lox 
embryos 
I first sought to analyse the extent of GFP expression after electroporation at E13.5 
and to show evidence for activation of the Wnt/!-catenin pathway in these cells. To 
this end I chose to analyse cerebella from electroporated embryos after 24 and 48 
hours.  
6.3.1 Electroporation of Cre-GFP plasmid was evident at E14.5 and E15.5, but 
no activation of the Wnt/!-catenin pathway was observed 
A total of 44 embryos were electroporated with Cre-GFP plasmid at E13.5 for 
collection at E14.5. Of these, 35 survived giving an 80% survival rate. 11 embryos 
were identified as GFP+ upon dissection, giving an electroporation success rate of 
25%. Immunohistochemistry on sagittal sections from the right cerebellar 
hemisphere in GFP+ embryos analysed at E14.5 revealed widespread expression of 
GFP along the length of the VZ and in cells and processes radiating out from the VZ, 
indicating the successful uptake of plasmid DNA by the cells surrounding the 
ventricle (Fig. 6.2A-B). GFP+ cells were also evident within the URL, EGL and 
DHB. It is worth noting that this expression pattern was not always consistent 
between embryos, as minor changes in the volume of plasmid DNA injected, the site 
of injection and the orientation of the electrodes leads to more or less plasmid uptake 
in different regions surrounding the ventricle (Appendix 4). Sections from Apclox/lox 
embryos were also analysed for !-catenin expression in order to determine if 
electroporation of the plasmid DNA had led to Cre expression, the recombination of 
Apc and the subsequent activation of Wnt/!-catenin signalling. However, in all 
sections analysed by immunohistochemistry !-catenin expression was normal (Fig. 
6.2C-D) and no ectopic nuclear expression was observed despite the abundance of 
GFP expression (compare Fig. 6.2B and Fig. 6.2D). This result suggests the 
possibility that, despite the fact GFP expression was activated, 24 hours may not 
have been sufficient for Apc recombination and subsequent Wnt/!-catenin pathway 





To test this assumption I analysed sections taken from the right cerebellar 
hemisphere of embryos collected at E15.5 after electroporation at E13.5, allowing 48 
hours for the effects of Cre-GFP plasmid electroporation to manifest. Of the 72 
embryos electroporated for collection at E15.5, 53 had survived giving a survival rate 
of 74%. Of all these embryos 13 were identified as GFP+, giving a success rate of 
18%. Immunohistochemistry revealed a similar pattern of GFP expression to that 
observed at E14.5, with GFP+ cells identified at the VZ and in the cells and 
processes radiating away (Fig. 6.2E-F). Variation was also observed between 
embryos, with some showing expression of GFP within the DHB, RL and in 
differing patterns along the VZ (Appendix 4). Immunohistochemistry for !-catenin 
was also carried out on these sections of E15.5 cerebellum but results were similar to 
what was observed at E14.5 with no ectopic nuclear localisation detected (Fig. 6.2G-
H). Cells that expressed GFP (Fig. 6.2F) did not show any evidence of ectopic !-
catenin expression (Fig. 6.2H), suggesting that activation of the Wnt/!-catenin 
pathway had not occurred in electroporated cells after 48 hours. 
Figure 6.2 - Electroporation of Cre-GFP plasmid into E13.5 cerebellum did not 
result in Wnt/!-catenin pathway activation at E14.5 or E15.5. 
Apclox/lox embryos were electroporated (EP) with Cre-GFP plasmid at E13.5 and 
analysed for the expression of GFP and !-catenin at E14.5 (A-F) and E15.5 (E-H). 
While widespread GFP expression along the VZ and sporadically in the URL and 
EGL (white arrows) is evident at E14.5 (A-B) and E15.5 (E-F), indicating successful 
electroporation, no ectopic expression of !-catenin is observed at either age (C-D, 




















































6.3.2 Electroporation of Cre-GFP plasmid to Apclox/lox embryos causes Wnt/!-
catenin pathway activation by E16.5 
A total of 62 embryos were electroporated with Cre-GFP plasmid at E13.5 and 
analysed at E16.5. Of these 58 survived, giving a survival rate of 93.5% and 20 were 
identified as GFP+, giving a success rate of 32.2%. GFP+ embryos were analysed by 
immunohistochemistry to determine the extent of GFP expression. By this time point 
the GFP expression within all cerebellum sections analysed had extended well 
beyond the initial domains in contact with the fourth ventricle. In the cerebellum 
GFP+ cells could be clearly observed at the VZ and in a widely dispersed population 
of cells radiating away from the VZ (Fig. 6.3A), consistent with the developing glial 
and interneuron cell lineages. GFP expression was also observed in cells at the LRL 
and within the DHB (Fig. 6.3B). Consistent with observations at earlier time points, 
there was a certain amount of variation between each of the embryos analysed with 
regards to the extent of GFP expression in the cerebellum and DHB as a result of 
minor differences between the injection and electroporation between embryos 
(Appendix 4).  
 
From a gross perspective expression of !-catenin within the cerebellum and DHB of 
Apclox/lox embryos appeared normal (Fig. 6.3A-B), but higher magnification revealed 
the nuclear localisation of !-catenin in a majority of the GFP+ cells. GFP can be 
observed clearly in the nuclei of cells within the VZ (Fig. 6.3C) and the ectopic 
nuclear expression of !-catenin could be seen in a very similar pattern, with a 
majority of the GFP+ cells showing nuclear localisation of !-catenin (Fig. 6.3 D-E). 
This was also observed in the DHB, where the pattern of GFP expression (Fig. 6.3F) 
was strikingly similar to the pattern of nuclear !-catenin expression (Fig. 6.3G-H). 
These data support the activation of Wnt/!-catenin signalling in electroporated cells 
at E16.5. Combined with the above data (Fig. 6.2), this suggests that the sequence of 
events required between electroporation of the Cre-GFP plasmid into an Apclox/lox cell 
and the subsequent activation of the Wnt/!-catenin pathway takes up to 72 hours in 
this model system.  
Figure 6.3 - Ectopic !-catenin localisation in E16.5 cerebellum and DHB of 
Apclox/lox embryos electroporated with Cre-GFP plasmid at E13.5.
E13.5 embryos were injected with Cre-GFP plasmid at E13.5 and the cerebellum (A, 
C-E) and DHB (B, F-H) were analysed for the expression of GFP and  !-catenin. 
GFP expression was evident in cells at the VZ and migrating away (C). Nuclear !
-catenin was also observed in cells in this region (D) colocalising with GFP 
expression (E, white arrows in C-E). This was also observed in the DHB (F-G). 























6.4 Late embryonic effects of Cre-GFP electroporation to E13.5 
Apclox/lox embryos 
With activation of the Wnt/!-catenin pathway established in Apclox/lox cells 72 hours 
after electroporation with Cre-GFP plasmid, I next sought to determine the effects of 
pathway upregulation in electroporated cells during late embryogenesis. While a 
larger developmental window would potentially allow longer for any potential 
effects to become manifest, E18.5 represents a point in development where a number 
of the key cerebellar lineages are going through important developmental processes 
including cell specification, proliferation, differentiation and migration. Thus, 
focusing my analysis at this point allows for the identification of a phenotype with 
regards to these processes as they occur, rather than looking for an end result. 
6.4.1 Electroporation of Cre-GFP plasmid results in widespread GFP 
expression by E18.5 regardless of Apc genotype 
A total of 106 embryos were electroporated with Cre-GFP plasmid at E13.5 and left 
until E18.5. Of these 80 survived, giving a survival rate of 75.5%, and 32 were 
GFP+, giving a success rate of 30.2%. Immunohistochemistry for GFP in sagittal 
section taken from the entire MHB region revealed a pattern of widespread GFP 
expression within the cerebellum, DHB and PGN. Apclox/+ and Apclox/lox embryos were 
compared and few differences were observed between them. In both cases, GFP 
expression was evident in the ventral region of the cerebellum and in a widely 
dispersed pattern throughout consistent with developing interneuron and glial 
lineages radiating from the VZ (Fig. 6.4A-B). Interestingly, few GFP+ cells were 
observed within the EGL of any sections analysed except for one of the Apclox/lox 
embryos, which showed several clusters of GFP+ cells within the EGL. There also 
appeared to be clustering of GFP+ cells within the cerebellum to a greater extent than 
in Apclox/+ embryos (white arrows in Fig. 6.4B).  
 
In addition to GFP expression within the cerebellum, it was also evident within the 




observed within the LRL and in cells migrating through the DHB from the LRL. 
While subtle differences were evident between all embryos analysed (Appendix 5), 
the extent of GFP+ cell migration through the DHB appeared reduced in the Apclox/lox 
embryos compared to the Apclox/+ embryos. However, the identification of GFP+ cells 
in the PGN of both Apclox/+  (Fig. 6.4E) and Apclox/lox  (Fig. 6.4F) embryos suggests 
that migration from the LRL is not impaired following electroporation.  
 
It is also important to note that there was no detectable difference in the total number 
of GFP+ cells per section between the two Apc genotypes (Table 6.1). The four 
Apclox/lox embryos analysed revealed an average number of GFP+ cells/section of 
115.7 (±38.4), while Apclox/+ embryos revealed 161 GFP+ cells/section (±71.9). A 
student’s T-test between these two data sets did not reveal a significant difference 
(p=0.309). However, an added complication to address is that a number of the mice 
in each of these genotype groups also contained the R26YFP reporter allele. This 
reporter should become stably expressed in cells that have undergone Cre-mediated 
recombination and in any progeny that arise from them. In addition, the YFP protein 
is detected with the immunohistochemistry methods used to detect GFP. Thus, 
animals carrying the R26YFP allele might be expected to contain more GFP+ cells 
than those without (because expression of the activated R26YFP allele is permanent 
whereas expression of the electroporated Cre-IRES-GFP is likely to be transient). 
Quantitation of GFP expressing cells in the animals used above but compared 
between R26YFP genotype instead revealed that this was indeed the case (Table 6.1). 
Animals with the reporter had an average of 150.8 (±84.9) GFP+ cells/section, while 
animals without had 84.9 (±11.5), a significant difference (p=0.030, student’s T-test). 
Taken together, we can conclude that mice with the reporter allele contain more GFP 
expressing cells. However, mice of each R26YFP genotype were present in both Apc 
genotype groups (Appendix 6).  
Figure 6.4 - Distribution of GFP+ electroporated cells in the E18.5 cerebellum 
and HB of embryos electroporated with Cre-GFP plasmid at E13.5.
Apclox/+ and Apclox/lox E13.5 embryos were injected with Cre-GFP plasmid and GFP 
expression was analysed at E18.5. In both Apclox/+ (A) and Apclox/lox (B) embryos 
GFP+ cells can be observed dispersed throughout the cerebellum from the VZ. In the 
Apclox/lox cerebellum small clusters of GFP+ cells were also seen (white arrows). GFP 
expression was also observed in the DHB in both Apclox/+ (C) and Apclox/lox (D) 
embryos, though Apclox/lox embryos consistently showed clustering of GFP+ cells at 
the LRL while Apclox/+ embryos had a more dispersed pattern. Both genotypes 
displayed GFP expression at the PGN (pontine grey nucleus, E-F), a result of 



























Table 6.1 - Comparison of total GFP+ cells/slice between Apc and R26YFP 
genotypes  
 
Genotype n Mean SD T-test 
Apclox/lox  4 115.7 38.4  
Apclox/+ 4 160.9 71.9  
    0.309 
R26YFP+/- 5 150.8 28.5  
R26YFP-/- 3 84.9 11.5  





6.4.2 Activation of the Wnt/!-catenin pathway is evident at E18.5 after 
electroporation with Cre-GFP plasmid.  
Having established the extent of GFP expression within the electroporated embryos 
at E18.5, I next sought to determine if the activation of the Wnt/!-catenin signalling 
pathway observed at E16.5 persists until E18.5. Sections from the cerebellum (Fig. 
6.5A) and DHB (Fig. 6.5B) were analysed by immunohistochemistry for the 
expression of GFP and !-catenin. High magnification of GFP expressing regions in 
the cerebellum (Fig. 6.3C) revealed the extent of ectopic nuclear !-catenin 
expression (Fig. 6.5D), which colocalised with GFP in a majority of cells (white 
arrows, Fig. 6.5E). Areas of GFP expression in the DHB (Fig. 6.5F) also exhibited 
considerable nuclear localisation of !-catenin (Fig. 6.5G) that colocalised with GFP 
(white arrows, Fig. 6.5H). Quantitation of VZ and LRL high magnification images 
(e.g. Fig. 6.5 C-H) from 10 individual Apclox/lox embryos revealed that an average of 
82% (±6.2%) of GFP+ cells also showed evidence for nuclear localisation of !-
catenin.  
 
In addition, I utilised these data to determine if there was a difference in the extent of 
nuclear !-catenin localisation between the two R26YFP genotypes (Table 6.2). 
Comparing the proportion of GFP+ cells with nuclear !-catenin expression between 
R6YFP+/- (n=3) and R6YFP-/- (n=7) individuals importantly revealed that there was no 
difference between the two (p=0.221). Thus, for the remaining experiments I carried 
out quantitation of GFP+ (i.e. electroporated) cells under that assumption that the 
majority of GFP+ cells demonstrated activated Wnt/!-catenin signalling and that the 
presence or lack of the R26YFP reporter allele did not affect the extent of the 
mutation in the electroporated cell population.  
Figure 6.5 - Electroporation of Cre-GFP plasmid into E13.5 Apcloxlox  embryos 
causes ectopic localisation of !-catenin in the cerebellum and DHB at E18.5. 
Embryos were injected with Cre-GFP plasmid at E13.5 and the cerebellum (A, C-E) 
and DHB (B, F-H) were analysed for the expression of GFP and  !-catenin. GFP 
expression was evident in cells migrating from the VZ (C). Nuclear !-catenin was 
also observed in cells in this region (D, crosshairs) colocalising with GFP expression 























Table 6.2 - Comparison of GFP+ cells with nuclear "-catenin expression 
between R26YFP genotypes 
 
Genotype n Mean (%) SD (%) T-test 
R26YFP+/-  3 78.7 2.2  
R26YFP-/- 7 84.2 6.8  






6.4.3 The PGN does not show evidence for activated Wnt/!-catenin signalling 
in electroporated cells 
An exception to the conclusion that a majority of electroporated cells show evidence 
for activated Wnt/!-catenin signalling was found after closer examination of the 
GFP+ cell population within the PGN (Fig. 6.6A). Consistent with the hypothesis 
that activated Wnt/!-catenin signalling acts to impair the migration of PGN neurons 
from the LRL (Gibson et al., 2010), few - if any - GFP+ cells were identified with 
nuclear localisation of !-catenin (Fig. 6.6B-D).  
6.4.4 Activation of the Wnt/!-catenin pathway results in reduced proliferation 
of mutant cells 
Consistent with published findings that Wnt/!-catenin signalling drives proliferation 
in certain contexts (Megason and McMahon, 2002; Yamaguchi et al., 1999), the 
results presented in Chapter 4 showed that increased Wnt/!-catenin signalling caused 
an increase in proliferation ex vivo. To determine if this was also the case in vivo I 
first administered BrdU to E18.5 Apcloxlox and Apclox/+ embryos electroporated with 
Cre-GFP plasmid at E13.5 two hours prior to fixation in order to generate a BrdU LI 
for each that could be used as a measure of proliferation. However, the proportion of 
BrdU+/GFP+ cells generated was too small for analysis. As an alternative measure, I 
compared PCNA expression between the two groups. PCNA expression is 
considerably more widespread, and while not as specific to a particular point in the 
cell cycle, gives a broad indication of proliferation as evident in Chapter 3. 
 
Immunohistochemistry for PCNA on cerebellum sections taken from E18.5 embryos 
revealed no immediate differences between the Apclox/+ (Fig. 6.7A-B) and Apclox/lox 
(Fig. 6.7C-D) embryos. PCNA was, in both cases, observed in a pattern indicating 
high proliferation within the EGL and scattered proliferation throughout the rest of 
the cerebellum. In order to determine the effects of electroporation on proliferation 
more specifically, I quantitated PCNA expression in just the GFP+ (i.e. 




from four individuals per genotype (n=4) and the proportion of PCNA+ cells was 
established (Fig. 6.7E). This revealed a surprising reduction in PCNA expression 
within the electroporated cell population of Apclox/lox embryos (13.4%±3.5%) 
compared to the Apclox/+ embryos (31.1%±4.2%), suggesting that in vivo the 
activation of Wnt/!-catenin signalling has an inhibitory effect on proliferation of 
cells in the developing cerebellum.  
6.4.5 Activation of the Wnt/!-catenin pathway results in reduced expression of 
Pax2 in mutant cells 
The entire complement of cerebellar interneurons are generated sequentially from 
progenitors at the VZ and within the WM from E13.5 onwards (Hoshino et al., 2005; 
Leto et al., 2009; Pascual et al., 2007; Sudarov et al., 2011). As ex vivo results 
indicated a potential inhibitory effect on the expression of interneuron lineage 
marker Pax2 (see Chapter 4) I sought to determine the effects of Cre-GFP plasmid 
electroporation on the expression of Pax2 in Apclox/lox embryos at E18.5. 
Immunohistochemistry on cerebellum sections from both Apclox/+ (Fig. 6.8A-B) and 
Apclox/lox (Fig. 6.8 C-D) embryos revealed extensive Pax2 expression within the 
developing cerebellum, consistent with the developing interneuron lineage.  
Quantitative analysis revealed a reduction in the extent of Pax2 expression within the 
GFP+ cell population in the Apclox/lox embryos (Fig. 6.8E). While Apclox/+ embryos 
displayed Pax2 expression in 47.9%(±12.5%) of GFP+ cells, this was reduced to 
20.5% (±3.4%) in Apclox/lox embryos. These data corroborate the finding in Chapter 4 
that activation of the Wnt/!-catenin signalling pathway inhibits the expression of 
Pax2.  
Figure 6.6 - Electroporation of Cre-GFP plasmid into E13.5 Apcloxlox  embryos 
does not result in ectopic localisation of !-catenin in the PGN at E18.5. 
Embryos were injected with Cre-GFP plasmid at E13.5 and the PGN of Apcloxlox  
embryos was analysed for expression of GFP and !-catenin (A). While extensive 
GFP expression was observed (B), there was little to no ectopic nuclear localisation 












Figure 6.7 - Activation of Wnt/!-catenin signalling causes reduced proliferation 
in mutant cells at E18.5. 
Embryos were injected with Cre-GFP plasmid at E13.5 and the expression of GFP 
and PCNA was compared between the Apclox/+ (A-B) and Apclox/lox (C-D) cerebellum 
at E18.5. Quantitation of GFP+ cells also expressing PCNA (white arrows) is 
consistent with a reduction in proliferation of GFP+ cells in the Apclox/lox cerebellum 



































Figure 6.8 - Activation of Wnt/!-catenin signalling causes reduced Pax2 
expression in mutant cells at E18.5. 
Embryos were injected with Cre-GFP plasmid at E13.5 and the expression of GFP 
and Pax2 was compared between the Apclox/+ (A-B) and Apclox/lox (C-D) cerebellum at 
E18.5. Quantitation of GFP+ cells also expressing Pax2 is consistent with a 
reduction in expression of Pax2 in GFP+ cells in the Apclox/lox cerebellum (E) (** = 



































6.4.6 Activation of the Wnt/!-catenin pathway results in reduced expression of 
Sox9 in mutant cells 
Sox9 is expressed by the VZ progenitors lining the fourth ventricle and those that 
have delaminated from the VZ into the WM (Kordes et al., 2005; Pompolo and 
Harley, 2001). It is also expressed in the cerebellar glial lineage (Kordes et al., 2005; 
Sottile et al., 2006). As ex vivo experiments revealed a reduction in Sox9 expression 
after activation of the Wnt/!-catenin signalling pathway (see Chapter 4), I sought to 
determine if this finding also applied in vivo.  
 
Cerebellum sections were analysed by immunohistochemistry from E18.5 Apclox/+ 
(Fig. 6.9A-B) and Apclox/lox (Fig. 6.9C-D) embryos electroporated with Cre-GFP 
plasmid at E13.5. Consistent with ex vivo data presented in Chapter 4, there was a 
reduction in Sox9 expression in the GFP+ cell population in Apclox/lox embryos 
compared to Apclox/+ embryos. While 34.7% (±4.8%) of GFP+ cells in Apclox/+ 
embryos expressed Sox9, this was reduced to 6.3% (±0.2%) in Apclox/lox embryos 
(Fig. 6.9E). In addition, non-quantitative analysis of GFP and Sox9 expression in the 
DHB revealed a similar finding. Clusters of GFP+ cells void of Sox9 expression 
were evident, despite the expression of Sox9 in the surrounding cells (Fig. 6.9F-G). 
These results support the conclusion that increased Wnt/!-catenin signalling in cells 
derived from the VZ and LRL has an inhibitory effect on the expression of Sox9.   
Figure 6.9 - Activation of Wnt/!-catenin signalling causes reduced Sox9 
expression in mutant cells at E18.5. 
Embryos were injected with Cre-GFP plasmid at E13.5 and the expression of GFP 
and Sox9 was compared between the Apclox/+ (A-B) and Apclox/lox (C-D) cerebellum at 
E18.5. Quantitation of GFP+ cells also expressing Sox9 is consistent with a 
reduction in expression of Sox9 in GFP+ cells in the Apclox/lox cerebellum (E).This 
phenomenon was also observed within GFP+ patches in the Sox9 expressing DHB 















































In Chapters 3 and 4 I presented evidence for Wnt/!-catenin pathway activity during 
cerebellum development that, based on ex vivo data, potentially plays a role in 
development of the VZ-derived cerebellar lineages (interneurons and glia). Thus, the 
aim of the work presented in this chapter was to investigate the functional 
consequences of Wnt/!-catenin pathway activation in vivo during cerebellum 
development. To this end, I used mice with a floxed Apc allele and targeted a Cre-
GFP encoding plasmid to cells lining the fourth ventricle using in utero 
electroporation early in development. The data presented in this chapter confirm the 
validity of this procedure in activating the Wnt/!-catenin pathway, and support the 
conclusions made in Chapter 4 that activated Wnt/!-catenin signalling affects the 
development of lineages from the VZ.  
6.5.1 Electroporation in the E13.5 fourth ventricle successfully targets VZ and 
DHB progenitors 
In utero electroporation has been demonstrated as an effective tool for precise spatio-
temporal genetic modification of the developing cerebellum and DHB  
(Dipietrantonio and Dymecki, 2009; Gibson et al., 2010; Grimaldi et al., 2009; 
Kalinovsky et al., 2011; Kawauchi and Saito, 2008). Similar to the study performed 
by Grimaldi et al. (2009), I used in utero electroporation in order to target a mutation 
to the VZ of the developing cerebellum. However, I was also able to target the LRL 
and DHB with this technique by adjusting the orientation of the electrodes as 
described by Gibson et al. (2010). After electroporation of Cre-GFP encoding 
plasmid to the fourth ventricle of E13.5 embryos, widespread GFP expression was 
observed at E14.5 indicating the successful plasmid uptake and expression in cells 
lining the ventricle (Fig. 6.2A). At this time point GFP expression was observed 
along the length of the VZ and in a number of delaminated cells migrating from the 
VZ, in the CP and also within the DHB. This pattern was also observed in the E15.5 
cerebellum (Fig. 6.2E). By E16.5 electroporation that had targeted the VZ (Fig. 
6.3A) or DHB (Fig. 6.3B) resulted in a pattern of GFP expression consistent with 




observed spreading throughout the developing tissue from the VZ (Fig. 6.3A), while 
in the DHB cells could be observed lining the ventricle and migrating ventrally 
through the tissue (Fig. 6.3B). This was consistent with the pattern of GFP 
expression observed at E18.5, which demonstrated a well-dispersed GFP+ cell 
population from the VZ throughout the developing cerebellum (Fig. 6.4A). GFP 
expression was also evident at the DHB in the cells lining the ventricle and in 
ventrally migrating cells (Fig. 6.4C). In addition, GFP expression was observed 
within the PGN (Fig. 6.4E), suggesting DHB cells electroporated at E13.5 had since 
migrated to the PGN by E18.5.  
 
An important point for consideration before judging the success of this technique is 
the level of consistency observed between electroporated embryos. Subtle 
differences in the plasmid injection and positioning of the electrodes for the 
subsequent electroporation can create considerable differences in plasmid uptake and 
GFP expression (Appendix 4-5). In order to circumvent the effects of this variability 
on further analysis, I undertook electroporations on a considerable sample size. A 
total of 284 individual embryos were electroporated, consisting of 44 for analysis at 
E14.5, 72 for analysis at E15.5, 62 for analysis at E16.5 and 106 for analysis at 
E18.5. From this pool of electroporated embryos, suitable consistency was obtained 
to minimise the effects of variability on further analysis.   
 
An additional limitation of in utero electroporation observed is the level of efficiency 
achieved. Despite the high number of embryos electroporated, only 226 survived, 
giving an overall survival rate of 79.6%. From this, a minority of embryos 
demonstrated levels of GFP expression detectable under a dissection microscope. Of 
all the embryos injected, 25% analysed at E14.5, 18.1% at E15.5, 32.2% at E16.5 
and 30.2% of embryos analysed at E18.5 were identified as GFP+. This gave a total 
electroporation efficiency rate of 26.8%. As above, I attempted to work around the 
relatively low survival rate and considerably lower efficiency rate of electroporated 





Limitations aside, the technique of in utero electroporation represents an effective 
tool for targeting mutations or labelling cells in a precise spatio-temporal manner 
during cerebellum development. By carrying out the procedure on a large number of 
embryos, and importantly by refining the technique over time, I was able to generate 
a pool of successfully electroporated embryos that demonstrated plasmid uptake in 
the cells surrounding the fourth ventricle and GFP expression in the cell lineages 
derived from them.  
6.5.2 Electroporation of Cre-GFP plasmid DNA into Apclox/lox embryos 
activated the Wnt/!-catenin signalling pathway after 72 hours 
In order to identify cells where Wnt/!-catenin signalling had become activated, I 
looked for the ectopic nuclear localisation of !-catenin protein by 
immunohistochemistry in Apclox/lox embryos. Interestingly, this was not observed at 
E14.5 (Fig. 6.2C-D) or E15.5 (Fig. 6.2G-H) after electroporation at E13.5. However, 
analysis at E16.5 revealed extensive ectopic expression of !-catenin within the 
electroporated VZ (Fig. 6.3C-E) and DHB (Fig. 6.3F-H). From these data I conclude 
that activation of the Wnt/!-catenin signalling pathway through Cre-recombinase 
mediated loss of a floxed Apc allele requires up to 72 hours in the developing 
cerebellum and DHB. This is consistent with previous findings that Cre mediated 
knockout of Apc in the cortex requires at least 48 hours for any effect to be observed 
(Ivaniutsin et al., 2009).  
 
The reasons for this are unclear but could potentially be due to the chain of events 
required to take place between electroporation and Wnt/!-catenin pathway 
activation. Firstly, the plasmid must be taken into the cell where the Cre-recombinase 
then gets transcribed and translated. The identification of GFP+ cells at E14.5 
indicates transcription and translation of the coding plasmid DNA does not take more 
than 24 hours. At this point the enzyme needs to locate the floxed DNA sequence 
and carry out recombination between the two sites – a process dependent on the 
efficiency of the enzyme. After this has been achieved the cytoplasmic levels of APC 




translocation to the nucleus occurs. Thus, depending on the half-life of the APC 
protein itself, it is not unreasonable to assume that the concordant reduction and 
increase in cytoplasmic APC and !-catenin levels respectively are likely to be the 
key rate limiting steps for Wnt/!-catenin pathway activation to occur.   
 
By E18.5 a widely dispersed GFP expression pattern was observed within the 
cerebellum and DHB. !-catenin immunohistochemitsry on this cell population 
revealed the maintenance of ectopic !-catenin expression indicating sustained 
Wnt/!-catenin pathway upregulation from E16.5. Analysis of high magniication 
images taken from the VZ and DHB of 10 Apclox/lox embryos revealed that 82% 
(±6.2%) of GFP+ (i.e. electroporated) cells also expressed detectable levels of 
nuclear !-catenin. Thus, while it is evident that a majority of GFP+ cells were mutant 
in terms of Wnt/!-catenin pathway activation, not all of the electroporated cells 
were. The competency of cells to respond to a Wnt/!-catenin signal, and the 
efficiency of the Cre enzyme are two potential explanations for this result.  
 
The ability of a cell or tissue to respond to particular external signals has long been 
recognised as an important mechanism for generating a heterogeneous cell 
population from relatively few inductive signals (Waddington, 1940). Thus, it is 
possible that in the cerebellum or DHB not all cells have the capacity to respond to 
the loss of Apc in the same way. However, the specific factors that could be 
contributing to this heterogeneity remain to be defined. Secondly, the efficiency of 
the Cre-recombinase enzyme itself is also likely to affect the proportion of 
electroporated cells that activate the Wnt/!-catenin pathway. Cre-recombinase 
efficiency in this case is unknown, but it is possible that it does not successfully 
recombine the floxed Apc allele in 100% of cells it is produced in.  These 
confounding factors aside, the evidence presented in this chapter still suggests that a 
majority of Apclox/lox cells electroporated with Cre-recombinase do respond by 
eventually activating the Wnt/!-catenin signalling pathway. Having established this, 
I next sought to determine what the effects of this pathway activation were on 




6.5.3 Effects of in vivo Wnt/!-catenin pathway activation on migration and 
proliferation of VZ derived cell lineages at E18.5 
The work presented in Chapters 3 and 4 suggests a potential role for Wnt/!-catenin 
signalling in development of VZ derived cell lineages. However, there is little 
published evidence to support this and to allow further hypotheses on the specific 
function to be generated. Gibson et al. presented the only published study that 
attempts to dysregulate Wnt/!-catenin signalling in VZ derived cells but did not 
observe any effects (Gibson et al., 2010). Thus, it was not immediately clear what the 
effects of Wnt/!-catenin pathway activation would be in these cells after Cre-
induced loss of Apc. However, based on the various cellular processes known to be 
controlled by Wnt/!-catenin signalling I would have hypothesised that effects on 
migration and proliferation of the VZ cell lineages could arise.  
 
APC is known to be an important regulator of cell migration through the Wnt/!-
catenin pathway in the context of intestinal epithelia (Sansom et al., 2004). APC has 
also been long established as a regulator of neuronal migration in a Wnt-independent 
manner (Näthke et al., 1996). These studies suggest that either through Wnt/!-
catenin signalling or not, loss of Apc would impair migration of the electroporated 
cells from the VZ. However, comparison of GFP expression between Apclox/+ and 
Apclox/lox embryos did not reveal any gross differences in the extent electroporated 
cells had migrated through the developing cerebellum (Fig. 6.4A-B). Interestingly, a 
number of GFP+ cell clusters were observed in Apcloxlox embryos that were not 
evident in any Apclox/+ embryos, which could be suggestive of a migratory or 
adhesion defect in some cells. Ultimately though, the variability between 
electroporated embryos did not allow for a quantitative comparison in cell migration 
between the two genotypes and further work using a different in vivo model would 
be required to more thoroughly test the effects of Wnt/!-catenin pathway activation 
on migration of VZ derived cell lineages.  
 
Wnt/!-catenin signalling is known to drive proliferation in certain contexts (Giraldez 




1999; Yamaguchi et al., 1999) and the results presented in Chapter 4 suggest that 
activation of the pathway in cerebellar slice culture promotes proliferation. However, 
comparison of PCNA expression in the GFP+ cell population revealed a reduction in 
Apclox/lox embryos compared to Apclox/+ embryos, suggesting that activation of the 
Wnt/!-catenin pathway in this context has an inhibitory effect on proliferation. 
Interestingly, Gibson et al. did not observe any change in proliferation after 
activation of !-catenin in their Blbp-Cre mouse model. However, it is important to 
note that the markers used to detect proliferation were different (BrdU label retention 
compared to PCNA expression used here) and the nature of the mutation was 
different. Importantly though, Gibson et al. limited their analysis to the VZ 
monolayer only and not the mutant VZ-derived cells within the cerebellum. Thus, it 
is possible that the reduction in PCNA expression identified here represents a 
reduction in the proliferation or premature cell cycle exit of progenitors that have 
delaminated from the VZ monolayer.  
 
One confounding limitation is the observation that total numbers of GFP+ cells 
within the cerebellum does not differ between the two genotypes. One could 
hypothesise that the reduction in proliferation of electroporated cells observed in 
Apclox/lox embryos should result in fewer GFP+ cells being present. However, this was 
not evident.  It is possible that the reduction in proliferation had not manifest in a 
significant reduction in the GFP+ population over the developmental window used 
for these experiments. That is, the time from detectable Wnt/!-catenin pathway 
activation (E16.5) to this analysis (E18.5) may not have been sufficient to allow the 
reduction in proliferation identified through PCNA expression to have an effect on 
the total pool of GFP+ cells. A longer chase after the electroporation would therefore 
be required to test this.  
6.5.4 Effects of in vivo Wnt/!-catenin pathway activation on the expression of 
VZ derived cell lineage markers at E18.5 
The data presented in Chapter 4 supports the hypothesis that activation of the Wnt/!-
catenin pathway in the E18.5 cerebellum, ex vivo at least, causes a reduction in the 




suggesting a potential dysregulation of cell lineages generated at the VZ. Thus, after 
electroporation of Cre-GFP plasmid to the cerebellum of Apclox/lox mice I 
hypothesised that the electroporated cells would display a similar reduction in the 
expression of these two markers. Consistent with this, the expression of both Pax2 
(Fig. 6.8) and Sox9 (Fig. 6.9) in GFP+ cells was significantly reduced in Apclox/lox 
compared to Apclox/+ embryos. These findings suggest that, while the generation and 
migration of GFP+ cells from the VZ appears to be relatively unaffected, activated 
Wnt/!-catenin signalling in these cells could be driving a transcriptional change that 
appears to be consistent with an altered cell fate. Parallels can be drawn between this 
conclusion and the established role of Wnt/!-catenin signalling in regulation of the 
self renewal and differentiation of cell lineages arising from radial glia during 
cortical development (Chenn and Walsh, 2002; Hirabayashi et al., 2004; Munji et al., 
2011; Zhou et al., 2006). However, further modelling of Wnt/!-catenin pathway 
activation and inhibition at the VZ during cerebellum development is now required 
to test this further.  
6.5.5 Effects of in vivo Wnt/!-catenin pathway activation on LRL derived cell 
lineages at E18.5 
While trying to establish the developmental origins of medulloblastoma, Gibson et 
al. revealed that activated Wnt/!-catenin signalling in the LRL during development 
resulted in impaired migration of LRL-derived neurons and the resulting formation 
of preneoplastic lesions on the surface of the DHB (Gibson et al., 2010). As in utero 
electroporation has been previously shown to successfully target plasmid uptake to 
the LRL (Dipietrantonio and Dymecki, 2009; Gibson et al., 2010; Kalinovsky et al., 
2011; Kawauchi et al., 2006), this presented an opportunity to undertake a 
complementary analysis of the effects of Wnt/!-catenin pathway upregulation by 
targeting the Cre-GFP plasmid to the LRL of Apclox/lox embryos.  
 
After Cre-GFP plasmid electroporation targeted to the LRL and DHB at E13.5, 
GFP+ cells were evident persisting within the LRL, spread through DHB and in the 
LRL-derived neurons of the PGN by E18.5 in both Apclox/+ and Apclox/lox embryos 




in Apclox/lox embryos appeared to retain more GFP expression compared to the Apclox/+ 
embryos which showed a more dispersed pattern of GFP expression through the 
DHB. In addition, while GFP was observed in the PGN of both genotypes, 
suggesting that differentiation and migration of PGN neurons from the LRL had 
taken place, there was no detectable nuclear expression of !-catenin within the GFP+ 
cell population in the Apclox/lox PGN (Fig. 6.6). This is consistent with the normal 
development of a population of electroporated cells expressing GFP but - for reasons 
alluded to above - not showing evidence for Apc recombination having taken place. 
Furthermore, the identification of clusters of GFP+ cells within the DHB that did not 
express Sox9 (Fig. 6.9F-G), even though the DHB is a Sox9 expression domain, 
suggests that Wnt/!-catenin pathway activation may be having a similar 
transcriptional effect to that observed in the VZ-derived cells within the cerebellum.  
 
Ultimately, while some evidence from these experiments supports the findings from 
Gibson et al., the technique and subsequent analysis was insufficient to test the 
hypothesis thoroughly. The aforementioned variability between electroporated 
embryos, and the ability to only target a small percentage of the total LRL cell 
population likely precluded the ability to detect obvious changes similar to those 
observed by Gibson et al.  
6.5.6 Summary 
Combined, the data presented here builds on the findings from previous chapters. I 
have demonstrated that the technique of in utero electroporation can be successfully 
used to activate the Wnt/!-catenin signalling pathway in the developing cerebellum. 
After activation of the pathway in a subset of cells within the VZ at E16.5, 
subsequent defects are observed in proliferation of the cells derived from the VZ 
along with a reduction in expression of interneuron and glial lineage markers Pax2 
and Sox9. In addition, a potential migratory defect was observed in electroporated 
cells within the LRL. These data provide validation to extend this work to a further 
in vivo analysis of the effects of activated Wnt/!-catenin signalling in cells derived 





7 Final discussion 
 
7.1 Summary of findings presented in this thesis 
The work presented in this thesis encompasses a descriptive analysis of Wnt/!-
catenin signalling pathway activity throughout cerebellum development and a 
functional investigation into its role. Here I discuss the results presented in the 
context of the aims outlined in Chapter 1.  
7.1.1 Wnt/!-catenin signalling activity is present transiently in discrete 
progenitor populations during cerebellum development 
In order to investigate the dynamics of Wnt/!-catenin signalling activity during 
cerebellum development, I utilised mice carrying a BAT-gal Wnt reporter allele 
(Maretto et al., 2003). As discussed in Chapter 3, the complexities of the Wnt/!-
catenin signalling pathway, particularly the context specificity of the transcriptional 
response, poses  difficulties for using endogenous reporters of the pathway. Thus, the 
BAT-gal transgenic reporter allele, despite its limitations (Barolo, 2006), presents a 
useful tool for generating an informative preliminary data set on the activity of the 
Wnt/!-catenin signalling pathway in an unknown system.  
 
The early cerebellum contains three domains important to its future development: the 
IsO, the VZ and the RL. The IsO is specified first (around E7.5) at the MHJ as a 
gene expression boundary and maintains a self-regulating gene expression circuit 
that provides the inductive cues for the development of the surrounding tissue. 
Following the establishment of this centre, the early cerebellar cell lineages are then 
generated from around E10.5 from the VZ, which extends caudally from the IsO 
lining the dorsal aspect of the fourth ventricle, and the RL, which is a transient 
region forming the interface between the most caudal aspect of the VZ and the roof 
plate (Fig. 1.4). Consistent with published findings that demonstrate the function of 




1992; Thomas and Capecchi, 1990), I have identified expression of the BAT-gal 
reporter allele in this region from E12.5 onwards supporting the conclusion that 
Wnt1 in this event is likely signalling through the Wnt/!-catenin pathway (Lancaster 
et al., 2011). From this point, the expression of the BAT-gal begins to regress with 
the diminishing activity of the IsO as a functional signalling centre.  
 
The RL is a transient germinal centre that can be divided into two domains, the URL 
to the anterior and the LRL to the posterior. While the former generates all 
glutamatergic cell lineages in the cerebellum from E10.5, the lower generates 
neurons of the various pre-cerebellar nuclei that reside in the HB. Expression of the 
BAT-gal reporter in both these domains at E12.5 and E14.5 supports a role for 
Wnt/!-catenin signalling in development of the cell lineages that arise from there. 
This is consistent with the identification of Wnt1 and Wnt3a expression in both the 
URL and LRL (Davis and Joyner, 1988; Dymecki and Tomasiewicz, 1998; Fischer 
et al., 2007; Louvi et al., 2007; Nichols and Bruce, 2006; Wilkinson et al., 1987). 
The pattern of BAT-gal reporter expression observed from E12.5-E14.5 at the URL 
is consistent with the specification and early migration of GPCs. While this could 
overlap with the DCN neurons (which are born up until E12.5), the lack of BAT-gal 
expression within the SPS supports the conclusion that this cell lineage is not 
responding to a Wnt/!-catenin signal. By E18.5 a striking reduction of BAT-gal 
expression was evident within the newly formed EGL, suggesting that while Wnt/!-
catenin signalling was active during the specification of GPCs, it is not involved in 
their continued expansion. This is consistent with numerous lines of evidence that 
conclude expansion of the GPC population within the EGL occurs in response to 
alternative signalling pathways (Dahmane and Ruiz i Altaba, 1999; Dakubo et al., 
2006; Solecki et al., 2001; Wechsler-Reya and Scott, 1999).  
 
Illustrating the well-established dynamic nature of Wnt/!-catenin signalling during 
development, the VZ, which was void of BAT-gal reporter expression at E12.5 and 
E14.5, demonstrated a considerable induction of the reporter from E18.5 onwards. 
The VZ is the birth place of GABAergic neurons and glia for the cerebellum. From 




an early cohort of Pax2+ interneuron progenitors. From this point on, the VZ shifts 
solely to the production of interneurons and astrocytes, both of which derive from 
progenitors that delaminate from the VZ and multiply in the WM (Leto et al., 2006; 
Milosevic and Goldman, 2002; Milosevic and Goldman, 2004; Sudarov et al., 2011; 
Zhang and Goldman, 1996). However, the potency of these progenitors is not yet 
established (i.e. whether or not the interneuron and glial lineages arise from two 
separate pools of WM progenitors or if they arise from asymmetric division within a 
single progenitor pool). The observation of BAT-gal reporter expression along the 
VZ and within the developing cerebellar anlage during the perinatal time points 
would be consistent with its expression in multipotent progenitors or a lineage 
restricted population. Double immunofluorescence at this time point between !-gal 
and Pax2 or Sox9, which labels interneurons and progenitors/glia respectively, ruled 
out the presence of !-gal expression within lineage-restricted interneurons (Fig. 3.5). 
Due to the fact Sox9 is expressed in both multipotent progenitors and the glial 
lineage, I am unable to determine if the !-gal+ cells observed in the cerebellum at 
this time point represents a multipotent progenitor population, a glial restricted 
population or both. Given the recent identification of a multipotent cerebellar stem 
cell population that persists throughout adulthood (Lee et al., 2005), it is tempting to 
speculate that Wnt/!-catenin signalling could be somehow involved.  
 
Analysis at later time points revealed that expression of the BAT-gal reporter was 
sustained until P21 in a progressively restricted pattern consistent with the Bergmann 
glia. Double immunofluorescence with Sox9 and s100! within the PCL confirmed 
this (Fig. 3.7,9,11). This is interesting given the findings that Bergmann glia are born 
at the VZ shortly following the PCs and closely follow their migration (Sudarov et 
al., 2011; Yamada and Watanabe, 2002). The observations presented here, that the 
BAT-gal reporter is not expressed within the VZ at E14.5 but is expressed within the 
developing cerebellum from E18.5 onwards are consistent with Bergmann glia 
activating a response to the Wnt/!-catenin signalling pathway after their birth and 
during their subsequent migration and maturation and/or the additional birth of 




7.1.2 A possible role for Wnt/!-catenin signalling in development of glial and 
interneuron lineages from the VZ 
Based on the findings from analysis of BAT-gal Wnt/!-catenin reporter expression 
during the late embryonic and early postnatal time points, I hypothesised a potential 
role for the pathway in development of the glial lineage from progenitors at the VZ 
and within the WM. Numerous lines of evidence suggest Wnt/!-catenin signalling 
plays a role in regulating the proliferation, self-renewal and differentiation of radial 
glia within the developing cortex (Chenn and Walsh, 2002; Hirabayashi et al., 2004; 
Ivaniutsin et al., 2009; Munji et al., 2011; Zhou et al., 2006) so it is not unreasonable 
to anticipate a similar mechanism occurring within the developing cerebellum. 
However, there are considerable limitations to our knowledge of cerebellum 
progenitor activity compared to the comparatively well-characterised system in the 
cortex, which makes comparison difficult.  
 
In order to test this hypothesis and to investigate the function of Wnt/!-catenin 
signalling during cerebellum development, I took both an ex vivo and in vivo 
approach to constitutively activate the pathway and characterise the effects on 
generation of cell lineages derived from the VZ. Using a GSK3! inhibitor to 
constitutively activate the Wnt/!-catenin signalling pathway ex vivo in slices of 
E18.5 cerebellum revealed that, while cell death was unaffected, a reduction in the 
expression of interneuron lineage marker Pax2 and, strikingly, the progenitor/glial 
markers Sox9 and GFAP (Fig. 4.8,9,10). Interestingly, the reduction in Pax2 was 
limited to the distal regions of the slice, while the reduction in Sox9 and GFAP was 
considerably more widespread and to a much greater extent – as revealed through 
both immunohistochemistry and qRT-PCR. In order to investigate this further, I 
carried out genetic activation of the Wnt/!-catenin signalling pathway in vivo during 
cerebellum development. By electroporating a Cre-GFP expressing plasmid into the 
VZ of Apclox/lox embryos at E13.5 I was able to induce constitutive Wnt/!-catenin 
signalling in a subset of VZ-derived cells. Consistent with the effects observed after 
pathway activation ex vivo, embryos analysed at E18.5 (five days after 




a reduction in the expression of Pax2 and Sox9 in the electroporated cells. 
Importantly, these results suggest that activating the Wnt/!-catenin signalling 
pathway did not force the balance of interneuron or glial generation from a single 
multipotent progenitor pool in any one direction. This is in contrast to the 
observation of BAT-gal reporter expression exclusively in the Sox9 and s100! 
expressing population, which would suggest a role in glial development.  
 
Taking into consideration the activity of the Wnt/!-catenin pathway observed 
through expression of the BAT-gal reporter, and the effects on VZ-derived lineage 
marker expression after constitutive activation both ex vivo and in vivo, I propose a 
model where the Wnt/!-catenin pathway could regulate multiple steps in the 
progression from VZ radial glia to fully differentiated interneurons and astrocytes 
(Fig. 7.1). Firstly, the observation made in Chapter 3 that BAT-gal reporter 
expression is expressed from the VZ and within the developing cerebellum by E18.5 
in an exclusively Sox9+ cell population suggests a potential role in the development 
of a VZ-derived cell lineage. Furthermore, the observation that BAT-gal reporter 
expression is maintained at levels detectable by immunohistochemistry through until 
P21 in a cell population that becomes progressively restricted to the Bergmann glia 
would be consistent with the hypothesis that Wnt/!-catenin signalling is involved in 
the development and maturation of this cell lineage. While little evidence exists to 
support this, a recent study by Wang et al. (2011) has demonstrated that 
dysregulation of Wnt/!-catenin signalling in Bergmann glia is associated with a 
disruption in their morphology and cerebellar localisation. Given this finding, it 
might be assumed that activation of the Wnt/!-catenin signalling pathway during 
development would promote the generation of glia from VZ or WM progenitors. 
However, ex vivo and in vivo activation of the pathway by inhibiting GSK3! or APC 
respectively resulted in a quantifiable reduction in the expression of glial markers 
Sox9 and GFAP, in addition to a reduction in interneuron marker Pax2. These data 
would be consistent with experimental manipulation of the pathway blocking the 
differentiation of VZ-derived progenitors into either lineage and instead promoting a 
modified cell fate – either increased self-renewal of a progenitor population of 
differentiation into an alternative cell lineage.  
Figure 7.1 - Model for Wnt/!-catenin signalling function in development of cell 
lineages from the VZ.
Based on the observations that Wnt/!-catenin activity was observed in the 
developing glial population and that constitutive activation of the pathway led to a 
reduction in the expression of Sox9 and Pax2 in vivo I propose a model whereby 
multiple steps in the progression from VZ radial glia to fully differentiated 
interneurons and glia could be regulated by Wnt/!-catenin activity. The observation 
of Wnt/!-catenin activity in the Bergmann glia population suggests a potential role in 
maturation of this cell population. In addition, the reduction in expression of both 
interneuron and glial markers after pathway deregulation would be consistent with an 















7.1.3 Contribution of activated Wnt/!-catenin signalling to the aetiology of 
medulloblastoma  
The final aim of this thesis was to reconcile the descriptive and functional analyses 
of Wnt/!-catenin signalling with a potential hypothesis for the aetiology of 
medulloblastoma. While a subset of medulloblastomas with activated Wnt/!-catenin 
signalling is well defined (Ellison et al., 2005; Kool et al., 2008; Schwalbe et al., 
2011; Thompson et al., 2006), a potential developmental origin of this class of 
disease has only recently been identified (Gibson et al., 2010). It has been 
hypothesised in the past that, as opposed to the induction of Shh subtype 
medulloblastoma within the EGL, the Wnt subtype arises from the dysregulation of 
development at the VZ (Gilbertson and Ellison, 2008). Consistent with this 
hypothesis, I have observed the activation of Wnt/!-catenin signalling within the VZ 
and in cell lineages arising from there in a temporally regulated manner. The 
observations made here that constitutive activation of the pathway in these cells leads 
to changes in proliferation and expression of cell fate markers is consistent with 
activated Wnt/!-catenin signalling promoting a number of phenotypic changes to 
these cells that could potentially induce a neoplastic progression.  
 
This hypothesis is at odds with recent findings by Gibson et al. (2010), who propose 
that the Wnt molecular subtype of medulloblastom arises from a migration defect 
arising in the LRL progenitors. The observations made in Chapter 3 that the BAT-gal 
reporter and downstream Wnt target gene Axin2 are both expressed in the LRL 
support the conclusion that Wnt/!-catenin signalling is a developmental regulator for 
this region. The further observation in Chapter 6 that LRL Apclox/lox cells 
electroporated with a Cre-expressing plasmid tend to cluster on the DHB surface and 
do not migrate to the PGN is consistent with similar observations made by Gibson et 
al. (2010). However, as discussed in Chapter 1, the results presented in this study fall 
short of conclusively excluding the potential for medulloblastoma from other 
germinal centres and thus further clarification is required in order to reconcile the 





7.2 Future directions 
The limited scope of the work presented in this thesis and the assumptions made in 
my proposed model have generated a number of questions that need to be addressed 
in order to more convincingly appreciate the role Wnt/!-catenin signalling plays in 
development of the cerebellum and to more conclusively test the ideas proposed for 
the developmental origins of Wnt subtype medulloblastoma.   
7.2.1 Further descriptive analysis of Wnt/!-catenin signalling during 
cerebellum development 
The data presented in Chapter 3 represents a descriptive analysis of Wnt/!-catenin 
activity throughout cerebellum development. This information has not been 
described previously and thus presents a novel set of pilot information on which to 
build a more thorough analysis. Firstly, although the laminar structure of the 
cerebellum is homogenous throughout, analysis of gene expression and input/output 
fibre organization reveals additional levels of cerebellar organization (Sillitoe and 
Joyner, 2007). A number of molecules are known to be expressed in distinct 
parasagittal domains in the adult cerebellum, most notable among these is the 
aldolase ZebrinII (Brochu et al., 1990), which is expressed by PCs and displays a 
characteristic zebra-like pattern of sagittal stripes on the surface of the cerebellum. 
The development of this organization is known to take place during the first two 
postnatal weeks and has been linked to the developmental regulator En2 (Millen et 
al., 1995). As an abundance of BAT-gal reporter expression has been observed in the 
cerebellum during this early postnatal time point, a logical progression would be to 
determine a more accurate spatial map of its expression across the anterior-posterior 
and medial-lateral axes, paying particular attention to the possibility of its expression 
in parasagittal domains. This would allow the potential role of Wnt/!-catenin 
signalling in the development of the cerebellar circuitry to be explored.  
 
In addition to a more precise spatial analysis of Wnt/!-catenin activity during 
cerebellum development, a quantitative analysis on the extent of BAT-gal reporter 




Wnt/!-catenin pathway activity to be generated. From the data presented in Chapter 
3 it is clear that the extent of BAT-gal expression reduces over time, though it is not 
clear at what point expression peaks and how fast it ceases after that point. A 
combination of immunohistochemistry and quantitative qRT-PCR should address 
this adequately.  
 
In order to probe the mechanism of Wnt/!-catenin pathway activity further, I 
propose an additional line of experiments examining the extent of Wnt ligand and Fz 
receptor expression over a developmental time course, similar to that undertaken by 
Yaguchi et al. describing the spatiotemporal expression pattern of different FGF 
genes during cerebellum development (Yaguchi et al., 2009). There are 19 different 
Wnt ligands and 10 Fz receptors, all of which have been associated with different 
processes and diseases (Logan and Nusse, 2004). Importantly, a number of Wnt 
ligands (e.g. Wnt5A) are thought to signal through !-catenin independent pathways. 
The RT-PCR analysis of Wnt ligand expression presented in Chapter 3 is a starting 
point for this analysis.  
 
Lastly, insight into the downstream mechanism of the pathway could be achieved 
through a transcriptional investigation into the Wnt responding cells identified at the 
different time points during development. Use of a fluorogenic LacZ substrate can be 
used to isolate live LacZ+ cells for subsequent sorting and transcriptional profiling 
after dissociation of the cerebellum at defined points in development. This 
experiment would add an important dimension of information to the identification of 
active Wnt/!-catenin signalling already observed during development.  
7.2.2 Determining the cell fate of Wnt responding cells during cerebellum 
development 
One of the key findings from the data presented within this thesis is the identification 
of Wnt/!-catenin signalling in the RL and VZ, both defined germinal centres, at 
different points during development. While the data presented in Chapter 3 would 
suggest that the pathway is playing a role in the specification of GPCs within the RL 




offer definitive evidence for the fate of the cells responding to the Wnt/!-catenin 
signal in these germinal centres. This approach has been demonstrated previously 
using a Cre recombinase driven by a specific Wnt gene (Dymecki and Tomasiewicz, 
1998; Louvi et al., 2007; Rodriguez and Dymecki, 2000) to activate a reporter gene 
such as LacZ. However, the limitation of these studies is that all cells expressing the 
Cre throughout development will become labelled. Alternatively, genetic inducible 
fate mapping provides a method for tracing the development of cells that express a 
known marker at a particular point in time (Joyner and Zervas, 2006). In short, 
engineering a Wnt-specific inducible Cre would allow for only the cells expressing 
the Cre during the period of induction to activate reporter expression and thus the 
temporal generation of different cell lineages from these germinal centres could be 
characterised. This would be particularly advantageous in determining the potency of 
the Wnt/!-catenin responsive cells at the VZ (i.e. are they able to generate both 
interneurons and glia or is the expression of the Wnt reporter limited to a glial 
restricted progenitor?).  
7.2.3 Clarification of Wnt/!-catenin function by reduction of signalling 
activity during development.  
In order to fully characterise the function of Wnt/!-catenin signalling during 
cerebellum development, an investigation into the effects of spatiotemporal 
inhibition of the pathway needs to be carried out. In Chapter 4 and 6 I presented data 
that suggests a possible link between the Wnt/!-catenin signalling pathway and 
development of VZ-derived cell lineages, potentially in the form of progenitor cell 
regulation (Fig. 7.1). Analysing the effects of Wnt/!-catenin pathway inhibition in 
the same model systems would test the validity of these results and provide further 
evidence into the function of Wnt/!-catenin signalling during development.  
 
As an extension from the work presented here, two key experiments can be 
undertaken. Firstly, an optimisation of the ex vivo culture conditions to allow 
adequate time for a Wnt/!-catenin pathway inhibitor to take effect would allow the 




activation of the pathway in this system was the striking reduction in Sox9 and 
GFAP expression, thus I would hypothesis that inhibition of the pathway would 
cause the opposite effect – an increase in Sox9/GFAP expression. A rescue 
experiment could also be attempted, where a pathway inhibitor is added to the 
culture after treatment with an activator. Secondly, the effects of pathway activation 
observed in vivo after electroporation of a Cre expressing plasmid into the fourth 
ventricle of Apclox/lox embryos could be validated by additional electroporation 
experiments where a dominant-negative Tcf expressing plasmid (Tetsu and 
McCormick, 1999) is administered. Again, based on the observations made in 
Chapter 6, I would hypothesis that an inhibition of the pathway in this manner would 
result in an increase in Sox9 expression.  
 
While these experiments would provide a valuable data set for the interpretation of 
data presented in this thesis, an inducible in vivo system would provide a more 
thorough analysis of Wnt/!-catenin pathway inhibition during cerebellum 
development. A number of different Cre alleles have been described with activity in 
different progenitor populations during cerebellum development, including Math1-
Cre expressed in the RL (Matei et al., 2005), Ptf1a-Cre expressed in the VZ 
(Yamada et al., 2007), and Nestin- , Blbp- and GFAP-Cre transgenes expressed in a 
wider pool of progenitors comprising the RL and VZ (Carlén et al., 2006; Hegedus et 
al., 2007; Marino et al., 2000). To carry out genetic inhibition of the Wnt/!-catenin 
signalling pathway, I would propose using the Ptf1a-Cre in order to target the VZ. 
However, suitable candidate genes to target with LoxP mediated recombination in 
order to inhibit the pathway without affecting other cellular functions are few. In 
addition, targeting specific Wnt ligands for mutation would be dependent on a better 
understanding of which ligands are expressed during cerebellum development. An 
alternative would be to use viral mediated introduction of a specific pathway 
inhibitor such as dominant-negative Tcf (Tetsu and McCormick, 1999). This 
approach would allow precise temporal inhibition of the pathway, but would be 
spatially limited to the VZ monolayer. Ultimately, the hypothesis that Wnt/!-catenin 
regulates the generation of cell lineages from the VZ requires an analysis of this 




7.2.4 Extended analysis on the effects of Wnt/!-catenin constitutive activation 
in different cell lineages during cerebellum development 
In order to extend the functional characterisation of Wnt/!-catnein signalling in 
cerebellum development and to investigate the developmental origins of Wnt subtype 
medulloblastoma further, a more detailed analysis into the effects of pathway 
activation on development of VZ-derived cell lineages needs to be carried out. The 
data presented in Chapters 4 to 6 demonstrate a potential role for Wnt/!-catenin 
signalling in the development of VZ-derived cell lineages and the hypothesis from 
this is that dysregulation of the VZ progenitors could contribute to tumourigenesis. 
Unlike inhibition of the pathway, conditional genetics presents a readily available 
tool in this case.  
 
Several studies have been reported investigating the effects of Wnt/!-catenin 
pathway activation in different progenitor populations during cerebellum 
development. Most notably the recent studies by Lorenz et al. (2011) and Gibson et 
al. (2010) that used a combination of floxed Apc or constitutively active !-catenin 
alleles targeted by Math1- or Blbp-Cre tansgenes. However, neither of these studies 
utilised inducible Cre alleles, meaning there was limited temporal control over the 
induction of the mutation. In addition, the results from these studies do not reconcile 
with each other. In particular, the long term analysis of VZ-derived cells that were 
subject to constitutive Wnt/!-catenin signalling was not carried out by Gibson et al. 
(2010). Importantly, activation of Wnt/!-catenin signalling through loss of APC in 
Bergmann glia (a VZ-derived cell lineage) resulted in progressive degeneration 
during postnatal life (Wang et al., 2011), suggesting there are long term effects to the 
mutation. Thus, I propose using an inducible Cre recombinase to target constitutive 
activation of the Wnt/!-catenin signalling pathway to the VZ at defined 
developmental stages. These experiments would offer additional insight into the role 
Wnt/!-catenin signalling plays in the aetiology of medulloblastoma and help to 






7.3 Concluding remarks 
The development of highly complex structures such as the CNS relies on the 
precisely coordinated spatiotemporal activity of different developmental signalling 
pathways. While a number of different pathways are known to regulate various 
processes in cerebellum development, the role of Wnt/!-catenin signalling has not 
yet been fully explored. Importantly, ectopic activation of the pathway predisposes to 
a well-defined subtype of medulloblastoma. Based on observations made in other 
tissues, there is a clear link between a role for Wnt/!-catenin signalling in 
stem/progenitor cell regulation and its dysregulation in cancer. Thus, I hypothesised 
that Wnt/!-catenin signalling is involved in cerebellum development and that 
dysregulation of its normal function contributes to medulloblastoma. Utilising a 
transgenic Wnt reporter I have shown a highly dynamic pattern of Wnt/!-catnein 
activity in defined cell lineages during cerebellum development, including two key 
progenitor populations within the RL and VZ – supporting a role for Wnt/!-catenin 
signalling as a developmental regulator in the cerebellum. Functional investigation 
revealed a potential link with the developing glial and interneuron lineages from the 
VZ, though further work is now required in order to more accurately determine the 
extent and nature of Wnt/!-catenin activity during cerebellum development and to 
clarify its function in the different cell lineages. While a mechanism for the 
pathogenesis of Wnt/!-catenin induced medulloblastoma still eludes us, a better 
understanding of the role the pathway plays in development will reveal how 
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Appendix 1 – Reference gene selection 
 










Appendix 2 – Phenol-chloroform isoamyl alcohol DNA precipitation  
 
1. Add one volume of phenol-chloroform isoamyl alcohol (1:1) to linearised 
plasmid 
 
2. Mix till emulsion forms 
 
3. Centrifuge >13,000 RPM for five minutes, keep supernatant  
 
4. Add 0.1 volume NaAc (3M). Mix 
 
5. Add two volumes -20°C absolute ethanol. Mix, leave at -20°C for >1hr 
 
6. Centrifuge ten minutes, discard supernatant 
 
7. Add one volume 80% ethanol, centrifuge five minutes, discard supernatant 
 





Appendix 3 – Solutions used for RNA in situ hybridisation 
 
Hybridisation buffer 
50% formamide  (Fisher) 
10% dextran sulfate  (Sigma) 
1 mg/ml yeast RNA   (BM) 




50% formamide  (Fisher) 
1x SSC 
0.1% Tween-20  (Sigma) 
 
MABT  
100 mM maleic acid 
150 mM NaCl (pH 7.5) 




20% Sheep serum  (Sigma) 
2% Blocking reagent  (BM) 
 
Pre-staining buffer (pH 9.5) 
100 mM NaCl 
50 mM MgCl2 
100 mM Tris 






NBT/BCIP staining buffer 
100 mM NaCL 
50 mM MgCl2 
100 mM Tris-HCl (pH 9.5) 
0.1% Tween-20  (Sigma) 
10% Polyvinyl alcohol (Sigma) 















Appendix 6 – Comparison of GFP expression between genotypes 
 
Total GFP+ cells/section compared between Apc genotype and 
R26YFP genotype  
    










20.1 Lox/+ YFP- 85.67 
APCFLX 
29.2 Lox/+ YFP+ 171.33 
APCFLX 
29.3 Lox/+ YFP+ 109.67 
APCFLX 
33.3 Lox/+ YFP- 96 
APCFLX 
23.1 Lox/Lox YFP+ 153.67 
APCFLX 
23.2 Lox/Lox YFP+ 168.67 
APCFLX 
29.1 Lox/Lox YFP+ 248.33 
APCFLX 
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Abstract
The adult cerebellum is composed of several distinct cell types with well defined developmental origins. However, the
molecular mechanisms that govern the generation of these cell types are only partially resolved. Wnt/b-catenin signalling
has a wide variety of roles in generation of the central nervous system, though the specific activity of this pathway during
cerebellum development is not well understood. Here, we present data that delineate the spatio-temporal specific pattern
of Wnt/b-catenin signaling during mouse cerebellum development between E12.5 and P21. Using the BAT-gal Wnt/b-
catenin reporter mouse, we found that Wnt/b-catenin activity is present transiently at the embryonic rhombic lip but not at
later stages during the expansion of cell populations that arise from there. At late embryonic and early postnatal stages,
Wnt/b-catenin activity shifts to the cerebellar ventricular zone and to cells arising from this germinal centre. Subsequently,
the expression pattern becomes progressively restricted to Bergmann glial cells, which show expression of the reporter at
P21. These results indicate a variety of potential functions for Wnt/b-catenin activity during cerebellum development.
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Introduction
The cerebellum forms as a result of a highly regulated
programme of cell specification, proliferation, differentiation and
migration (reviewed in [1]). At the cellular level, the cerebellum is
organised into distinct neuronal layers: the outermost molecular
layer (ML), the Purkinje cell monolayer (PCL), the densely
populated internal granule layer (IGL) and the innermost white
matter (WM). The diverse cell types that make up these layers
originate from two distinct germinal centres in the early
cerebellum; the ventricular zone - a monolayer of cells lining the
fourth ventricle on the ventral surface of the cerebellar anlage, and
the rhombic lip - a transient structure in the most posterior part of
the cerebellar anlage that forms the interface between the neural
tube and non-neural roofplate ectoderm (reviewed in [2]).
The rhombic lip gives rise to the entire complement of
glutamatergic neurons that populate the IGL. The first glutamatergic
neurons born are the projection neurons of the deep cerebellar nuclei
(DCN). In the mouse these arise between embryonic day (E) 10.5 and
E12.5 [3], and migrate along the sub pial stream to the rostral end of
the developing cerebellum. From E12.5 onwards, the rhombic lip
generates granule progenitor cells (GPCs) and unipolar brush cells
(UBCs) [4,5,6]. Exiting the rhombic lip, GPCs migrate rostrally
across the pial surface of the cerebellum to form a secondary germinal
zone, the external germinal layer (EGL), which covers the pial surface
of the cerebellum. This cell layer proliferates extensively until the
second postnatal week, producing a vast number of mature granule
cells (GCs), which become post-mitotic within the EGL before
migrating radially along Bergmann glial fibres into the IGL, a process
that is complete by postnatal day (P) 21 [1,7,8].
Distinct from the rhombic lip, the ventricular zone gives rise to
all cerebellar cells of the c-aminobutyric acid (GABA)ergic, and
glial lineages. The first of these, the Purkinje cells, are born from
E10.5 then migrate radially towards the pial surface of the
cerebellum and settle as a distinct monolayer of cells around the
time of birth (E19.5-E20) [9]. Closely following this the Bergmann
glia are generated and migrate radially behind the developing
Purkinje cell population before undergoing morphological matu-
ration postnatally [10,11]. Interneurons (including stellate, basket,
Golgi and Lugaro interneurons) and the remaining glial
population (velate and fibrous astrocytes) are then generated in a
sequential manner. These cell types are derived from progenitors
that delaminate from the ventricular zone and continue to divide
in the WM [12,13,14,15,16,17].
These tightly coordinated developmental processes rely on the
spatio-temporal specific activity of several key signalling pathways. The
sonic hedgehog (Shh) signalling pathway, for example, is the main
mitogenic factor driving GPC proliferation within the EGL [18,19].
The Wnt/b-catenin signalling pathway has been shown to play an
important part in regulation of neural stem and progenitor populations
within the central nervous system [20,21], but its role in cerebellum
development is only partially defined. Wnt1 is an important regulator
of early cerebellum development. It is expressed at the isthmus and
rhombic lip [22,23,24,25], and in cells of the granule lineage [26] and
Wnt12/2 mutant mice completely lack or exhibit a severely
underdeveloped cerebellum [27,28,29]. No specific role for Wnt/b-
catenin signalling in later stages of cerebellum development has yet
been described. However, activating mutations in components of the
Wnt/b-catenin signalling pathway have been identified in medullo-
blastomas, a paediatric tumour that arises in the posterior fossa
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(cerebellum plus brainstem) [30,31]. Further, individuals carrying
germline mutations in the tumour suppressor gene APC that
constitutively activate Wnt/b-catenin signalling have a greatly elevated
risk of developing medullobastoma [32]. This raises the possibility that
Wnt/b-catenin signalling regulates developmental processes in the
cerebellum, and that activation of this pathway may cause these
processes to go awry, predisposing to the development of medullo-
blastoma (reviewed in [33]). Recent in vivo evidence supports this [34].
In order to investigate possible roles played by Wnt/b-catenin
signalling during development of the cerebellum, we used the
BAT-gal reporter transgenic mouse strain [35] to identify regions
of the developing cerebellum where Wnt/b-catenin signalling is
active. At mid-gestational stages, we found active Wnt/b-catenin
signalling in the rhombic lip. At perinatal stages, activity was seen
in the ventricular zone, but not in the EGL. Postnatally, signalling
became progressively more restricted, and very few proliferating
cells expressed the BAT-gal transgene. Surprisingly, we found that
many of the Wnt/b-catenin responsive cells in the postnatal
cerebellum were Bergmann glia.
Results
Wnt/b-catenin signalling is active at the isthmus and
rhombic lip
The BAT-gal transgenic reporter strain expresses a lacZ gene
under the control of b-catenin/T cell factor (TCF) responsive
elements [35] and has been widely used as a general reporter of
Wnt/b-catenin activity. We first examined the expression of b-
galactosidase (the protein product of the LacZ transgene) from
E12.5 to E14.5 in cerebellum sections from BAT-gal+ embryos. b-
galactosidase expression was observed in a progressively restricted
pattern (Fig. 1). Firstly, at E12.5 expression was observed at the
isthmus in the anterior region of the cerebellum and at the
rhombic lip forming the posterior region of the cerebellum
(Fig. 1A). In addition b-galactosidase expressing (b-gal+) cells were
observed spread diffusely through the anterior and posterior
regions of the cerebellum, although were notably sparse within the
ventricular zone.
In contrast, at E14.5 b-galactosidase expression was more
restricted to the anterior and posterior ends of the cerebellum.
While b-gal+ cells were absent from the ventricular zone, they
were observed clearly at the rhombic lip (Fig. 1B). Staining for
proliferating cell nuclear antigen (PCNA), which marks prolifer-
ating cells including those in the rhombic lip area, confirmed the
presence of b-gal+ cells at the rhombic lip and within the
population of early GPCs that have begun to migrate in an
anterior direction along the pial surface of the cerebellum
(arrowheads in Fig. 1B–C).
Since b-galactosidase protein is a stable protein and can persist
in tissue after lacZ gene expression ceases [36], we also examined
expression of lacZmRNA by in situ hybridization (Fig. 1D–E). The
expression pattern found was very similar to that observed by
Figure 1. BAT-gal expression in the E12.5 and E14.5 cerebellum. (A) DAB Immunohistochemistry for b-galactosidase (b-gal) on sagittal
sections of E12.5 cerebellum revealed two key expression domains: the isthmus (Is) and the cerebellar rhombic lip (RL). At E14.5 (B) expression was
also found in the early external granule layer (EGL, black arrowheads) but was notably absent from the ventricular zone (VZ) lining the fourth ventricle
(IV). (C) Double immunofluorescence for b-gal and PCNA confirms the expression of b-gal in the RL and EGL (white arrowheads). b-gal protein was
validated as a Wnt/b-catenin reporter by in situ hybridisation for LacZ (D, E) and Wnt target Axin2 (F, G)) mRNA. At both time points b-gal protein and
LacZ mRNA were expressed in the same domains as Axin2, although the LacZ mRNA expression appeared less diffuse than that of Axin2. (A–B
counterstained with hematoxylin. Scale bars: A, B, D–E = 100 mm, B = 50 mM).
doi:10.1371/journal.pone.0023012.g001
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immunohistochemistry (compare Fig. 1A to 1D and 1B to 1E),
although there are slight differences that would suggest the b-
galactosidase protein expression may to some extent label cells that
are no longer responding to a Wnt/b-catenin signal. For example,
b-galactosidase protein expression was found in the dorsal aspect
of the choroid plexus, whereas the expression of LacZ mRNA is
restricted to the rhombic lip. Importantly however, the key b-gal
protein expression domains identified (rhombic lip and isthmus)
mirror those of the LacZ expression.
As an independent verification that BAT-gal reporter expres-
sion in the developing cerebellum truly indicates Wnt/b-catenin
activity we also performed in situ hybridisation for Axin2. Axin2
encodes a negative feedback inhibitor of the Wnt/b-catenin
signalling pathway. It is a direct target of TCF/LEF-mediated
transcription and is therefore widely used as a readout of Wnt/b-
catenin signalling [37]. Within the isthmus and the rhombic lip,
the expression of Axin2 (Fig. 1F–G) closely mirrored both LacZ
mRNA expression (Fig. 1D–E) and b-galactosidase protein
expression (Fig. 1A–B). However, at E12.5, Axin2 expression was
not detected in the anterior portion of the cerebellum immediately
below the isthmus (Fig. 1F). At E12.5 and E14.5, Axin2 showed
more diffuse expression in a gradient from both the upper and the
lower rhombic lips (Fig. 1F–G), compared to both LacZ staining
and b-galactosidase protein expression.
Wnt/b-catenin signalling is active in the ventricular zone
but not in the EGL of the perinatal cerebellum
We next examined BAT-gal reporter expression at two perinatal
stages, E18.5 and P1. In contrast to the highly restricted expression
of b-galactosidase seen at E14.5, we found much more widespread
expression at these time points (Fig. 2). b-gal+ cells were spread
through several developing cell layers of the cerebellum, though
were notably absent from the EGL (Fig. 2A–B). This pattern is also
observed in the expression of LacZ (Fig. 2C–D), indicating that
perdurance of b-galactosidase is not a significant issue at these
ages.
While the rhombic lip and early migratory GPCs showed
abundant expression of b-galactosidase at E14.5, the absence of
detectable b-galactosidase expression within the EGL of the
perinatal cerebellum suggests that Wnt/b-catenin signalling is not
involved in the continued development of this cell population.
PCNA staining clearly labels the EGL at E18.5 and P1 and co-
staining for b-galactosidase clearly supported the lack of b-gal+
cells in the EGL at these stages (Fig. 2E–F).
An abundance of b-gal+ cells were identified in the cerebellar
ventricular zone at E18.5 (Fig. 2A) and P1 (Fig. 2B), in contrast to
E14.5. PCNA labelling clearly delineates the ventricular zone at
these stages, visible as a thin layer of cells lining the fourth
ventricle. Double staining for b-galactosidase and PCNA con-
firmed the presence of proliferative b-gal+ cells within the
ventricular zone (arrowheads in Fig. 2G–H). Interestingly, by P1
there were a number of b-gal+ cells that did not express PCNA,
indicative of a non-proliferative cell type. b-gal+ cells were also
found within the developing cerebellar anlage, consistent with cells
migrating from the progenitor monolayer (Fig. 2E–H). Some of
these were PCNA-positive (arrowheads in Fig. 2E–F).
Wnt/b-catenin signalling becomes increasingly restricted
and does not correlate with proliferation during
postnatal development
We next examined patterns of BAT-gal reporter expression at
later postnatal stages. By P5, all of the layers that make up the
mature cerebellum (WM, IGL, PCL, ML) can be identified - along
with the transient EGL. We found b-gal+ cells in each of these
layers, except for the EGL (Fig. 3A–B). A similar pattern was
observed at P10 (Fig. 4A–B), although b-gal+ cells were most
abundant within the PCL and WM at this stage. Increasingly
restricted distribution was also seen at P21, by which time b-gal+
cells were largely restricted to the PCL (Fig. 5A–B). This pattern
was also observed in the expression of LacZ mRNA (Fig. 3B, 4B),
further illustrating that b-galactosidase immunohistochemistry
accurately reflects expression of the BAT-gal transgene till P10.
However, by P21 there was no identifiable expression of LacZ
mRNA (data not shown) indicating that the b-gal+ cell types
identified at that late stage may no longer be responding to a Wnt/
b-catenin signal and could be maintaining detectable levels of the
Figure 2. BAT-gal expression in the E18.5 and P1 cerebellum.
DAB immunohistochemistry for b-gal in sagittal sections of the E18.5
cerebellum (A) reveals widespread expression, including predominant
staining in the VZ (black arrowheads). A similar pattern is observed at
P1 (B). These expression patterns are mirrored by those observed for
LacZ mRNA visualised with in situ hybridisation (C–D). Double
immunofluorescence for b-gal and PCNA reveals an almost complete
lack of BAT-gal reporter expression in the EGL at both E18.5 (E) and P1
(F), though b-gal+ cells can be observed within the developing
cerebellum at both time points, in some cases colocalised with PCNA
(white arrows). At the VZ, BAT-gal expression can be observed
colocalised with PCNA (white arrowheads) at both E18.5 (G) and P1
(H). (A–B counterstained with hematoxylin. Scale bars: A, B = 100 mm,
E–H= 50 mm).
doi:10.1371/journal.pone.0023012.g002
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b-galactosidase protein from when they last transduced a Wnt/b-
catenin signal.
As Wnt/b-catenin signalling is commonly associated with the
control of cell proliferation, we wanted to determine whether the
BAT-gal expression pattern correlated with proliferation between
P5 and P10 (the most highly proliferative period of cerebellar
development). We therefore performed double immunofluores-
cence staining for b-galactosidase and PCNA. A number of
PCNA+ cells were seen in each layer at P5 (Fig. 3D), becoming
restricted to the EGL, WM and PCL by P10 (Fig. 4D) reflecting
the overall decrease in proliferation by this point. By P21 PCNA+
cells were largely restricted to the WM (data not shown), reflecting
the proliferation of white matter progenitors. While b-gal+ cells
were identified in all these key regions, very few b-gal+/PCNA+
cells were seen at P5 (Fig. 3D), and none were identified at P10
(Fig. 4D) or P21 (data not shown). Thus, we found little evidence
for correlation between Wnt/b-catenin signalling and proliferation
in the postnatal cerebellum, despite the identification of many b-
gal+ cells in proliferative regions such as the WM and PCL.
Wnt/b-catenin signalling is seen in Bergmann glia in the
postnatal cerebellum
We next sought to identify the specific cell type(s) within the
postnatal cerebellum in which Wnt/b-catenin signalling is active.
The locations of the b-gal+ cell population identified at each
postnatal stage examined suggested a number of possible cell
types, including interneuron and glial progenitors within the WM,
granule cells, astrocytes, oligodendrocytes and interneurons within
the IGL, Purkinje cells and Bergmann glia within the PCL and
interneurons within the ML. To determine the identity of the b-
Figure 4. BAT-gal expression in the P10 cerebellum. (A) DAB b-
gal immunohistochemistry and (B) LacZ in situ hybridisation in P10
cerebellum. (C) Higher magnification of the region boxed in (A) reveals
a more restricted pattern than that seen at P5, with strongest staining
observed within the PCL (black arrowheads – also in B). At higher
magnification, b-gal+ cells within the PCL (white arrowheads) were
observed in close proximity to both PCNA+ (D) and Pax2+ (E) cells
(unfilled arrowheads), though no colocalisation was observed between
b-gal and PCNA or Pax2. (F) Double immunofluorescence for b-gal and
NeuN confirms the presence of b-gal+ cells at the PCL on the edge of
the IGL, while double immunofluorescence for b-gal and calbindin (G)
confirms the lack of BAT-gal reporter expression in Purkinje cells (PC).
(H) Colocalisation with glial marker s100b confirms the identity of b-
gal+ cells within the PCL as Bergmann glia (white arrowheads), though
not all Bergmann glia express b-galactosidase (unfilled arrowhead). (A, C
are counterstained with hematoxylin and D–H with Topro3 Scale bars:
A = 500 mm, B–C=100 mm, D–H= 50 mm).
doi:10.1371/journal.pone.0023012.g004
Figure 3. BAT-gal expression in the P5 cerebellum. (A) DAB
immunohistochemistry for b-gal and (B) LacZ in situ hybridisation in the
P5 cerebellum. (C) Higher magnification of the region boxed in (A)
reveals expression spread through all layers except the EGL. The
Purkinje cell layer (PCL) and the white matter (WM) in particular
contained many b-gal+ cells (black and white arrowheads respectively).
Double immunofluorescence for b-gal and PCNA (D) revealed the
presence of b-gal+ cells within the PCL and white matter (white
arrowheads). Although b-gal+ cells were observed in close proximity to
proliferating cells (unfilled arrowheads) very few b-gal+/PCNA+ cells
were observed. Double immunofluorescence for b-gal and Pax2 (E)
showed the close proximity of b-gal+ cells (white arrowhead) to Pax2+
interneurons (unfilled arrowhead) but no double-labelled cells were
observed. Double immunofluorescence for b-gal and NeuN showed b-
gal+ cells (white arrows) located outwith the IGL. (A,C counterstained
with hematoxylin and D–F with Topro3. Scale bars: A = 500 mm, B–
C= 100 mm, D–E= 50 mm).
doi:10.1371/journal.pone.0023012.g003
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gal+ cells we performed double immunofluorescence experiments
between b-galactosidase and a number of marker proteins known
to label specific cerebellar cell types.
The transcription factor Pax2 is expressed in committed
cerebellar interneurons after their exit from the ventricular zone
and prior to their terminal differentiation [15]. Thus, colocalisa-
tion between Pax2 and b-galactosidase would indicate that
committed interneuron progenitors were responding to a Wnt/
b-catenin signal. The pattern of Pax2 expression identified at all
three stages analysed was consistent with that expected for
interneuron precursors. However, although many b-gal+ and
Pax2+ cells were observed in the same cell layers, often in close
proximity to each other, no colocalisation was observed in any
sections analysed (Fig. 3E, 4E, 5C).
The b-gal+ cells in the IGL, PCL and ML could also be
migratory post-mitotic granule cells, exiting the EGL towards their
final destination in the IGL. However, double immunofluores-
cence between b-galactosidase and NeuN, a marker for post-
mitotic granule cells [38], did not reveal any colocalisation of the
two proteins in any sections analysed (Fig. 3F, 4F, 5D). Thus,
Wnt/b-catenin signalling appears unlikely to be directly involved
in the migration of post-mitotic granule cells.
Many b-gal+ cells were clearly localised to the PCL, suggesting
the possibility that Purkinje cells may be responding to Wnt/b-
catenin signalling. However, no colocalisation was observed
between b-galactosidase and calbindin, a marker that clearly
identifies Purkinje cells from P10, at either P10 (Fig. 4G) or P21
(Fig. 5E). Interestingly, many of the b-gal+ cells in the PCL were in
close proximity to Purkinje cells, consistent with the location of
Bergmann glia.
To determine whether Wnt/b-catenin signalling indeed marks a
population of glial cells, we performed double immunofluores-
cence with s100b, a marker for Bergman glia and other astrocytes
from P10 [39]. As expected, we identified b-gal+/s100b+ cells in
the PCL at P10 (Fig. 4H) and P21 (Fig. 5F) consistent with the
conclusion that a population of Bergman glia respond to a Wnt/b-
catenin signal during development.
Discussion
In this study we have investigated the distribution of Wnt/b-
catenin signalling during development of the cerebellum from
E12.5 to P21 primarily using the BAT-gal Wnt reporter mouse
strain [35]. The specific roles played by Wnt/b-catenin signalling
during development of the cerebellum are not yet well char-
acterised. Here, we provide evidence for a specific and dynamic
spatio-temporal pattern of Wnt/b-catenin signalling through
different stages of cerebellum development (summarised in Fig. 6).
Wnt/b-catenin signalling is active at the rhombic lip but
not expansion or differentiation of GPCs
Our experiments revealed expression of the BAT-gal reporter at
the rhombic lip at E12.5 and early EGL at E14.5. The rhombic lip
gives birth to projection neurons of the deep cerebellar nuclei from
E10.5 to E12.5 [3] followed by GPCs and unipolar brush cells
from E12.5 onwards [4,5,6]. Because unipolar brush cells migrate
along a different path than the dorsal stream that forms the EGL,
we conclude that the BAT-gal reporter expression observed at
E12.5 and E14.5 is potentially limited to GPCs and late born
DCN neurons.
Consistent with this, a number of studies have identified
expression of Wnt1 at the rhombic lip and at the isthmus
[22,23,24,25,26] and loss of Wnt1 leads to a severe developmental
phenotype of the cerebellum, most likely due to a failure to
maintain the isthmus [27,28,29]. Due to the consistency between
the known expression pattern of Wnt1, and its proven role as a key
signalling molecule in this area, it is possible that Wnt1 activity is
responsible for the active Wnt/b-catenin signalling at the
embryonic isthmus and rhombic lip identified in our experiments.
However, it remains to be established whether additional Wnt
genes are expressed in this area.
While active Wnt/b-catenin signalling was observed in the early
migrating GPCs at E14.5 (Fig. 1A–B), this was lost in the GPCs
observed in the EGL during later stages of development. By E18.5,
BAT-gal expression within the EGL was minimal and from P1
onwards, it was undetectable (Fig. 2A–D). These data are
consistent with a potential role for Wnt/b-catenin signalling
during early specification of GPCs but not in their further
migration or proliferation. This is consistent with the fact that
proliferation of this cell population during late embryogenesis and
early postnatal development is driven by Sonic hedgehog secreted
by neighbouring Purkinje cells [18,19].
Additionally, the absence of NeuN expression in any of the b-
gal+ cells observed from P5-P21 demonstrates that Wnt/b-catenin
signalling is also not active in the migration of terminally
differentiated GCs from the EGL to the IGL. (Fig. 3E, 4E, 5D).
NeuN is abundantly expressed in most classes of neurons [38] and
has been identified in all stages of post-mitotic granule cell
development [40]. Thus, the lack of NeuN expression in b-gal+
Figure 5. BAT-gal expression in the P21 cerebellum. (A) DAB
immunohistochemistry for b-gal in the P21 cerebellum. (B) Higher
magnification of the region boxed in (A) reveals that BAT-gal reporter
expression is largely restricted to the PCL (black arrowheads), with few
b-gal+ cells observed in other layers. Double immunofluorescence
experiments confirmed this localisation of b-gal+ cells (C–F). Double
immunofluorescence for Pax2 (C), NeuN (D) and Calbindin (E) show the
b-gal+ cells (white arrows) located in the PCL do not express markers of
interneurons, granule neurons or PCs respectively. (F) Colocalisation
with glial marker s100b confirms the identity of these cells as Bergmann
glia (white arrows). (A–B are counterstained with hematoxylin and C–F
with Topro3. Scale bars: A = 500 mm, B = 100 mm, C–F= 50 mm).
doi:10.1371/journal.pone.0023012.g005
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cells located in these regions indicates that they are not of the
granule lineage.
A potential role for Wnt/b-catenin signalling in
development of cell lineages from the cerebellar
ventricular zone
At E18.5 and P1, many b-gal+ cells were seen in the ventricular
zone (Fig. 2), although none were found there earlier (Fig. 1). This
indicates that Wnt/b-catenin signalling is active in cell lineages
originating at the ventricular zone at these time points. Purkinje cells
arise at the onset of cerebellar neurogenesis between E10.5 and
E12.5 [8,9]. The interneuron lineage can then be detected by the
expression of Pax2 in scattered cells at the ventricular zone from
E13.5 to E17.5 [15] from where they migrate radially as Pax2+
lineage restricted progenitors [14,15]. Concurrently, gliogenesis
begins at the ventricular zone from E13.5, identified through the
expression of S100b, BLBP and Sox9 [41]. The early Bergmann
glial population exits the ventricular zone at E14.5 and follows a
migratory path behind Purkinje cells [10]. Birth of the remaining
cerebellar glial populations (astrocytes and oligodendrocytes) follows
from this point. Our data suggest that the cell populations born at
the ventricular zone between E18.5 and P1 could be doing so in
response to a Wnt/b-catenin signal. Based upon the timing of
known cell populations arising from the ventricular zone, this is
most likely limited to glial and interneuron progenitors.
Wnt/b-catenin signalling may persist in the glial
population throughout postnatal cerebellum
development
Further to the identification of b-gal+ cells at the ventricular
zone, we also observed a population of b-gal+ cells within all other
layers of the cerebellum (excluding the EGL) from E18.5 through
to P21. Lack of colocalisation between b-galactosidase and Pax2
(Fig. 3E, 4E, 5C), NeuN (Fig. 3F, 4F, 5D) and Calbindin (Fig. 4G,
5E) ruled out the possibility of the b-gal+ cell population being of
the interneuron, granule or Purkinje cell types respectively.
The remaining alternative is that the b-gal+ cell population
identified within the developing cerebellum are glia. Oligoden-
drocytes are thought to arise from extra-cerebellar tissue [42], while
velate and fibrous astrocytes arise from ventricular zone derived
WM progenitor cells. Bergmann glia are thought to follow a slightly
different developmental path. Rather than arising during gliogenesis
from WM progenitors like the rest of the astrocyte lineage, a
population of early Bergmann glia arise from the ventricular zone
and migrate in close proximity to - and remain developmentally
intertwined with - Purkinje cells [10]. This wave of migration occurs
from E14.5 onwards, and by E18.5 these glia come to lie in a pattern
similar to that seen for some of the b-gal+ cell population we
identified, outlining the developing folia inferior to the EGL. A b-
gal+ cell population in this pattern was seen at all postnatal stages,
though the number of labelled cells appears to decrease with age.
While limitations of the antibody used mean we were unable to
confirm the identity of this cell population prior to P5, colocalisation
of b-galactosidase with s100b in cells present in close proximity to
Purkinje cells at both P10 (Fig. 4G) and P21 (Fig. 5F) supports the
hypothesis that some Bergmann glia respond to a Wnt/b-catenin
signal during development. Expression of LacZ mRNA identified at
all stages except for P21 supports a potential role for Wnt/b-catenin
signalling during development, and would suggest that residual b-
galactosidase protein has been identified at P21.
Interestingly, the lack of b-galactosidase expression at the
ventricular zone at E14.5 indicates that Wnt/b-catenin signalling
is not involved in the birth of the Bergmann glia but may be
potentially involved in its further development and maturation.
This is consistent with the postnatal dynamic transformation of
Bergmann glia alongside dendritogenesis and synaptogenesis of
Purkinje cells [11] and suggests a possible role for Wnt/b-catenin
in this process.
Relevance to the developmental origins of
medulloblastoma
We have shown that Wnt/b-catenin signalling is active in a
highly dynamic and varied spatiotemporal pattern during key
stages of cerebellum development. Surprisingly, Wnt/b-catenin is
also active in a subset of Bergmann glia in the postnatal
cerebellum. How these results relate to the development of
medulloblastoma is confounded by recent findings by Gibson al
Figure 6. Summary of Wntb-catenin signalling during cerebellum development. Wnt/b-catenin signalling is present in a dynamic spatio-
temporal specific pattern in the developing cerebellum. Initially it is observed at the cerebellar rhombic lip but by E18.5 its expression expands into a
more widespread pattern with particularly strong expression at the VZ during the birth of glia and interneurons. During postnatal development it is
largely restricted to the PCL, consistent with a subpopulation of Bergmann glia.
doi:10.1371/journal.pone.0023012.g006
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[34]. These authors provide evidence that constitutive activation
of the Wnt/b-catenin pathway in BLBP expressing cerebellar
precursors causes a defect in cell migration from the lower
rhombic lip - which manifests eventually as medulloblastoma if
tumour suppressor TP53 is also deactivated - while cell
populations arising from the ventricular zone and rhombic lip
do not show evidence for any developmental defect. Interestingly,
we found BAT-gal and Axin2 expression in the lower rhombic lip
(Fig. 1) supporting their conclusion that the lower rhombic lip is a
Wnt responsive area. However, our findings that Wnt/b-catenin
signalling activity is in the upper rhombic lip and in cells arising
from the ventricular zone now warrants more in depth functional
investigation to determine the role of this pathway in development
of these cell populations.
Methods
Mice
The licence authorising this work was approved by the
University of Edinburgh’s Ethical Review Committee on 22nd
September 2008 (application number PL35-08) and by the Home
Office on 6th November 2008. Animal husbandry was in
accordance with the UK Animals (Scientific Procedures) Act
1986 regulations. To minimise animal suffering, pregnant dams
were culled by cervical dislocation under terminal anaesthesia
according to the Code of Practice for Humane Killing of Animals
under Schedule 1 to the Animals (Scientific Procedures) Act 1986
issued by the Home Office. The day the vaginal plug was detected
was designated E0.5 and the day of birth as P0. BAT-gal mice
were maintained on a C57BL/6J genetic background and were
genotyped as described previously [35]. Wild type mice on the
same background were obtained by crossing mice hemizygous for
the BAT-gal transgene and used as negative controls.
Histology
Embryos were collected at E12.5 and E18.5 and pups between P1
and P21. Whole E12.5 embryos, heads from E14.5 embryos and
brains dissected from E18.5 embryos were immersion fixed in 4%
paraformaldehyde (PFA) in phosphate buffered saline (PBS)
overnight at 4uC. P1, 5, 10 and 21 pups were anaesthetised with
Avertin and transcardially perfused with PFA, followed by tissue
dissection and overnight immersion fixation in fresh PFA. Embryonic
and postnatal tissue for immunohistochemistry and immunofluores-
cence were all processed following standard conditions [43],
embedded in paraffin wax and cut in serial 10 mm sections on a
sagittal plane. Tissue for in situ hybridisation was cryoprotected in
30% sucrose/PBS overnight before embedding in 30% sucrose/
OCT (1:1) and snap freezing. Frozen sections were cut on a cryostat
at 14 mm. At least two animals were analysed at each age.
Immunohistochemistry, immunofluorescence and in situ
hybridisation
Immunohistochemistry and immunofluorescence were performed
according to standard protocols. Antigen retrieval was achieved by
microwaving sections at full power in 10 mM citrate buffer (pH6.0)
for five minutes followed by 15 minutes at medium power. Primary
antibodies were rabbit anti-b-galactosidase (Molecular Probes,
1:1000 for immunohistochemistry, 1:500 for immunofluorescence),
mouse anti-b-galactosidase (DSHB, 1:500), mouse anti-PCNA
(Abcam, 1:500), mouse anti-Pax2 (Covance, 1:200), mouse anti-
NeuN (Millipore, 1:500), mouse anti-Calbindin (Swant, 1:500),
mouse anti-s100b (Abcam, 1:500). Secondary non-fluorescent
antibodies were biotinylated anti-rabbit IgG (Dako, 1:200).
For single immunohistochemistry experiments the dark brown
signal was revealed after incubation with the ABC kit (Vector),
followed by a diaminobenzidine (DAB) and hydrogen peroxide
reaction using the DAB detection kit (Vector). For double
immunofluorescence experiments, all primary antibodies were
detected using goat anti-rabbit IgG or goat anti-mouse IgG
secondary antibodies conjugated to Alexa fluor 568 or 488 dyes
(Invitrogen, 1:200) respectively. Appropriate controls were used in
all cases by incubating sections with all but the primary antibodies.
No staining was observed under these conditions.
In situ hybridisation on frozen section was performed as
described previously [44]. LacZ and Axin2 antisense riboprobes
[45] were labelled using the digoxigenin RNA labelling kit (Roche)
according to the manufacturer’s instructions.
Microscopy
A Leica brightfield microscope connected to a Leica DFC 480
digital camera was used to capture images of DAB labelled
sections. A Leica brightfield microscope connected to a Leica
DFC360Fx camera was used to capture images of fluorescently
labelled sections.
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